amending Decree of the Ministry of Health No 57 / 1997 Coll., laying down the medicinal products fully covered by the public health insurance and the amount of the payments of individual active substances, as amended
According to § 15 (5) of Act No. 48 / 1997 Coll., on Public Health Insurance and on the amendment and addition of certain related laws, the Ministry of Health provides for:
Decree No. 57 / 1997 Coll., No 220 / 1997 Coll., No 317 / 1997 Coll., No 72 / 1998 Coll., No 133 / 1998 Coll., No 209 / 1998 Coll., No 291 / 1998 Coll., No 59 / 1999 Coll., No 117 / 1999 Coll., No 199 / 1999 Coll., No 295 / 1999 Coll., No 53 / 2000 Coll., No 144 / 2000 Coll. is amended as follows:
Section B of Annex No 2, which lists the medicinal products fully covered by the health insurance and the level of the reimbursement of each active substance, reads as follows:
"Medicinal products fully covered by public health insurance and the amount of the reimbursement of individual active substances
| 1 | A01AA | léčiva k profylaxi zubního kazu (fluorid sodný) | p.o. | |
| 1.1 | A01AA01 | fluorid sodný | p.o. | 1.1 | MG | 0,88 | |
| 64958 | ZYMAFLUOR 1/4MG | tbl 200x0.55mg | NCH | CH |
| 00211 | NATRIUM FLUORATUM SLOVAKOFARMA | tbl 250x0,55mg | SLO | SK |
| 2 | A01AB | protiinfekční léčiva pro lokální aplikaci | lok. | H |
| 2.1 | A01AB10 | Natamycin | lok. | 20 | MG | 7,48 | |
|
| 2.2 | A01AB03 | Chlorhexidin | lok. | 100 0 | ML | 178,70 | H |
| 3 | A01AC | kortikosteriody pro lokální aplikaci | lok. | L/DER,STO, ORL |
| 3.1 | A01AC01 | triamcinolon | lok. | 1 | GM | 13,69 | L/DER,STO,ORL |
|
| 3.2 | A01AC02 | dexametason | lok. | 1 | GM | 11,68 | L/DER,STO,ORL |
| 4 | A02A | adsorbční antacida | p.o. | |
| 4.1 | A02AD | kombinace hliníku, vápníku a hořčíku (pevné lékové formy) | p.o. | 10 | DF | 7,54 | |
| 00156 | GASTROGEL SLOVAKOFARMA | tbl 50x500mg | SLO | SK |
| 4.2 | A02AD | kombinace hliníku, vápníku a hořčíku (tekuté lékové formy) | p.o. | 50 | ML | 7,54 | |
|
| 4.3 | A02AD01 | kombinace hliníku, vápníku a hořčíku (obvyklé kombinace solí – pevné lékové formy) | p.o. | 10 | DF | 7,54 | |
|
| 4.4 | A02AD01 | kombinace hliníku, vápníku a hořčíku (obvyklé kombinace solí – tekuté lékové formy) | p.o. | 50 | ML | 7,54 | |
|
| 4.5 | A02AD04 | hydrotalcit (pevné lékové formy) | p.o. | 10 | DF | 7,54 | |
|
| 4.6 | A02AD04 | hydrotalcit (tekuté lékové formy) | p.o. | 50 | ML | 7,54 | |
| 5 | A02BA | antiulceróza ze skupiny H2-antagonistů | p.o. | |
| 5.1 | A02BA01 | Cimetidin | p.o. | 0.80 | GM | 4,05 | |
| 87755 | CIMETIDINE CADILA | tbl obd 100x200mg | CAD | IND |
| 5.2 | A02BA02 | ranitidin nad 75 miligramů do 150 miligramů včetně v jedné tabletě | p.o. | 0.30 | GM | 4,05 | |
| 12346 | HISTAC 150 | tbl obd 20x150mg | RXY | IND |
| 96056 | RANISAN | tbl obd 30x150mg | PMP | CZ |
| 45321 | RANISAN | tbl obd 500x150mg | PMP | CZ |
| 91280 | RANITAL 150MG | tbl obd 30x150mg | LEK | SLO |
| 68844 | APO-RANITIDINE | tbl obd 100x150mg | APT | CND |
| 02777 | RANIITIN 150 | tbl obd 30x150mg | TRT | IND |
| 80541 | RANITIN 150 | tbl obd 100x150mg | TRT | IND |
| 56515 | ULRAN 150 | tbl obd 20x150mg | KRK | SLO |
| 5.3 | A02BA02 | ranitidin nad 150 miligramů v jedné tabletě | p.o. | 0.30 | GM | 3,85 | |
| 12347 | HISTAC 300 | tbl obd 10x300mg | RXY | IND |
| 02729 | RANIITIN 300 | tbl obd 30x300mg | TRT | IND |
| 80542 | RANITIN 300 | tbl obd 100x300mg | TRT | IND |
| 56515 | ULRAN 300 | tbl obd 30x300mg | KRK | SLO |
| 5.4 | A02BA03 | famotidin do 20 mg včetně v 1 tabletě | p.o. | 40 | MG | 4,05 | |
| 96193 | FAMOSAN | tbl obd 20x20 | PMP | CZ |
| 80537 | QUAMATEL 20 | tbl obd 28x20 mg | GED | H |
| 59595 | FAMOSAN 20MG | tbl 50x20mg | PMP | CZ |
| 47262 | FAMOSAN 20MG | tbl obd 500x20mg | PMP | CZ |
| 75832 | APO-FAMOTIDINE 20MG (LEKOVKA) | tbl obd 100x20mg | APT | CND |
| 5.5 | A02BA03 | famotidin nad 20 mg v 1 tabletě | p.o. | 40 | MG | 3,85 | |
| 96194 | FAMOSAN | tbl obd 20x40mg | PMP | CZ |
| 47263 | FAMOSAN 40MG | tbl obd 500x40mg | PMP | CZ |
| 80538 | QUAMATEL 40MG | tbl obd 14x40mg | GED | H |
| 67539 | ULCERAN 40 | tab. obd 500x40 mg | MOE | CY |
| 67537 | ULCERAN 40 | tab. obd 30x40 mg | MOE | CY |
| 67536 | ULCERAN 40 | tab. obd 10x40 mg | MOE | CY |
| 83206 | FAMOSAN | tbl obd 10x40mg | PMP | CZ |
| 75836 | APO-FAMOTIDINE 40MG (LEKOVKA) | tbl obd 100x40mg | APT | CND |
| 5.6 | A02BA04 | Nizatidin | p.o. | 0.30 | GM | 4,05 | |
|
| 5.7 | A02BA06 | Roxatidin | p.o. | 0.15 | GM | 4,05 | |
|
| 5.8 | A02BA07 | ranitidin bismut citrát | p.o. | 0.8 | GM | 30,01 | |
| 6 | A02BA | antiulceróza ze skupiny H2-antagonistů | parent. | H |
| 6.1 | A02BA01 | Cimetidin | parent. | 0.80 | GM | 32,06 | H |
| 91782 | LOCK - 2E | inj. 5x2 ml 100mg/1ml | CAD | IND |
| 59027 | LOCK - 2E | inj. 5x2 ml/200mg | CAD | IND |
| 6.2 | A02BA02 | Ranitidin | parent. | 0.30 | GM | 68,43 | H |
|
| 6.3 | A02BA03 | Famotidin | parent. | 40 | MG | 68,43 | H |
| 7 | A02BB | antiulceróza ze skupiny prostaglandinů | p.o. | Z |
| 7.1 | A02BB01 | Misoprostol | p.o. | 0.80 | MG | 47,36 | Z |
| 97404 | CYTOTEC | tbl 50x200rg | SEA | GB |
| 60435 | CYTOTEC | tbl 56x200rg | SEA | GB |
| 55825 | CYTOTEC | tbl 30x200rg | SEA | GB |
| 8 | A02BC | antiulceróza ze skupiny inhibitorů protonové pumpy | p.o. | L/GIT,INT |
| 8.1 | A02BC01 | omeprazol (do 10 mg v jedné dávce včetně) | p.o. | 20 | MG | 25,22 | L/GIT,INT |
| 53974 | HELICID 10 | cps 14x10mg | LEX | CZ |
| 57408 | HELICID 10 | cps 28x10mg | LEX | CZ |
| 8.2 | A02BC01 | omeprazol (nad 10 mg v jedné dávce) | p.o. | 20 | MG | 13,00 | L/GIT,INT |
| 03076 | LOMAC | cps 28x20mg | CIA | IND |
| 75974 | LOMAC | cps 14x20mg | CIA | IND |
| 53345 | GASEC-20 | cps 7x20mg | MHA | CH |
| 12507 | GASEC-20 | cps 14x20mg | MHA | CH |
| 53346 | GASEC-20 | cps 28x20mg | MHA | CH |
| 56500 | HELICID 20 | cps 14x20mg | LEX | CZ |
| 59897 | HELICID 20 | cps 28x20mg | LEX | CZ |
| 60160 | ULTOP | cps 14x20mg | KRK | SLO |
| 75166 | ORTANOL | cps 14x20mg | LEK | SLO |
| 70933 | ORTANOL | cps 28x20mg | LEK | SLO |
| 58224 | OMEPRAZOL-E | cps ent 7x20mg | EGI | H |
| 58225 | OMEPRAZOL-E | cps ent 14x20mg | EGI | H |
| 58226 | OMEPRAZOL-E | cps ent 28x20mg | EGI | H |
| 8.3 | A02BC02 | Pantoprazol | p.o. | 40 | MG | 13,00 | L/GIT,INT |
|
| 8.4 | A02BC03 | Lansoprazol | p.o. | 30 | MG | 13,00 | L/GIT,INT |
|
| 8.5 | A02BC05 | esomeprazol (do 20mg v jedné dávce včetně) | p.o. | 20 | MG | 12,61 | L/GIT,INT |
|
| 8.6 | A02BC05 | esomeprazol (nad 20mg v jedné dávce ) | p.o. | 20 | MG | 6,50 | L/GIT, INT |
| 9 | A02BC | antiulceróza ze skupiny inhibitorů protonové pumpy | parent. | H |
| 9.1 | A02BC01 | Omeprazol | parent. | 20 | MG | 185,06 | H |
| 76644 | LOSEC 40 MG PRO INFUS. | inj sic 5x40 mg | AST | S |
| 9.2 | A02BC02 | Pantoprazol | parent. | 40 | MG | 185,06 | H |
| 10 | A02BX | ostatní léčiva peptického vředu | p.o. | |
| 10.1 | A02BX | ostatní léčiva peptického vředu (bismut subsalicylat) | p.o. | 3 | DF | 22,29 | |
|
| 10.2 | A02BX02 | Sukralfát | p.o. | 4 | GM | 10,46 | |
| 91217 | VENTER | tbl 50x1 gm | KRK | SLO |
| 93131 | VENTER | gra 50x2gm | KRK | SLO |
| 10.3 | A02BX03 | Pirenzepin | p.o. | 0.1 | GM | 8,55 | |
| 91602 | GASTROZEPIN | tbl 50 (5x10) x 25 mg | SLO | SK |
| 10.4 | A02BX05 | zásaditý citronan bismutitý | p.o. | 0.48 | GM | 23,07 | |
| 11 | A02BX | ostatní léčiva peptického vředu | parent. | H |
| 11.1 | A02BX03 | Pirenzepin | parent. | 20 | MG | 105,58 | H |
| 12 | A02DA | antiflatulencia a spasmolytika ATC skupiny A03A | p.o. | |
| 12.1 | A02DA01 | silikony (pevné lékové formy) | p.o. | 0.50 | GM | 11,24 | |
| 91846 | CEOLAT | ctb 20x80mg | SVP | D |
| 12.2 | A02DA01 | silikony (tekuté lékové formy) | p.o. | 0.50 | GM | 19,89 | |
| 55950 | SAB SIMPLEX | sus 50x15ml(sacky) | PDA | D |
| 93500 | SAB SIMPLEX | sus 1x30ml | PDA | D |
| 84580 | LEFAX | sus 1x50ml | ASH | D |
| 12.3 | A03AA04 | Mebeverin | p.o. | 0.30 | GM | 4,94 | |
|
| 12.4 | A03AA05 | Trimebutin | p.o. | 0.30 | GM | 4,94 | |
|
| 12.5 | A03AX58 | Alverin | p.o. | 0.18 | GM | 4,94 | |
| 13 | A03AB | anticholinergika s kvarterní oniovou skupinou | p.o. | |
| 13.1 | A03AB03 | Oxyfenon | p.o. | 25 | MG | 2,30 | |
|
| 13.2 | A03AB06 | otilonium bromid | p.o. | 0.12 | GM | 12,42 | |
|
| 13.3 | A03AB11 | Poldin | p.o. | 12 | MG | 2,30 | |
|
| 13.4 | A03AB20 | trospium chlorid | p.o. | 40 | MG | 12,42 | |
| 12528 | SPASMEX 15 | tbl 50x15mg | PFL | D |
| 12527 | SPASMEX 15 | tbl 30x15mg | PFL | D |
| 12525 | SPASMEX 5 | tbl 30x5mg | PFL | D |
| 14 | A03AD | muskulotropní spasmolytika | p.o. | |
| 14.1 | A03AD01 | Papaverin | p.o. | 0.1 | GM | 0,68 | |
|
| 14.2 | A03AD02 | Drotaverin | p.o. | 0.1 | GM | 4,94 | |
| 02551 | NO-SPA | tbl 20x40mg | CHN | H |
| 46627 | NO-SPA FORTE | tbl 10x80mg | CHN | H |
| 46628 | NO-SPA FORTE | tbl 20x80mg | CHN | H |
| 15 | A03AD | muskulotropní spasmolytika | parent. | |
| 15.1 | A03AD01 | Papaverin | parent. | 0.1 | GM | 17,94 | |
| 03576 | PAPAVERIN SPOFA | inj. 10x2 ml/60 mg | SPX | CZ |
| 15.2 | A03AD02 | Drotaverin | parent. | 0.1 | GM | 25,32 | |
| 59649 | NO-SPA | inj 5x4 ml/80 mg | CHN | H |
| 16 | A03BA | alkaloidy beladony s terciální aminovou skupinou | p.o. | |
| 16.1 | A03BA01 | Atropin | p.o. | 1.5 | MG | 0,49 | |
| 17 | A03BA | alkaloidy beladony s terciální aminovou skupinou | parent. | |
| 17.1 | A03BA01 | atropin (1 mg a více v 1 ampuli) | parent. | 1.5 | MG | 7,91 | |
| 00394 | ATROPIN BIOTIKA 1MG | inj 10x1ml/1mg | HBS | SK |
| 17.2 | A03BA01 | atropin (do 1mg v 1 ampuli) | parent. | 1.5 | MG | 15,15 | |
| 00392 | ATROPIN BIOTIKA 0.5MG | inj 10x1ml/0.5mg | HBS | SK |
| 18 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | p.o. | |
| 18.1 | A03BB01 | Butylskopolamin | p.o. | 60 | MG | 14,31 | |
| 01317 | BUSCOPAN | drg 20x10 mg | BOE | D |
| 19 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | p.rect. | |
| 19.1 | A03BB01 | Butylskopolamin | p.rect. | 60 | MG | 14,66 | |
| 20 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | parent. | |
| 20.1 | A03BB01 | Butylskopolamin | parent. | 60 | MG | 38,16 | |
| 98169 | BUSCOPAN | inj 5x1ml/20mg | BOE | D |
| 21 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | p.o. | |
| 21.1 | A03DA | syntetická anticholinergika v komb. s analgetiky | p.o. | 2 | DF | 3,96 | |
|
| 21.2 | A03DA02 | pitofenon kombinace s analgetiky (pevné lékové formy) | p.o. | 2 | DF | 3,96 | |
| 21.3 | A03DA02 | pitofenon kombinace s analgetiky (tekuté lékové formy) | p.o. | 2 | ML | 5,28 | |
| 22 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | p.rect. | |
| 22.1 | A03DA02 | pitofenon kombinace s analgetiky | p.rect. | 2 | DF | 12,90 | |
| 23 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | parent. | |
| 23.1 | A03DA02 | pitofenon kombinace s analgetiky | parent. | 2 | DF | 46,00 | |
| 88709 | ALGIFEN | inj 5x5ml | HBS | SK |
| 24 | A03EA | spasmolytika, psycholeptika, analgetika v kombinaci | p.rect. | |
| 24.1 | A03EA | antispasmodika, psycholeptika, analgetika v komb. | p.rect. | 2 | DF | 12,17 | |
| 25 | A03FA | prokinetika (cisaprid) | p.o. | L/GIT,INT,PDD,PSY |
| 25.1 | A03FA02 | cisaprid (pevné lékové formy, nad 5 mg do 10 mg včetně v 1 tabletě) | p.o. | 30 | MG | 31,10 | L/GIT,INT,PDD,PSY |
|
| 25.2 | A03FA02 | cisaprid (pevné lékové formy, nad 10 mg v 1 tabletě) | p.o. | 30 | MG | 28,00 | L/GIT,INT,PDD,PSY |
|
| 25.3 | A03FA02 | cisaprid (tekuté lékové formy) s obsahem 1 mg v 1 ml | p.o. | 30 | MG | 44,58 | L/GIT,INT,PDD,PSY |
| 93392 | PREPULSID | sus 1x200ml | JAN | I |
| 25.4 | A03FA02 | cisaprid (tekuté lékové formy dělené - sáčky) | p.o. | 30 | MG | 31,10 | L/GIT,INT,PDD,PSY |
| 47213 | PREPULSID | sus 20x10ml sacky | JAG | I |
| 47214 | PREPULSID | sus 50x10ml sacky | JAG | I |
| 26 | A03FA | prokinetika (ostatní) | p.o. | |
| 26.1 | A03FA01 | metoclopramid hydrochlorid | p.o. | 30 | MG | 4,15 | |
| 56594 | MCP HEXAL 10 | tbl 20x10mg | FST | D |
| 56695 | MCP HEXAL 10 | tbl 50x10mg | FST | D |
| 56696 | MCP HEXAL 10 | tbl 100x10mg | FST | D |
| 56698 | MCP HEXAL KAPKY | gtt 1x100ml/400mg | WPH | D |
| 26.2 | A03FA03 | domperidon | p.o. | 30 | MG | 4,15 | |
|
| 26.3 | A03FA05 | alizaprid | p.o. | 0.15 | GM | 4,15 | |
|
| 26.4 | A03FA | Itoprid | p.o. | 0.15 | GM | 30,00 | |
|
| 26.5 | A03FA | tegaserod | p.o. | 12 | MG | 30,00 | |
| 27 | A03FA | prokinetika | p.rect. | |
| 27.1 | A03FA01 | metoclopramid | p.rect. | 30 | MG | 41,50 | |
|
| 27.2 | A03FA02 | cisaprid | p.rect. | 30 | MG | 48,92 | |
|
| 27.3 | A03FA03 | domperidon | p.rect. | 0.12 | GM | 41,50 | |
| 28 | A03FA | prokinetika | parent. | O |
| 28.1 | A03FA01 | metoclopramid | parent. | 30 | MG | 21,43 | O |
| 93105 | DEGAN | inj 50x2ml/10mg | LEK | SLO |
| 28.2 | A03FA05 | alizaprid | parent. | 0.15 | GM | 16,47 | O |
| 29 | A04AA | antiemetika ze skupiny serotoninových antagonistů | p.o. | X |
| 29.1 | A04AA01 | ondansetron (pevné lékové formy do 4 mg v jedné tabletě včetně) | p.o. | 16 | MG | 826,30 | X |
| 84744 | EMESET- 4 | tbl obd 1x6x4mg | CIA | IND |
| 84794 | EMESET- 4 | tbl obd 10x6x4mg | CIA | IND |
| 98170 | ZOFRAN | tbl 10x4mg | GLA | GB |
| 29.2 | A04AA01 | ondansetron (pevné lékové formy nad 4 mg v jedné tabletě) | p.o. | 16 | MG | 612,50 | X |
| 84443 | EMESET- 8 | tbl obd 1x6x8mg | CIA | IND |
| 84793 | EMESET- 8 | tbl obd 10x6x8mg | CIA | IND |
| 98177 | ZOFRAN | tbl 10x8mg | GLA | GB |
| 29.3 | A04AA01 | ondansetron (pevné rychle rozpustné lékové formy do 4 mg v jedné tabletě včetně) | p.o. | 16 | MG | 944,40 | X |
| 53485 | ZOFRAN ZYDIS 4MG | tbl sol 10x4mg | GOW | GB |
| 29.4 | A04AA01 | ondansetron (pevné rychle rozpustné lékové formy nad 4 mg v jedné tabletě) | p.o. | 16 | MG | 700,00 | X |
| 53486 | ZOFRAN ZYDIS 8MG | tbl sol 10x8mg | GOW | GB |
| 29.5 | A04AA01 | ondansetron (tekuté lékové formy) | p.o. | 16 | MG | 882,60 | X |
| 56050 | ZOFRAN | sir 1x50ml/40mg | GLP | GB |
| 29.6 | A04AA01 | ondansetron (léková forma čípků) | p.rect. | 16 | MG | 774,65 | X |
| 56742 | ZOFRAN | sup 1x16mg | GWE | F |
| 29.7 | A04AA02 | granisetron | p.o. | 2 | MG | 612,50 | X |
| 29.8 | A04AA03 | tropisetron | p.o. | 5 | MG | 612,50 | X |
|
| 29.9 | A04AA04 | dolasetron | p.o. | 200 | MG | 612,50 | X |
| 30 | A04AA | antiemetika ze skupiny serotoninových antagonistů | parent. | X |
| 30.1 | A04AA01 | ondansetron (do 4 mg v jedné ampuli včetně) | parent. | 16 | MG | 1326,60 | X |
| 84441 | EMESET | inj 5x2ml/4mg | CIA | IND |
| 80479 | ZOFRAN | inj 5x2ml 2mg/ml | GLA | I |
| 30.2 | A04AA01 | ondansetron (nad 4 mg v jedné ampuli) | parent. | 16 | MG | 1114,90 | X |
| 84442 | EMESET | inj 5x4ml/8mg | CIA | IND |
| 80480 | ZOFRAN | inj 5x4ml 2mg/ml | GLA | I |
| 30.3 | A04AA02 | granisetron | parent. | 3 | MG | 731,90 | X |
|
| 30.4 | A04AA03 | tropisetron (nad 2,5 mg v jedné ampuli) | parent. | 5 | MG | 731,90 | X |
| 66849 | NAVOBAN | inj 10x5ml | SAN | CH |
| 96863 | NAVOBAN | inj 1x5ml | SAN | CH |
| 30.5 | A04AA03 | tropisetron (do 2,5 mg včetně v jedné ampuli) | parent. | 5 | MG | 1259,60 | X |
| 56247 | NAVOBAN | inj 1x2ml/2mg | NPA | CH |
| 30.6 | A04AA04 | dolasetron | parent. | 100 | MG | 731,90 | X |
| 31 | A04AD | různá antiemetika | p.o. | |
| 31.1 | A04AD | různá antiemetika (theoklát embraminu) | p.o. | 50 | MG | 3,30 | |
| 88321 | MEDRIN | tbl 20x25mg | LEX | CZ |
| 31.2 | A04AD | různá antiemetika (theoklát moxastinu) | p.o. | 0.1 | GM | 3,32 | |
| 32 | A04AD | různá antiemetika | p.rect. | |
| 32.1 | A04AD01 | různá antiemetika (theoklát moxastinu) | p.rect. | 0.1 | GM | 9,38 | |
| 33 | A05AA | hepatika ze skupiny žlučových kyselin | p.o. | L/GIT,INF |
| 33.1 | A05AA01 | kyselina chenodeoxycholová | p.o. | 1 | GM | 21,46 | L/GIT,INF |
|
| 33.2 | A05AA02 | kyselina ursodeoxycholová | p.o. | 0.75 | GM | 27,08 | L/GIT,INF |
| 91017 | URSOFALK | cps 100x250mg | FAK | D |
| 97864 | URSOSAN | cps 50x250mg | PMP | CZ |
| 34 | A05AX | ostatní hepatika | p.o. | |
| 34.1 | A05AX | jiná léčiva onemocnění žlučníku (fenipentol) | p.o. | 3 | DF | 1,61 | |
| 00146 | FEBICHOL | cps 50x100mg | SLO | SK |
| 34.2 | A05AX02 | hymekromon | p.o. | 1.20 | GM | 5,96 | |
| 93157 | ISOCHOL (DRAZOVKA) | drg 30x400mg | LEX | CZ |
| 97881 | ISOCHOL (BLISTR 3X10) | drg 30x400mg | LEX | CZ |
| 35 | A05BA | léčiva onemocnění jater | p.o. | |
| 35.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | p.o. | 4 | DF | 11,73 | |
|
| 35.2 | A05BA | léčiva onemocnění jater (silymarin v kombinaci) | p.o. | 0.21 | GM | 5,81 | |
|
| 35.3 | A05BA03 | silymarin (do 70 mg včetně v jedné tabletě) | p.o. | 0.21 | GM | 5,81 | |
| 76762 | SILYMARIN AL 50 | drg 30x50mg | APA | D |
| 35.4 | A05BA03 | silymarin (nad 70 mg v jedné tabletě) | p.o. | 0.21 | GM | 4,40 | |
| 36 | A05BA | léčiva onemocnění jater | parent. | H |
| 36.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | parent. | 1 | DF | 43,64 | H |
| 92325 | ESSENTIALE N | inj. 5x5ml | NAT | D |
| 36.2 | A05BA03 | silymarin | parent. | 0.35 | GM | 2395,68 | H |
| 31341 | LEGALON SIL | inj sic 4x350mg | MAU | D |
| 37 | A06A | osmoticky působící nevstřebatelné cukry | p.o., p.rect. | L/GIT,INT,GER |
| 37.1 | A06AD10 | kombinace minerálních solí (k přípravě Golytelyho roztoku) | p.o. | 4 | DF | 242,70 | |
| 69482 | FORTRANS | plv 1x4 (sacky) | BEF | F |
| 37.2 | A06AD11 | laktulóza | p.o. | 6,7 | GM | 5,28 | L/GIT,INT,GER, PDD,CHI |
| 02816 | LACTULOSA INFUSIA | sir 1x500 ml 50% | IHO | CZ |
| 86612 | LACTULOSA INFUSIA | sir 1x250 ml 50% | IHO | CZ |
| 37.3 | A06AD12 | laktitol | p.o. | 10 | GM | 3,71 | L/GIT,INT,GER, CHI |
|
| 37.4 | A06AG10 | sorbitol v kombinaci s kont. laxativem | p.rect. | 2 | DF | 174,01 | |
| 92489 | YAL | Sol 10x 67.5ml | TRM | D |
| 38 | A07AA | střevní antimykotická léčiva | p.o. | |
| 38.1 | A07AA01 | neomycin | p.o. | 5 | GM | 609,91 | H |
|
| 38.2 | A07AA02 | nystatin | p.o. | 1.5 | MU | 5,96 | |
|
| 38.3 | A07AA03 | natamycin | p.o. | 0.3 | GM | 41,01 | |
| 02046 | PIMAFUCIN | tbl obd 20x100 mg | YEU | NL |
| 38.4 | A07AA11 | rifaximin | p.o. | 0.8 | GM | 75,00 | P |
The product is indicated for use in:
1) hepatic encephalopathy
2) Prophylaxis in colorectal surgery
3) pseudomembranose colitis
4) bacterial infections associated with non-specific inflammatory diseases of the bowel (Crohn 's disease and ulcerative colitis) susceptible to rifaximin.
| 44285 | NORMIX | tbl obd 12x200mg | ASW | I |
| 39 | A07EA | kortikosteroidy pro rektální aplikaci nebo působící v tlustém střevu | p.rect., p.o. | |
| 39.1 | A07EA06 | budesonid | p.rect. | 2 | MG | 250,00 | L/GIT,INT |
Treatment with oral budesonide is performed by a gastro-enterologist or an intern in an acute attack or chronic phase of Crohn 's disease, in particular where the need for steroid treatment occurs and the need to minimise their systemic effects.
| 83424 | ENTOCORT | enm 7x2mg | AST | S |
| 39.2 | A07EA06 | budesonid | p.o. | 9 | MG | 117,56 | P |
| 64786 | BUDENOFALK | cps ent 50x3mg | FAK | D |
| 64787 | BUDENOFALK | cps ent 100x3mg | FAK | D |
| 39.3 | A07EB01 | natrium kromoglykát | p.o. | 800 | MG | 75,10 | P |
Diagnosis demonstrates and treatment is indicated by an allergologist and a clinical immunologist based on an allergologic examination of skin possibly exposure tests or a specific IgE antibody: with proven food allergy with severe local or overall symptoms that cannot be fully corrected by elimination of food allergens.
| 93797 | NALCROM | cps 100x100mg | FIS | GB |
| 40 | A07EC | aminosalicylová kyselina a její deriváty | p.o. | L/GIT,INT |
Mesalazine powder - modified-release tablets:
It is a first-choice aminosalicylate in idiopathic intestinal inflammation (Crohn's disease) affecting the upper part of the digestive tract, the small intestine and the adjacent part of the colon (ileocolitis). It is not a first-choice aminosalicylate for the location of idiopathic intestinal inflammation in the colon, it is indicated here if other aminosalicylates fail.
| 40.1 | A07EC01 | sulfasalazin | p.o. | 2 | GM | 17,21 | L/GIT,INT,REV |
| 72968 | SALAZOPYRIN EN | tbl 100x500 mg | KBP | S |
| 04304 | SULFASALAZIN EN | tbl 100x500 mg | KRK | SLO |
| 02159 | SULFASALAZIN | tbl 50x500 mg | KRk | SLO |
| 40.2 | A07EC02 | mesalazin (potahované tablety) | p.o. | 1.5 | GM | 26,30 | L/GIT,INT |
| 93235 | SALOFALK 250 | tbl ent 100x250 mg | FAK | D |
| 75567 | SALOFALK 500 | tbl obd ent100x500mg | FAK | D |
| 40.3 | A07EC02 | mesalazin (tablety s řízeným uvolňováním) | p.o. | 1.5 | GM | 46,44 | P |
| 85929 | PENTASA SR 500 MG (LAHVIČKA) | tbl ret 100x500 mg | FEI | DK |
| 86616 | PENTASA SR 500 MG (BLISTR) | tbl ret 100x500 mg | FEI | DK |
| 41 | A07EC | aminosalicylová kyselina a její deriváty | p.rect. | L/GIT,INT |
| 41.1 | A07EC02 | mesalazin (enm.) | p.rect. | 1.5 | GM | 86,66 | L/GIT |
| 93770 | SALOFALK 4GM | enm 7x60gm | FAK | D |
| 76700 | ASACOL 4GM | enm 1x100ml/4gm | TLT | CH |
| 41.2 | A07EC02 | mesalazin (čípky do 250 mg včetně) | p.rect. | 1.5 | GM | 142,78 | L/GIT |
| 93239 | SALOFALK 250 | sup 30x250mg | FAK | D |
| 93238 | SALOFALK 250 | sup 10x250mg | FAK | D |
| 41.3 | A07EC02 | mesalazin (čípky nad 250 mg) | p.rect. | 1.5 | GM | 119,40 | L/GIT |
| 75568 | SALOFALK 500 | sup 10x500mg | FAK | D |
| 42 | A07FA | protiprůjmové mikroorganismy | p.o. | L/PDD,GIT,GER |
| 42.1 | A07FA01 | organismy produkující kyselinu mléčnou, tekuté lékové formy | p.o. | 2 | ML | 3,76 | L/PDD,GIT,GER |
| 09158 | HYLAK FORTE | gtt 1x30ml | MCK | D |
| 09159 | HYLAK FORTE | gtt 1x100ml | MCK | D |
| 42.2 | A07FA01 | organismy produkující kyselinu mléčnou, pevné lékové formy | p.o. | 4 | DF | 3,86 | L/PDD,GIT,GER |
|
| 42.3 | A07FA | protiprůjmové mikroorganismy (Escherichia coli) | p.o. | 1 | DF | 43,99 | L/PDD |
|
| 42.4 | A07BC05 | diosmectit (plv. susp.) | p.o. | 1 | DF | 3,86 | L/PDD |
| 43 | A09AA | Enzymové přípravky | p.o. | |
Treatment with Wobenzyme is indicated by an oncologist, surgeon or lymphologist in lymphoedema following radical surgery for malignancy.
| 43.1 | A09AA | Enzymové přípravky (s pankreatinem, dle lipázy) | p.o. | 5000 | U | 1,03 | |
| 04139 | PANZYNORM FORTE | drg 30 | KRK | SLO |
| 43.2 | A09AA | multienzymy (Wobenzym) | p.o. | 6 | DF | 8,80 | P |
|
| 43.3 | A09AA02 | multienzymy (dle lipázy, do 10.000 U v 1 tabletě včetně) | p.o. | 5000 | U | 1,47 | |
| 02420 | PANCREOLAN FORTE | tbl ent 30x220mg | LEX | CZ |
| 43.4 | A09AA02 | multienzymy (dle lipázy, nad 10.000 do 20.000 U včetně v jedné tabletě) | p.o. | 5000 | U | 1,45 | |
| 21362 | PANGROL 400 | tbl obd 48 | BCE | D |
| 43.5 | A09AA02 | multienzymy (dle lipázy, nad 10.000 do 20.000 U včetně v jedné tabletě) – formy mikropelet | p.o. | 5000 | U | 1,90 | |
|
| 43.6 | A09AA02 | multienzymy (dle lipázy, nad 20.000 U v jedné tabletě) | p.o. | 5000 | U | 1,61 | |
| 44 | A09AC | pepsin a kyselinotvorné látky | p.o. | |
| 44.1 | A09AC01 | pepsin a kyselinotvorné látky | p.o. | 2 | DF | 2,79 | |
| 45 | A10A | insuliny (rozpustné humánní) | parent. | L/DIA |
| 45.1 | A10AB01 | insulin lidský rychle účinkující 100 U/ml, cartridge | parent. | 40 | U | 26,20 | L/DIA |
| 92608 | HUMULIN R CARTRIDGE | inj 5x3ml/300ut | LIL | F |
| 96732 | HUMULIN R CARTRIDGE | inj 5x1.5ml/150ut | LIL | F |
| 45.2 | A10AB01 | insulin lidský rychle účinkující, lahv. | parent. | 40 | U | 18,85 | L/DIA |
| 40876 | INSULIN - HM R | inj 1x10ml/1 ku | LEX | CZ |
| 44576 | HUMULIN R 100 M.J./ML | inj 1x10ml/1ku | LIL | F |
| 97520 | HUMULIN R | inj 1x10ml/400ut | LIL | F |
| 45.3 | A10AB01 | insulin lidský rychle účinkující pro aplikaci do insulinových pump | parent. | 40 | U | 27,96 | L/DIA |
| 76316 | VELOSULIN HM | inj 1x10ml/1 ku | NOO | DK |
| 45.4 | A10AB04 | insulin-lispro krátce působící, lahv. | parent. | 40 | U | 28,28 | L/DIA |
|
| 45.5 | A10AB04 | insulin-lispro krátce působící, cartridge 100U/ML | parent. | 40 | U | 30,49 | Z |
|
| 45.6 | A10AB05 | insulin-aspart krátce působící, lahv. | parent. | 40 | U | 28,28 | L/DIA |
|
| 45.7 | A10AB05 | insulin-aspart krátce působící, cartridge 100U/ML | parent. | 40 | U | 30,49 | Z |
| 46 | A10A | insuliny (rozpustné monokomponentní) | parent. | |
| 46.1 | A10AB03 | insulin vepřový rychle účinkující | parent. | 40 | U | 16,52 | |
| 83725 | INSULIN-MONO N | inj 1x10ml/400ut | LEX | CZ |
| 47 | A10A | insuliny (suspenzní humánní) | parent. | L/DIA |
| 47.1 | A10AC01 | insulin lidský středně dlouze účinkující 100U/ml, cartridge | parent. | 40 | U | 26,20 | L/DIA |
| 92607 | HUMULIN N(NPH)CARTRIDGE | inj 5x3ml/300ut | LIL | F |
| 96713 | HUMULIN N(NPH)CARTRIDGE | inj 5x1.5ml/150ut | LIL | F |
| 47.2 | A10AC01 | insulin lidský středně dlouze účinkující, lahv. | parent. | 40 | U | 18,85 | L/DIA |
| 40875 | INSULIN-HM NPH | inj 1x10ml/1ku | LEX | CZ |
| 42468 | HUMULIN L | inj 1x10ml 40ut/ml | LIL | F |
| 44567 | HUMULIN N 100 M.J./ML | inj 1x10ml/1ku | LIL | F |
| 97521 | HUMULIN N | inj 1x10ml/400ut | LIL | F |
| 47.3 | A10AD01 | insulin lidský kombinace středně a rychle účinného 100U/ml, cartridge | parent. | 40 | U | 26,20 | L/DIA |
| 92604 | HUMULIN M2(20/80)CARTRIDGE | inj 5x3ml/300ut | LIL | F |
| 92605 | HUMULIN M3(30/70)CARTRIDGE | inj 5x3ml/300ut | LIL | F |
| 47.4 | A10AD01 | insulin lidský kombinace středně a rychle účinného, lahv. | parent. | 40 | U | 18,85 | L/DIA |
| 40878 | INSULIN-HM MIX 30 | inj 1x10ml/1ku | LEX | CZ |
| 44570 | HUMULIN M3(30/70) 100 M.J./ML | inj 1x10ml/1ku | LIL | F |
| 78283 | HUMULIN M2(20/80) | inj 1x10ml | LIL | F |
| 78284 | HUMULIN M3(30/70) | inj 1x10ml | LIL | F |
| 47.5 | A10AE01 | insulin lidský dlouhodobě účinkující | parent. | 40 | U | 18,85 | L/DIA |
| 78281 | HUMULIN U | inj 1x10ml 40ut/ml | LIL | F |
| 48 | A10A | insuliny (suspenzní monokomponentní) | parent. | |
| 48.1 | A10AC03 | insulin vepřový středně dlouze účinkující | parent. | 40 | U | 12,66 | |
| 83726 | INSULIN-MONO D | inj 1x10ml/400ut | LEX | CZ |
| 48.2 | A10AC30 | insulin kombinace zvířecí středně dlouze účinkující | parent. | 40 | U | 12,66 | |
| 83727 | INSULIN-MONO ID | inj 1x10ml/400ut | LEX | CZ |
| 48.3 | A10AE30 | insulin kombinace zvířecí dlouhodobě účinkující | parent. | 40 | U | 12,66 | |
| 49 | A10BA | léčiva snižující hladinu cukru ze skupiny derivátů biguanidu a inhibitorů alfa-glukosidáz | p.o. | |
| 49.1 | A10BA02 | metformin hydrochlorid | p.o. | 2 | GM | 7,33 | |
| 53961 | METFORMIN 850 LECIVA | tbl obd 50x850mg | LEX | CZ |
| 56503 | SIOFOR 500 | tbl obd 60x500mg | BCE | D |
| 56504 | SIOFOR 850 | tbl obd 60x850mg | BCE | D |
| 92477 | GLUCOPHAGE 850MG | tbl obd 30x850mg | LIP | F |
| 92478 | GLUCOPHAGE 850MG | tbl obd 100x850mg | LIP | F |
| 92694 | GLUCOPHAGE 500MG | tbl obd 50x500mg | LIP | F |
| 49.2 | A10BA03 | buformin | p.o. | 0.2 | GM | 3,47 | |
| 02558 | SILUBIN RETARD | drg 60x100 mg | GRU | D |
| 08498 | ADEBIT | tbl 40x50mg | CHN | H |
| 49.3 | A10BF01 | akarboza | p.o. | 0.3 | GM | 10,26 | |
|
| 49.4 | A10BG02 | rosiglitason | p.o. | 6 | MG | 63,00 | Z |
| 04025 | AVANDIA 4MG | tbl obd 28x4mg | SKM | F |
| 50 | A10BB | léčiva snižující hladinu cukru ze skupiny derivátů sulfonylmočoviny | p.o. | |
| 50.1 | A10BB01 | glibenklamid (do 1 mg v jedné tabletě včetně) | p.o. | 10 | MG | 2,30 | |
|
| 50.2 | A10BB01 | glibenklamid (nad 1 mg v jedné tabletě) | p.o. | 10 | MG | 0,93 | |
| 91783 | BETANASE | tbl 10x10x5mg | CAD | IND |
| 91880 | MANINIL 5 | tbl 120x5mg | BCE | D |
| 50.3 | A10BB01 | glibenklamid (mikronizované formy, do 1,75 mg včetně v jedné tabletě) | p.o. | 7 | MG | 1,37 | |
| 94523 | GLUCOBENE | tbl 120x1.75mg | MCK | D |
| 50.4 | A10BB01 | glibenklamid (mikronizované formy, nad 1,75 mg v jedné tabletě) | p.o. | 7 | MG | 0,93 | |
| 94525 | GLUCOBENE | tbl 120x3.5mg | MCK | D |
| 50.5 | A10BB02 | chlorpropamid | p.o. | 0.37 | GM | 0,78 | |
|
| 50.6 | A10BB03 | tolbutamid | p.o. | 1.5 | GM | 2,40 | |
| 00120 | DIRASTAN | tbl 5x10x500 mg | SLO | SK |
| 50.7 | A10BB04 | glibornurid | p.o. | 38 | MG | 4,79 | |
|
| 50.8 | A10BB05 | tolazamid | p.o. | 1 | GM | 2,49 | |
|
| 50.9 | A10BB07 | glipizid | p.o. | 10 | MG | 4,33 | |
| 87110 | ANTIDIAB | tbl obd 30x5 mg | KRK | SLO |
| 88628 | MINIDIAB | tbl 30x5 mg | PHA | I |
| 50.10 | A10BB08 | gliquidon | p.o. | 60 | MG | 5,82 | |
| 99336 | GLURENORM | tbl 30x30 mg | SLO | SK |
| 50.11 | A10BB09 | gliklazid | p.o. | 0.16 | GM | 6,90 | |
|
| 50.12 | A10BB12 | glymepirid do 2 mg v jedné tabletě včetně | p.o. | 2 | MG | 6,90 | |
|
| 50.13 | A10BB12 | glymepirid nad 2 mg v jedné tabletě | p.o. | 2 | MG | 5,86 | |
|
| 50.14 | A10BD02 | metformin a glibenklamid - kombinace | p.o. | 3 | DF | 5,85 | |
|
| 50.15 | A10BX02 | repaglinid | p.o. | 1 | DF | 5,00 | Z |
| 51 | A11CA | vitamin A a jeho deriváty | p.o. | |
| 51.1 | A11CA01 | retinol (vitamin A) | p.o. | 50 | KU | 1,17 | |
| 00347 | VITAMIN A SLOVAKOFARMA | cps 50x30ku | SLO | SK |
| 52 | A11CA | vitamin A a jeho deriváty | parent. | |
| 52.1 | A11CA01 | retinol (vitamin A) | parent. | 50 | KU | 10,75 | |
| 00396 | AXEROPHTHOL BIOTIKA | inj 5x1ml/50ku | BTA | SK |
| 53 | A11CC | vitamin D a jeho deriváty (kalcitriol) | p.o. | P |
Treatment is performed by an internist, endocrinologist, urologist, pediatrician and physician on the dialysis unit:
(a) treatment of renal osteodystrophy in patients with chronic renal insufficiency (particularly in patients on dialysis),
(b) vitamin D resistant curve treatment,
(c) treatment of vitamin D resistant osteomalacia,
(d) treatment with vitamin D and calcium-resistant hypoparathyroidism.
| 53.1 | A11CC04 | kalcitriol | p.o. | 1 | RG | 41,30 | P |
| 91548 | ROCALTROL | cps 30x0.25rg | HLR | CH |
| 91550 | ROCALTROL | cps 30x0.50rg | HLR | CH |
| 58255 | ROCALTROL 0.25MCG | cps 30x0.25rg | RPS | D |
| 58256 | ROCALTROL 0.50MCG | cps 30x0.50rg | RPS | D |
| 54 | A11CC | vitamin D a jeho deriváty (ostatní) | p.o. | |
| 54.1 | A11CC01 | ergokalciferol (tekuté lékové formy, do 200 U/ml včetně) | p.o. | 6 | KU | 13,10 | |
|
| 54.2 | A11CC01 | ergokalciferol (tekuté lékové formy, nad 200 U/ml) | p.o. | 6 | KU | 0,78 | |
| 00716 | INFADIN | gtt 1x10ml 10mg/1ml | SLO | SK |
| 54.3 | A11CC01 | ergocalciferol (pevné lékové formy) | p.o. | 6 | KU | 0,54 | |
|
| 54.4 | A11CC02 | dihydrotachysterol | p.o. | 1 | MG | 17,13 | |
| 94445 | TACHYSTIN | gtt 1x20ml/20mg | ANW | D |
| 54.5 | A11CC03 | alfakalcidol | p.o. | 1 | RG | 27,40 | P |
Treatment with alfakalcidol is performed by an internist, an endocrinologist, a urologist, a pediatrician and a physician in the dialysis unit:
(a) treatment of renal osteodystrophy in patients with chronic renal insufficiency (particularly in patients on dialysis),
(b) vitamin D resistant curve treatment,
(c) treatment of vitamin D resistant osteomalacia,
(d) treatment with vitamin D and calcium-resistant hypoparathyroidism.
| 54.6 | A11CC05 | cholekalciferol – tekuté lékové formy | p.o. | 0.5 | MG | 3,91 | |
|
| 54.7 | A11CC05 | cholekalciferol - pevné lékové formy | p.o. | 0.5 | MG | 1,04 | |
| 55 | A11CC | vitamin D a jeho deriváty (kalcitriol) | parent. | P |
Treatment is performed by an internist, endocrinologist, urologist, pediatrician or physician working on a dialysis unit:
treatment of severe forms of renal osteopathy not responding to oral treatment with calcitriol.
| 55.1 | A11CC04 | kalcitriol | parent. | 1 | RG | 174,20 | P |
| 76423 | CALCIJEX | inj 25x1ml/2rg | ABB | USA |
| 94426 | CALCIJEX | inj 25x1ml/1rg | ABB | USA |
| 56568 | CALCIJEX | inj 100x1ml/2rg | ABB | USA |
| 64631 | CALCIJEX 1MCG/ML | inj 25x1ml/1rg | ABN | CND |
| 64632 | CALCIJEX 2MCG/ML | inj 25x1ml/2rg | ABN | CND |
| 75281 | CALCIJEX | inj 100x1 ml/1rg | ABB | USA |
| 56 | A11CC | vitamin D a jeho deriváty (ostatní) | parent. | |
| 56.1 | A11CC01 | ergokalciferol | parent. | 6 | KU | 0,78 | |
| 00405 | CALCIFEROL BIOTIKA FORTE | inj 1x1ml/7.5mg | BTA | SK |
| 56677 | CALCIFEROL BIOTIKA FORTE | inj 5x1ml/7.5mg | BTA | SK |
| 56.2 | A11CC05 | cholekalciferol | parent. | 1 | KU | 0,93 | |
| 11093 | VIGANTOL 50000 | inj 5x1ml/1,25ml | MEC | D |
| 57 | A11DA | vitamin B1 a jeho deriváty | parent. | H |
| 57.1 | A11DA | thiamin (vit. B1), prostý | parent. | 75 | MG | 5,38 | H |
|
| 57.2 | A11DA01 | thiamin (vit. B1) | parent. | 50 | MG | 5,38 | H |
| 00616 | THIAMIN LECIVA | inj 10x2 ml/100 mg | LEX | CZ |
| 58.1 | A11GA01 | kyselina askorbová (vitamín C) | parent. | 0.2 | GM | 3,91 | H |
| 92729 | ACIDUM ASCORBICUM BIOTIKA | inj 5x5 ml/500 mg | HBS | SK |
| 92730 | ACIDUM ASCORBICUM BIOTIKA | inj 50x5 ml/500 mg | HBS | SK |
| 59 | A11HA | vitamin B2, B6 a E | parent. | H |
| 59.1 | A11HA02 | pyridoxin hydrochlorid (vitamín B6) | parent. | 0.16 | GM | 15,84 | H |
| 00584 | PYRIDOXIN LECIVA | inj 5x1 ml/50mg | LEX | CZ |
| 59.2 | A11HA03 | tokoferol (vitamín E, do 30 mg/ml včetně) | parent. | 0.2 | GM | 69,90 | H |
|
| 59.3 | A11HA03 | tokoferol (vitamín E, nad 30 mg/ml) | parent. | 0.2 | GM | 7,58 | H |
|
| 59.4 | A11HA04 | riboflavin (vitamín B2) | parent. | 20 | MG | 6,11 | H |
| 60 | A11JA | kombinace vitamínů | parent. | H |
| 60.1 | A11JA | kombinace vitamínů | parent. | 10 | ML | 121,42 | H |
| 94847 | VITALIPID N INFANT | inf 10x10 ml | KBP | S |
| 60.2 | A11DB | kombinace vitamínů (vitamin B1, B6, B12) | parent. | 10 | ML | 121,42 | H |
| 67072 | MILGAMMA N | inj 5x2ml | WGP | D |
| 61 | A12A | soli vápníku včetně kombinací vápníku a fluoru | p.o. | |
| 61.1 | A12CX | Jiné minerální produkty (na obsah vápníku) | p.o. | 0.5 | GM | 1,14 | |
| 61.2 | A12AA03 | glukonát vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 0,59 | |
| 00064 | CALCIUM SLOVAKOFARMA | tbl 50x500 mg | SLO | SK |
| 61.3 | A12AA04 | uhličitan vápenatý (na obsah vápníku) tablety | p.o. | 0.5 | GM | 2,95 | |
| 53439 | VITACALCIN TABLETY | tbl 60x250mg | SLO | SK |
| 70536 | TBL.CALCII CARBON.PRAEC.0.5 MVM | tbl 1000x0.5gm | MVM | CZ |
| 61.4 | A12AA04 | uhličitan vápenatý (na obsah vápniku), šumivé tabety, | p.o. | 0.5 | GM | 1,60 | |
|
| 61.5 | A12AA04 | uhličitan vápenatý(na obsah vápniku) prášky | p.o. | 0.5 | GM | 2,34 | |
|
| 61.6 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem | p.o. | 1 | DF | 5,28 | |
|
| 61.7 | A12AA07 | chlorid vápenatý (tekuté lékové formy, na obsah vápníku) | p.o. | 0.2 | GM | 0,64 | |
|
| 61.8 | A12AA12 | octan vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 10,00 | |
|
| 61.9 | A12AA20 | vápník (kombinace různých solí, na obsah vápníku) | p.o. | 0.5 | GM | 2,54 | |
|
| 61.10 | A12AX | vápník v kombinaci s fluorem (fluorofosfat sodný) | p.o. | 1 | DF | 5,38 | L/INT,GYN,ORT REV |
|
| 61.11 | A12AX | vápník v kombinaci s fluorem (levoglutamid fluorofosfat) | p.o. | 1 | DF | 4,01 | L/INT,GYN,ORT REV |
| 62 | A12AA | soli vápníku | parent. | |
| 62.1 | A12AA03 | glukonát vápenatý (na obsah vápníku) | parent. | 3 | GM | 59,93 | |
| 00407 | CALCIUM BIOTIKA | inj 10x10ml/1gm | HBS | SK |
| 62.2 | A12AA07 | chlorid vápenatý (na obsah vápníku) | parent. | 0.2 | GM | 2,98 | |
| 00409 | CALCIUM CHLORATUM BIOTIKA | inj 5x10 ml 10% | HBS | SK |
| 63.1 | A12BA | draslík v kombinaci s hořčíkem (na obsah draslíku) | p.o. | 1 | GM | 9,78 | |
|
| 63.2 | A12BA | draslík (na obsah draslíku) | p.o. | 1.5 | GM | 2,44 | |
|
| 63.3 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | p.o. | 3 | GM | 2,64 | |
| 91600 | KALNORMIN | tbl 30x1gm | IDA | H |
| 55661 | KALIUM CHLORATUM INFUSIA - BLISTR | tbl obd 100x500 mg | IHO | CZ |
| 64 | A12BA | soli draslíku | parent. | O |
| 64.1 | A12BA | draslík v kombinaci s hořčíkem | parent. | 1 | DF | 13,20 | O |
| 02132 | CARDILAN | inj 10x10 ml | HBS | SK |
| 02031 | TROMCARDIN | inj 5x10 ml | TRM | D |
| 64.2 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | parent. | 3 | GM | 50,54 | O |
| 02486 | KALIUM CHLORATUM LECIVA 7.5% | inj 5x10ml 7.5% | LEX | CZ |
| 65 | A12CC | soli hořčíku (na obsah hořčíku) | p.o. | L/INT,NEU,PSY |
| 65.1 | A12CC03 | glukonat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
|
| 65.2 | A12CC04 | citronan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
|
| 65.3 | A12CC05 | aspartat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
|
| 65.4 | A12CC06 | mléčnan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
| 70535 | TBL.MAGNESII LACTICI 0.5 MVM | tbl 1000x0.5gm | MVM | CZ |
| 65.5 | A12CC09 | orotat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
|
| 65.6 | A12CC30 | kombinace hořečnatých solí (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
| 99891 | MAGNESIUM 250MG PHARMAVIT | tbl eff 20 | PVI | H |
| 66 | A12CC | soli hořčíku | parent. | O |
| 66.1 | A12CC02 | síran hořečnatý (koncentrace do 10 % včetně) | parent. | 1 | GM | 20,38 | O |
| 00498 | MAGNESIUM SULFURICUM BIOTIKA | inj 5x10ml 10% | HBS | SK |
| 66.2 | A12CC02 | síran hořečnatý (koncentrace nad 10%) | parent. | 1 | GM | 10,31 | O |
| 00499 | MAGNESIUM SULFURICUM BIOTIKA | inj 5x10ml 20% | HBS | SK |
| 67.1 | A12CD01 | fluorid sodný | p.o. | 88 | MG | 4,06 | |
| 09495 | OSSIN RETARDDRAGEES | tbl obd 100x40mg | GRU | D |
| 68 | A14A | anabolické steroidy | parent. | |
| 68.1 | A14AB01 | nandrolon phenpropionát | parent. | 2 | MG | 2,98 | |
| 00609 | SUPERANABOLON | inj 5x1ml/25mg | SPX | CZ |
| 69 | A16A | ostatní léčiva alimentárního traktu | parent. | O |
| 69.1 | A16AA01 | levokarnitin | parent. | 2 | GM | 356,82 | O |
| 69.2 | A16AX01 | tioktová kyselina | parent. | 0.2 | GM | 94,19 | O |
| 86092 | THIOCTACID 600 T | inj 5x24ml/600mg | ASD | D |
| 45320 | THIOCTACID 600 T | inj 5x24ml/600mg | HOD | D |
| 55380 | THIOGAMMA 600 INJECT | inj 20x20ml/600mg | SLH | D |
| 55381 | THIOGAMMA 600 INJECT | inj 500x20ml/600mg | SLH | D |
| 84378 | THIOGAMMA 600 INJECT | inj 5x20ml/600mg | SLH | D |
| 84379 | THIOGAMMA 600 INJECT | inj 10x20ml/600mg | SLH | D |
| 84380 | THIOGAMMA 600 INJECT | inj 50x20ml/600mg | SLH | D |
| 84381 | THIOGAMMA 600 INJECT | inj 100x20ml/600mg | SLH | D |
| 84382 | THIOGAMMA 600 INJECT | inj 1000x20ml/600mg | SLH | D |
| 69.3 | A16AA02 | ademetionin | parent. | 0,5 | GM | 108,54 | Z |
| 12319 | TRANSMETIL 500 MG | inj 5x500mg+5ml | KNO | I |
| 69.4 | A16AA02 | ademetionin | p.o. | 1 | GM | 59,83 | Z |
|
| 69.5 | A16AB02 | imiglucerasa | parent. | 200 | U | 40341,80, | Z |
|
| 69.6 | A08AA10 | sibutramin | p.o. | 10 | MG | 98,00 | P |
|
| 69.7 | A08AB01 | orlistat | p.o. | 360 | MG | 98,00 | P |
Sibutramine and orlistat prescribe diabetic patients with type 2 diabetes mellitus and BMI above 35 who are diagnosed with arterial hypertension (according to NYHA 1) requiring pharmacotherapy and / or pre-history of hyperlipoproteinaemia (see SPC for sibutramine), while in the selected patient there must be a weight decrease of at least 2 kg over 4 weeks in the use of sole directional (dietary and motion) measures; if, within an additional 4 weeks, the patient fails to develop this weight loss while following the regimen measures, or at least to maintain it, he is indicated for the treatment of antiobesity. Tolerance of anti-obesity treatment is evaluated 4 weeks after the start of treatment, 3 months after the start of anti-obesity treatment is evaluated for the effectiveness of this treatment. The efficacy criteria for anti-obesitic therapy and continuation of treatment are at least 2 of the following parameters: a further decrease in body weight of at least 5%, a decrease in fasting glucose of at least 0,5 mmol / l compared to the pre-treatment condition, a decrease in HbA1c of at least 5% of baseline, dose reduction of basic antidiabetic medication. Treatment with antiobesity is indicated for a maximum of 12 months.
| 70 | B01AA | antithrombotika ze skupiny antagonistů vitaminu K | p.o. | |
| 70.1 | B01AA03 | warfarin | p.o. | 7.5 | MG | 3,60 | |
| 94114 | WARFARIN | tbl 100x5 mg | ORN | SF |
| 94113 | WARFARIN | tbl 100x3 mg | ORN | SF |
| 70.2 | B01AA08 | ethylbiskumacetát (do 75 mg v jedné tabletě včetně) | p.o. | 0.6 | GM | 4,59 | |
|
| 70.3 | B01AA08 | ethylbiskumacetát (nad 75 mg v jedné tabletě) | p.o. | 0.6 | GM | 5,47 | |
| 71 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (antithrombin III) | parent. | U |
| 71.1 | B01AB02 | antithrombin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 2.1 | KU | 29367,29 | U |
|
| 71.2 | B01AB02 | antithrombin | parent. | 2.1 | KU | 29367,29 | U |
| 66533 | KYBERNIN P | inj 1x500ut+10ml aq | BEH | A |
| 66532 | KYBERNIN P | inj 1x1ku+20ml aqua | BEH | A |
| 85771 | KYBERNIN P | inj 1x500ut+10ml aq | CTO | D |
| 85772 | KYBERNIN P | inj 1x1ku+20ml aqua | CTO | D |
| 72 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (heparin) | parent. | O |
| 72.1 | B01AB01 | heparin | parent. | 10 | KU | 15,35 | O |
| 74999 | HEPARIN BIOCHEMIE 25000UT | inj 100x5ml/25ku | BCA | A |
| 93746 | HEPARIN LECIVA | inj 1x10ml/50ku | LEX | CZ |
| 00477 | HEPARIN RETARD LECIVA | inj 5x1ml/25ku | LEX | CZ |
| 73 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (ostatní) | p.o.,parent. | O |
| 73.1 | B01AB04 | dalteparin do 2,5 KU včetně v jedné ampuli | parent. | 3 | KU | 101,23 | O |
| 94857 | FRAGMIN | inj 10x0.2ml/2.5ku | PHA | S |
| 73.2 | B01AB04 | dalteparin nad 2,5 KU do 5 KU včetně v jedné ampuli | parent. | 3 | KU | 88,08 | O |
| 94858 | FRAGMIN | inj 10x0.2ml/5ku | PHA | S |
| 73.3 | B01AB04 | dalteparin nad 5 KU v jedné ampuli | parent. | 3 | KU | 64,67 | O |
| 94855 | FRAGMIN | inj 10x1ml/10ku | PHA | S |
| 94856 | FRAGMIN | inj 10x4ml/10ku | PHA | S |
| 73.4 | B01AB05 | enoxaparin do 20 mg včetně v jedné ampuli | parent. | 3 | KU | 101,23 | O |
|
| 73.5 | B01AB05 | enoxaparin nad 20 mg do 40 mg včetně v jedné ampuli | parent. | 3 | KU | 88,08 | O |
|
| 73.6 | B01AB05 | enoxaparin nad 40 mg do 80 mg včetně v jedné ampuli | parent. | 3 | KU | 81,87 | O |
|
| 73.7 | B01AB05 | enoxaparin nad 80 mg v jedné ampuli | parent. | 3 | KU | 64,67 | O |
|
| 73.8 | B01AB06 | nadroparin do 2,85 KU včetně v jedné ampuli | parent. | 3 | KU | 101,23 | O |
|
| 73.9 | B01AB06 | nadroparin nad 2,85 do 3,8 KU včetně v jedné ampuli | parent. | 3 | KU | 88,08 | O |
|
| 73.10 | B01AB06 | nadroparin nad 3,8 do 7,6 KU včetně v jedné ampuli | parent. | 3 | KU | 81,87 | O |
| 62402 | FRAXIPARINE | inj. 10x0,8ml/7,6ku | SWI | F |
| 73.11 | B01AB06 | nadroparin nad 7,6 KU do 10 KU v jedné ampuli včetně | parent. | 3 | KU | 64,67 | O |
|
| 73.12 | B01AB06 | nadroparin nad 10 KU v jedné ampuli | parent. | 3 | KU | 55,00 | O |
|
| 73.13 | B01AB07 | parnaparin do 3,2 KU v jedné ampuli včetně | parent. | 3 | KU | 88,08 | O |
| 76570 | FLUXUM 3200UT AXA | inj 6x0.3ml/3200ut | ASW | I |
| 73.14 | B01AB07 | parnaparin nad 3,2 do 4,250 KU včetně v jedné ampuli | parent. | 3 | KU | 80,89 | O |
| 56535 | FLUXUM 4250UI AXA | inj 6x0.4ml/4250ut | ASW | I |
| 73.15 | B01AB07 | parnaparin nad 4,250 KU v jedné ampuli | parent. | 3 | KU | 81,87 | O |
| 76571 | FLUXUM 6400UI AXA | inj 6x0.4ml/6400ut | ASW | I |
| 73.16 | B01AB08 | reviparin do 1,432 KU včetně v jedné ampuli | parent. | 3 | KU | 101,23 | O |
| 73.17 | B01AB08 | reviparin nad 1,432 KU v jedné ampuli | parent. | 3 | KU | 88,08 | O |
|
| 73.18 | B01AB11 | sulodexid | parent. | 600 | U | 63,44 | O |
|
| 73.19 | B01AB11 | sulodexid | p.o. | 250 | U | 12,46 | L/OPH,INT,NEU, DIA,GER |
|
| 73.20 | B01AB | certoparin | parent. | 3 | KU | 88,08 | O |
| 74 | B01AC | antiagregancia trombocytů | p.o. | P |
Treatment with ticlopidine and clopidogrel is performed by an internist, cardiologist or neurologist:
(a) allergy and evident intolerance to acetylsalicylic acid,
(b) numbness to acetylsalicylic acid detected by an aggregation test in a haematocoagulation laboratory;
(c) administration to patients following intervascular interventions (stents, PTCA, rotabulation, atherectomy, laser atheroplastics, etc.), usually in combination with acetylsalicylic acid for a limited period of time (usually one month after exercise).
Indobufen treatment is administered by an internist, cardiologist or neurologist:
(a) allergy and evident intolerance to acetylsalicylic acid,
(b) the need for only a short-term antiaggregation effect (e.g. prior to surgery).
Treatment with dipyridamol, including combination therapy, indicates a neurologist or intern for the secondary prevention of ischaemic stroke in patients who are intolerant to higher doses of acetylsalicylic acid or failure of antiplatelet therapy that is manifested by stroke.
| 74.1 | B01AC05 | ticlopidin | p.o. | 0.5 | GM | 30,40 | P |
| 66938 | TAGREN | tbl 30x250 mg | KRK | SLO |
| 74.2 | B01AC06 | kyselina acetylsalicylová (do 30 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,54 | |
| 72813 | ANOPYRIN 30MG | tbl 20x30mg | SLO | SK |
| 72812 | ANOPYRIN 30MG | tbl 50x30mg | SLO | SK |
| 74.3 | B01AC06 | kyselina acetylsalicylová (nad 100 do 150 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,98 | |
|
| 74.4 | B01AC06 | kyselina acetylsalicylová (nad 30 mg do 100 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,68 | |
| 99295 | ANOPYRIN 100MG | tbl 20x100mg | SLO | SK |
| 71960 | ANOPYRIN 100MG | tbl 50x100mg | SLO | SK |
| 01288 | GODASAL 100 | tbl 50 | PFL | D |
| 74.5 | B01AC07 | dipyridamol | p.o. | 400 | MG | 8,65 | P |
| 573811 | PERSANTIN | tbl obd 50 x 75 gm | BOE | D |
| 74.6 | B01AC10 | indobufen | p.o. | 0.3 | GM | 13,11 | P |
|
| 74.7 | B01AC | lysin acetylosalicylát (do 160 mg ekvivalentu kys. acetylosalicylové včetně v jedné dávce) | p.o. | 1 | DF | 0,68 | |
|
| 74.8 | B01AC04 | clopidogrel | p.o. | 75 | MG | 33,92 | P |
|
| 74.9 | B01AC | lysin acetylosalicylát (nad 160 mg ekvivalentu kys. acetylosalicylové v jedné dávce) | p.o. | 1 | DF | 0,64 | |
|
| 74.10 | B01AC30 | dipyridamol a kyselina acetylosalicylová v kombinaci | p.o. | 1 | DF | 12,00 | P |
| 75 | B01AC | antiagregancia trombocytů | parent. | H |
| 75.1 | B01AC07 | dipyridamol | parent. | 0.2 | GM | 224,45 | H |
|
| 75.2 | B01AC10 | indobufen | parent. | 0.3 | GM | 89,35 | H |
|
| 75.3 | B01AC13 | abciximab | parent. | 1 | DF | 15460,00 | H |
|
| 75.4 | B01AC11 | iloprost | parent. | 50 | RG | 660,60 | X |
|
| 75.5 | B01AC17 | tirofiban | parent. | 1 | DF | 8000,00 | H |
| 76 | B01AD | trombolytika | parent. | U |
Alteplase and urokinase at all workplaces:
(a) treatment for acute myocardial infarction who have been treated with streptokinase for the past 12 months or have a history of allergic reactions to streptokinase.
In workplaces which have specialised treatment in the contract with the health insurance company:
(a) intracoronary thrombolysis,
(b) thrombolysis of acute and subacute peripheral vessel closures.
| 76.1 | B01AD01 | streptokináza (do 0,75 MU včetně v jedné dávce) | parent. | 1.5 | MU | 3608,44 | U |
| 10937 | STREPTASE | inj sic 1x750 ku | BEH | D |
| 76.2 | B01AD01 | streptokináza (nad 0,75 MU v jedné dávce) | parent. | 1.5 | MU | 3426,91 | U |
| 94697 | KABIKINASE | inj sic 1x1.5mu | KBP | S |
| 62461 | STREPTASE | inj sic 1x1.5 MU | HMD | D |
| 76.3 | B01AD02 | alteplaza | parent. | 0.1 | GM | 43265,44 | U/P |
|
| 76.4 | B01AD04 | urokináza (do 100 KU v jedné dávce včetně) | parent. | 3 | MU | 53928,40 | U/P |
|
| 76.5 | B01AD04 | urokináza (nad 500 KU v jedné dávce) | parent. | 3 | MU | 42565,93 | U/P |
|
| 76.6 | B01AD04 | urokináza (nad 100 do 500 KU v jedné dávce včetně) | parent. | 3 | MU | 45346,56 | U/P |
|
| 76.7 | B01AD07 | retepláza | parent. | 20 | U | 43265,44 | U/P |
|
| 76.8 | B01AX03 | lepirudin | parent. | 1 | DF | 2300,00 | H |
| 77 | B02AA | antifibrinolytika ze skupiny aminokyselin | p.o. | |
| 77.1 | B02AA01 | kyselina aminokaproová | p.o. | 16 | GM | 38,86 | |
|
| 77.2 | B02AA02 | kyselina tranexámová (do 250 mg v jedné tabletě včetně) | p.o. | 2 | GM | 40,72 | |
|
| 77.3 | B02AA02 | kyselina tranexámová (nad 250 mg v jedné tabletě) | p.o. | 2 | GM | 38,57 | |
| 97410 | EXACYL | tbl fc 20x500mg | SFH | F |
| 97412 | EXACYL | sol 5x10 ml/1gm | KBP | S |
| 57480 | EXACYL | tbl obd 20x500 mg | SWP | P |
| 77.4 | B02AA03 | kyselina aminomethylbenzoová | p.o. | 0.25 | GM | 19,72 | |
| 02123 | PAMBA | tbl 10x250mg | CWO | D |
| 78 | B02AA | antifibrinolytika ze skupiny aminokyselin | parent. | |
| 78.1 | B02AA01 | kyselina aminokaproová | parent. | 16 | GM | 65,01 | |
|
| 78.2 | B02AA02 | kyselina tranexámová | parent. | 2 | GM | 63,74 | |
| 97411 | EXACYL | inj 5x5ml/500mg | SWI | F |
| 78.3 | B02AA03 | kyselina aminomethylbenzoová | parent. | 0.25 | GM | 192,40 | |
| 69793 | PAMBA | inj 5x5ml/50mg | CWO | D |
| 79 | B02AB | antifibrinolytika ze skupiny inhibitorů proteináz | parent. | H |
| 79.1 | B02AB01 | aprotinin | parent. | 500 | KU | 664,66 | H |
| 02787 | ANTILYSIN SPOFA | inj 5x10ml/100ku | SPX | CZ |
| 80 | B02BA | vitamin K a jeho deriváty a další lokální hemostyptika | p.o. | |
| 80.1 | B02BA01 | fytomenadion | p.o. | 20 | MG | 10,66 | |
| 00720 | KANAVIT | gtt 1x5ml 20mg/ml | SLO | SK |
| 80.2 | B02BX01 | etamsylat | p.o. | 0.75 | GM | 11,30 | L/OPH,HEM, ORL |
| 81 | B02B | vitamin K a jeho deriváty a další lokální hemostyptika | parent. | |
| 81.1 | B02BA | menadiolfosfat sodná sůl | parent. | 10 | MG | 14,27 | |
|
| 81.2 | B02BA01 | fytomenadion | parent. | 20 | MG | 15,84 | |
| 00489 | KANAVIT | inj 5x1ml/10mg | HBS | SK |
| 81.3 | B02BX01 | etamsylat | parent. | 0.75 | GM | 83,29 | O |
| 02213 | DICYNONE 250 | inj. 100x2ml/250mg | OML | CH |
| 01821 | DICYNONE 250 | inj. 20x2ml/250mg | OML | CH |
| 82 | B02BB | lidský fibrinogen | parent. | U |
| 82.1 | B02BB01 | lidský fibrinogen | parent. | 5 | GM | 5260,50 | U |
| 52772 | FIBRINOFEN IMMUNO I.V. | inj sic 1000mg + 50ml | IMM | A |
| 83 | B02BC | lokální hemostatika | lok. | |
| 83.1 | B02BC | lokální hemostatika (rektální lékové formy) | lok. | 1 | DF | 7,19 | |
| 88753 | SPOFAX (CIPKY HEMOSTAT.KON.) | sup 5x2.2gm | LEX | CZ |
| 83.2 | B02BC | lokální hemostatika (pěna) | lok. | 1 | C2 | 1,47 | |
|
| 83.3 | B02BC01 | absorbovatelná želatinová houba | lok. | 1 | C2 | 2,69 | |
|
| 83.4 | B02BC06 | thrombin (houba) | lok. | 1 | DF | 56,80 | |
|
| 83.5 | B02BC | lokální hemostatika – karboxycelulosa (zásyp) | lok. | 1 | GM | 15,40 | |
| 84 | B02BD | koagulační faktory (faktor VIII a faktor IX) | parent. | B/P |
Treatment with coagulation factor VIII is administered by a haematologist:
84) prevention and treatment of bleeding conditions in patients with congenital or acquired factor VIII deficiency,
(b) in patients with a low titre (up to 5 Bethesda units) inhibitor
(c) Pigs factor VIII is indicated in patients with high antibody titre against human factor VIII and low antibody titre against swine factor VIII.
Treatment with coagulation factor IX is administered by a haematologist:
prevention and treatment of bleeding conditions in patients with evidence of factor IX deficiency, possibly in patients with factor VIII inhibitor.
| 84.1 | B02BD02 | koagulační faktor VIII (středně čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 500 | U | 5083,42 | B/P |
|
| 84.2 | B02BD02 | koagulační faktor VIII (středně čištěný) | parent. | 500 | U | 5083,42 | B/P |
| 88800 | PORCINE FACTOR VIII:C(HYATE:C) | inj 20ml/400-700ut | SPY | GB |
| 84.3 | B02BD04 | koagulační faktor IX (středně čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 350 | U | 3284,67 | B/P |
|
| 84.4 | B02BD04 | koagulační faktor IX (středně čištěný) | parent. | 350 | U | 3284,67 | B/P |
|
| 84.5 | B02BD01 | kombinace koagulačních faktorů IX,II,VII a X | parent. | 350 | U | 3284,67 | B/P |
|
| 84.6 | B02BD02 | koagulační faktor VIII (vysoce čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 500 | U | 6109,88 | B/P |
|
| 84.7 | B02BD02 | koagulační faktor VIII (vysoce čištěný) | parent. | 500 | U | 6109,88 | B/P |
|
| 84.8 | B02BD04 | koagulační faktor IX (vysoce čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 350 | U | 4174,27 | B/P |
|
| 84.9 | B02BD04 | koagulační faktor IX (vysoce čištěný) | parent. | 350 | U | 4174,27 | B/P |
|
| 84.10 | B02BD02 | koagulační faktor VIII středně čištěný s von Willebrandovým faktorem | parent. | 500 | U | 7820,64 | B/P |
|
| 84.11 | B02BD02 | koagulační faktor VIII vysoce čištěný s von Wilebrandovým faktorem | parent. | 500 | U | 8553,83 | B/P |
| 85 | B02BD | koagulační faktory (ostatní koagulační faktory) | parent. | X |
| 85.1 | B02BD | srážecí faktory | parent. | 350 | U | 2975,02 | X |
|
| 85.2 | B02BD03 | aktivita obcházející inhibitor faktoru VIII | parent. | 10 | KU | 331888,41 | X |
|
| 85.3 | B02BD05 | koagulační faktor VII | parent. | 6 | KU | 87982,20 | X |
|
| 85.4 | B02BD08 | eptakog alfa (aktivovaný) | parent. | 2.5 | KU | 1508,65 | X |
| 89825 | NOVOSEVEN 1,2 MG (=60 KU) | inj. sic. 1x1,2 mg + sol | NOO | DK |
| 89826 | NOVOSEVEN 2,4 MG (=120 KU) | inj. sic. 1x2,4 mg + sol | NOO | DK |
| 92641 | NOVOSEVEN 4,8 MG (=240 KU) | inj. sic. 1x4,8 + sol | NOO | DK |
| 85.5 | B02BD07 | koagulační faktor XIII | parent. | 350 | U | 2975,02 | X |
| 85667 | FIBROGAMMIN P | inj 1x250ut+1x4ml | BEH | D |
| 85668 | FIBROGAMMIN P | inj 1x1.25ku+1x20ml | BEH | D |
| 86 | B03AA | soli dvojmocného železa | p.o. | |
| 86.1 | B03AA02 | fumarát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 2,74 | |
|
| 86.2 | B03AA02 | fumarát železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 2,98 | |
| 00677 | FERRONAT | sus 1x100ml/3gm | GNO | CZ |
| 86.3 | B03AA03 | glukonát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 5,33 | |
|
| 86.4 | B03AA03 | glukonát železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,33 | |
|
| 86.5 | B03AA05 | chlorid železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 5,33 | |
|
| 86.6 | B03AA05 | chlorid železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,67 | |
| 85662 | FERRO 66 | gtt1x20 ml | PRA | D |
| 86.7 | B03AA07 | síran železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 1,12 | |
| 04370 | FERRONAT RETARD | tbl obd 30 | LEX | CZ |
| 86.8 | B03AA07 | síran železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,33 | |
|
| 86.9 | B03AB | soli trojmocného železa (tekuté lékové formy) | p.o. | 0.1 | GM | 5,47 | |
| 87 | B03AC | soli trojmocného železa | parent. | O |
| 87.1 | B03AC | železo trojmocné | parent. | 0.1 | GM | 42,59 | O |
| 04084 | FERRUM LEK I.M. | inj 50x2ml/100mg | LEK | SLO |
| 03418 | FERRLECIT | inj 5x5ml/62,5mg | NAT | SLO |
| 87.2 | B03AC03 | komplex železo-sorbitol-citronová kyselina | parent. | 0.1 | GM | 25,56 | O |
| 88 | B03AD | soli dvojmocného železa v kombinaci s kyselinou listovou | p.o. | L/GYN,HEM |
| 88.1 | B03AD | chlorid železnatý/kyselina listová | p.o. | 0.1 | GM | 5,18 | L/GYN,HEM |
|
| 88.2 | B03AD | glukonát železnatý/kyselina listová | p.o. | 0.1 | GM | 5,18 | L/GYN,HEM |
|
| 88.3 | B03AD02 | fumarat železnatý/kyselina listová | p.o. | 0.1 | GM | 2,10 | L/GYN,HEM,INT |
| 89141 | FERRETAB COMP. | cps 100 | LAR | A |
| 89140 | FERRETAB COMP. | cps 30 | LAR | A |
| 88.4 | B03AD03 | síran železnatý/kyselina listová | p.o. | 0.1 | GM | 5,18 | L/GYN,HEM |
| 89 | B03AE | soli dvojmocného železa v ostatních kombinacích | p.o. | |
| 89.1 | B03AE01 | dvojmocné soli železa/kyselina listová/vitamin B12 | p.o. | 0.1 | GM | 5,57 | |
|
| 89.2 | B03AE02 | dvojmocné soli železa/kyselina listová/vitaminy | p.o. | 0.1 | GM | 5,33 | |
|
| 89.3 | B03AE10 | chlorid železnatý/kyselina listová | p.o. | 0.1 | GM | 5,33 | |
|
| 89.4 | B03AE10 | fumarat železnatý/kyselina listová | p.o. | 0.1 | GM | 5,33 | |
|
| 89.5 | B03AE10 | glukonat železnatý/kyselina listová | p.o. | 0.1 | GM | 5,33 | |
|
| 89.6 | B03AE10 | různé kombinace bez kyseliny listové | p.o. | 0.1 | GM | 1,70 | |
|
| 89.7 | B03AE10 | síran železnatý/kyselina listová | p.o. | 0.1 | GM | 5,57 | |
| 96043 | AKTIFERRIN COMPOSITUM | cps 100 | MCK | A |
| 89.8 | B03AE10 | síran železnatý/serin (pevné lékové formy) | p.o. | 0.1 | GM | 5,00 | |
|
| 89.9 | B03AE10 | síran železnatý/serin -tekuté lékové formy (kapky) | p.o. | 0.1 | GM | 6,89 | |
| 99138 | AKTIFERRIN | gtt 1x30ml | MCK | D |
| 89.10 | B03AE10 | síran železnatý/serin -tekuté lékové formy (sirup) | p.o. | 0.1 | GM | 9,00 | |
| 90 | B03BA | vitamin B12 a jeho deriváty | parent. | |
| 90.1 | B03BA01 | cyanokobalamin (do 0,3 mg v jedné ampuli včetně) | parent. | 0.02 | MG | 0,49 | |
| 00641 | VITAMIN B12 LECIVA 300RG | inj 5x1ml/300rg | LEX | CZ |
| 90.2 | B03BA01 | cyanokobalamin (nad 0,3 mg v jedné ampuli) | parent. | 0.02 | MG | 0,20 | |
| 92503 | NEUROBENE | inj 6x1ml/1000rg | MCK | D |
| 00643 | VITAMIN B12 LECIVA 1000RG | inj 5x1ml/1000rg | LEX | CZ |
| 91 | B03BB | kyselina listová a její deriváty | p.o. | |
| 91.1 | B03BB01 | kyselina listová | p.o. | 10 | MG | 1,33 | |
| 76064 | ACIDUM FOLICUM LECIVA | drg 30x10mg | LEX | CZ |
| 92 | B03XA | ostatní protianemická léčiva | parent. | K/P |
Treatment with erythropoietin is indicated by an oncologist, a hematologist, an intern or a pediatrician:
(a) treatment of clinically significant anaemia (with haemoglobin levels below 90 g / l, with higher manifestations of anaemia) in patients on dialysis, chronic renal failure patients, cancer patients following radical cytostatic therapy or radiation therapy,
(b) the treatment of anaemia in patients with aplastic anaemia, erythroblastophysis, myelodysplastic syndrome and bone marrow transplantation anaemia,
(c) the treatment of severe anaemia of immature children.
| 92.1 | B03XA01 | erythropoetin do 10 KU v jedné ampuli včetně | parent. | 2 | KU | 1011,84 | K/P |
| 85532 | EPREX | inj 6x10ku/ml+str. | CIL X | CH |
| 94346 | EPREX | inj 6x10ku/ml | CIL X | CH |
| 92.2 | B03XA01 | erythropoetin více než 10 KU v jedné ampuli | parent. | 2 | KU | 860,00 | K/P |
| 93 | B05AA | substituenty plazmy a plazmatické proteiny (albumin) | parent. | B |
|---|
| 93.1 | B05AA01 | albumin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 20 | GM | 2815,72 | B |
|
| 93.2 | B05AA01 | albumin | parent. | 20 | GM | 2815,72 | B |
| 10124 | HUMAN ALBUMIN 20% | inf 1x100ml | BTP | D |
| 20818 | HUMAN ALBUMIN 50 DESSAU | inf 1x100ml | PDE | D |
| 20819 | HUMAN ALBUMIN 50 DESSAU | inf 1x250ml | PDE | D |
| 97907 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x250ml | GFO | E |
| 97908 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x500ml | GFO | E |
| 97909 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x50ml | GFO | E |
| 97910 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x100ml | GFO | E |
| 98147 | ALBUMIN LIDSKY SP 20% SEVAC | inj 5x1ml | USO | CZ |
| 10117 | HUMAN ALBUMIN 20% | inf 1x50 ml | BTP | D |
| 93.3 | B05AA02 | ostatní bílkoviny plasmy užívané jako její náhrady | parent. | 100 | ML | 952,16 | B |
| 94 | B05AA | substituenty plazmy a plazmatické proteiny (ostatní) | parent. | O |
|---|
| 94.1 | B05AA05 | dextran (koncentrace 10%) | parent. | 500 | ML | 185,84 | O |
| 00589 | RHEODEXTRAN INFUSIA (SOL.PHYS.) | inf 1x500ml 10% | IHO | CZ |
| 00590 | RHEODEXTRAN INFUSIA 10% V GLUC. | inf 1x500ml | IHO | CZ |
| 94.2 | B05AA05 | dextran (koncentrace 6%) | parent. | 500 | ML | 108,80 | O |
| 00431 | DEXTRAN INFUSIA 6% V F1/1 | inf 1x500ml(sklo) | IHO | CZ |
| 94.3 | B05AA05 | dextran (koncentrace 6% v hyperosmolárním roztoku) | parent. | 500 | ML | 123,86 | O |
|
| 94.4 | B05AA06 | želatinové přípravky | parent. | 500 | ML | 227,87 | O |
| 56063 | GELIFUNDOL | inf 10x500ml | BTP | D |
| 02536 | GELIFUNDOL | inf 1x500ml | BTP | D |
| 62639 | HAEMACCEL 3,5% | inf 10x500 ml | HMD | D |
| 56412 | GELOFUSINE | inf 1x500 ml | BME | CH |
| 94.5 | B05AA07 | hydroxyethylškrob | parent. | 500 | ML | 390,05 | O |
| 98352 | ELOHAST 6% | inf 1x500ml(plast) | LPD | A |
| 98351 | ELOHAST 6% | inf 1x500ml(sklo) | LPD | A |
| 72155 | HAES-STERIL 6% | inf 1x500ml(plast) | FRE | D |
| 72154 | HAES-STERIL 6% | inf 1x500ml(sklo) | FRE | D |
| 44431 | HEMOHES 6% | inf 1x500 ml (p) | BME | D |
| 44467 | HEMOHES 10% | inf 1x500 ml (p) | BME | D |
| 55897 | HEMOHES 6% | inf 10x500ml(pe) | BME | D |
| 55902 | HEMOHES 10% | inf 10x500ml(pe) | BME | D |
| 95 | B05BA | roztoky k parenterální výživě (glukóza až do 40% koncentrace) | parent. | O |
|---|
| 95.1 | B05BA03 | glukóza 10% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 12,71 | O |
| 43919 | 10% DEXTROSE IN WATER USP SIFRA | inf 16x250ml(sklo) | SFR | I |
| 59433 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFF | I |
| 59437 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFH | E |
| 97735 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(sklo) | BFF | I |
| 95.2 | B05BA03 | glukóza 10% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,94 | O |
| 47000 | GLUKOZA 10 BRAUN | inf 1x500ml(plast) | BME | E |
| 47017 | GLUKOZA 10 BRAUN | inf 1x500ml(plast) | BME | CH |
| 59419 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E |
| 71735 | INFUSIO GLUCOSI 100 G/L MVM G10 | inf 1x500ml | MVM | CZ |
| 92534 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(pp) | SFR | I |
| 96877 | GLUKOZA 10 BRAUN | inf 1x500ml(plast) | BMM | D |
| 97736 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(sklo) | BFF | I |
| 95.3 | B05BA03 | glukóza 10% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 28,84 | O |
| 43918 | 10% DEXTROSE IN WATER USP SIFRA | inf 49x100ml(sklo) | SFR | I |
| 59432 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFF | I |
| 59436 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFH | E |
| 92530 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml (sklo) | SFR | I |
| 62374 | INFUSIO GLUCOSI 10 IMUNA | inf 1x100ml (sklo) | IMA | SK |
| 86346 | INFUSIO GLUCOSI 10% INFUSIA | inf 1x100ml (sklo) | IHO | CZ |
| 95.4 | B05BA03 | glukóza 10% (nad 500 ml v jednom balení) | parent. | 100 | ML | 5,82 | O |
| 43922 | 10% DEXTROSE IN WATER USP SIFRA | inf 12x1000ml(pp) | SFR | I |
| 43927 | 10% DEXTROSE IN WATER USP SIFRA | inf 4x2000ml(vak) | SFR | I |
| 47001 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BME | E |
| 47018 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BME | CH |
| 59434 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFF | I |
| 59438 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFH | E |
| 92533 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(sklo) | SFR | I |
| 92535 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(pp) | SFR | I |
| 92539 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(vak) | SFR | I |
| 92540 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml(vak) | SFR | I |
| 92772 | INFUSIO GLUCOSI 10 MEDIEKOS G10 | inf 1x2000ml(vak) | MKS | CZ |
| 96878 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BMM | D |
| 95.5 | B05BA03 | glukóza 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 30,01 | O |
| 55623 | INFUSIO GLUCOSI 20 IMUNA | inf 1x100ml(sklo) | IMA | SK |
| 57750 | GLUCOSE 20% INFUSION-HUMAN | inf 1x100ml | HUA | H |
| 95.6 | B05BA03 | glukóza 20% (nad 100 ml v jednom balení) | parent. | 100 | ML | 6,70 | O |
| 75194 | GLUCOSE - LOSUNG 20 SALVIA (PLAST) | inf 1x1000m 20% | CLS | D |
| 59422 | GLUCOSE 20%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFH | E |
| 95.7 | B05BA03 | glukóza 5% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 12,90 | O |
| 43929 | 5% DEXTROSE IN WATER USP SIFRA | inf 16x250ml(sklo) | SFR | I |
| 43934 | 5% DEXTROSE IN WATER USP SIFRA | inf 30x250ml(vak) | SFR | I |
| 46995 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BME | E |
| 47012 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BME | CH |
| 53818 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x250ml(pvc) | IHO | CZ |
| 59414 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFH | E |
| 62372 | INFUSIO GLUCOSI 5 IMUNA | inf 1x250ml(sklo) | IMA | SK |
| 66866 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x250ml(sklo) | IHO | CZ |
| 92520 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x250ml(sklo) | SFR | I |
| 92526 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x250ml(vak) | SFR | I |
| 96872 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BMM | D |
| 97729 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(sklo) | BFF | I |
| 95.8 | B05BA03 | glukóza 5% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,89 | O |
| 43930 | 5% DEXTROSE IN WATER USP SIFRA | inf 12x500ml(sklo) | SFR | I |
| 43931 | 5% DEXTROSE IN WATER USP SIFRA | inf 20x500ml(pp) | SFR | I |
| 43935 | 5% DEXTROSE IN WATER USP SIFRA | inf 20x500ml(vak) | SFR | I |
| 46996 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BME | E |
| 47013 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BME | CH |
| 57748 | GLUCOSE 5% INFUSION-HUMAN | inf 1x500ml(plast) | HUA | H |
| 59415 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E |
| 71734 | INFUSIO GLUCOSI 50 G/L MVM G5 | inf 1x500ml | MVM | CZ |
| 83695 | GLUCOSE I.V. B.P.50GM/LT CORE | inf 1x500ml | CPL | IND |
| 86341 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x500ml(plast) | IHO | CZ |
| 92521 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(sklo) | SFR | I |
| 92523 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(pp) | SFR | I |
| 92527 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(vak) | SFR | I |
| 96873 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BMM | D |
| 97730 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(sklo) | BFF | I |
| 95.9 | B05BA03 | glukóza 5% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 27,76 | O |
| 43928 | 5% DEXTROSE IN WATER USP SIFRA | inf 49x100ml(sklo) | SFR | I |
| 43933 | 5% DEXTROSE IN WATER USP SIFRA | inf 40x100ml(vak) | SFR | I |
| 46994 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BME | E |
| 47011 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BME | CH |
| 59413 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFH | E |
| 86200 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x100ml(sklo) | IHO | CZ |
| 92519 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml(sklo) | SFR | I |
| 92525 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml(vak) | SFR | I |
| 96871 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BMM | D |
| 97728 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(sklo) | BFF | I |
| 95.10 | B05BA03 | glukóza 5% (nad 500 ml v jednom balení) | parent. | 100 | ML | 3,96 | O |
| 43936 | 5% DEXTROSE IN WATER USP SIFRA | inf 10x1000ml(vak) | SFR | I |
| 43937 | 5% DEXTROSE IN WATER USP SIFRA | inf 4x2000ml(vak) | SFR | I |
| 83696 | GLUCOSE I.V. B.P.50GM/LT CORE | inf 1x1000ml | CPL | IND |
| 92528 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(vak) | SFR | I |
| 92529 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml(vak) | SFR | I |
| 95.11 | B05BA03 | glukóza do 10% včetně (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 91,31 | 0 |
| 47241 | GLUKOZA 5 BRAUN | inj 20x100ml(plast) | BMM | D |
| 95.12 | B05BA03 | glukóza nad 10% do 39 % (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 98,74 | O |
|
| 95.13 | B05BA03 | glukóza nad 20% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 18,18 | O |
| 86972 | ARDEANUTRISOL G 33 | inf 1x250ml | ARD | CZ |
| 55630 | INFUSIO GLUCOSI 40 IMUNA | inf 1x250ml (sklo) | IMA | SK |
| 95.14 | B05BA03 | glukóza nad 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 31,97 | O |
| 55628 | INFUSIO GLUCOSI 40 IMUNA | inf 1x100ml (sklo) | IMA | SK |
| 95.15 | B05BA03 | glukóza nad 20% (nad 250 ml v jednom balení) | parent. | 100 | ML | 8,26 | O |
| 75199 | GLUCOSE-LOSUNG 40 SALVIA (SKLO) | inf 1x1000ml 40% | CLS | D |
| 75206 | GLUCOSE-LOSUNG 40 SALVIA (PLAST) | inf 1x1000ml 40% | CLS | D |
| 95.16 | B05BA03 | glukóza inj. 40% (do 10 ml včetně v jedné ampuli ) | parent. | 100 | ML | 98,64 | O |
| 02587 | GLUKOZA 40 BRAUN | inf 20x10ml(pla.am) | BME | D |
| 02588 | GLUKOZA 40 BRAUN | inf 20x10ml(pla.am) | BME | E |
| 02589 | GLUKOZA 40 BRAUN | inf 20x10ml(pla.am) | BME | CH |
| 96 | B05BA | roztoky k parenterální výživě (ostatní) | parent. | H |
|---|
| 96.1 | B05BA01 | aminokyseliny (koncentrace do 6% včetně) | parent. | 100 | ML | 38,76 | H |
|
| 96.2 | B05BA01 | aminokyseliny (koncentrace nad 14%) | parent. | 100 | ML | 74,49 | H |
| 58907 | ELOAMIN 15% PUR | inf 6x1000 ml | FRK | A |
| 96.3 | B05BA01 | aminokyseliny (koncentrace nad 10% do 14% včetně) | parent. | 100 | ML | 77,86 | H |
| 55971 | SALVIAMIN 12,5 E | inf 1x1000 ml | CTT | F |
| 55969 | SALVIAMIN 12,5 E | inf 1x500 ml | CTT | F |
| 96.4 | B05BA01 | aminokyseliny (koncentrace nad 6% do 10 % včetně) | parent. | 100 | ML | 48,39 | H |
| 92631 | SALVIAMIN 10 E | inf 1x1000 ml | CTT | F |
| 96.5 | B05BA02 | tukové emulze (do 10% včetně do 100 ml v jednom balení včetně) | parent. | 100 | ML | 175,28 | H |
| 45303 | INTRALIPID 10% | inf 1x100ml | PAU | S |
| 96.6 | B05BA02 | tukové emulze (nad 10% do 100 ml v jednom balení včetně) | parent. | 100 | ML | 196,40 | H |
|
| 96.7 | B05BA02 | tukové emulze (do 10% včetně nad 100 ml v jednom balerní) | parent. | 100 | ML | 55,48 | H |
| 59154 | IVELIP 10% | inf 6x1000ml | CTT | F |
| 75442 | INTRALIPID | inf 12x500ml 10% | PAU | S |
| 96.8 | B05BA02 | tukové emulze (nad 10% nad 100 ml v jednom balení) | parent. | 100 | ML | 74,20 | H |
| 59157 | IVELIP 20% | inf 12x500ml | CTT | F |
| 59158 | IVELIP 20% | inf 6x1000ml | CTT | F |
| 96.9 | B05BA03 | fruktóza (koncentrace do 5% včetně) | parent. | 100 | ML | 14,47 | H |
|
| 96.10 | B05BA03 | fruktóza (koncentrace nad 10%) | parent. | 100 | ML | 17,74 | H |
|
| 96.11 | B05BA03 | fruktóza (koncentrace nad 5% do 10% včetně) | parent. | 100 | ML | 15,54 | H |
|
| 96.12 | B05BA03 | sorbitol (koncentrace do 5% včetně) | parent. | 100 | ML | 8,02 | H |
|
| 96.13 | B05BA03 | sorbitol (koncentrace nad 10%) | parent. | 100 | ML | 11,10 | H |
|
| 96.14 | B05BA03 | sorbitol (koncentrace nad 5% do 10% včetně) | parent. | 100 | ML | 8,60 | H |
| 71730 | INFUSIO SORBITOLI 100 G/L MVM | inf 1x500ml | MVM | CZ |
| 89919 | INFUSIO SORBITOLI 10% INFUSIA | inf 1x500ml(sklo) | IHO | CZ |
| 96.15 | B05BA03 | xylitol (koncentrace do 5% včetně) | parent. | 100 | ML | 16,62 | H |
|
| 96.16 | B05BA03 | xylitol (koncentrace nad 5%) | parent. | 100 | ML | 22,83 | H |
|
| 96.17 | B05BA10 | kombinace bez obsahu aminokyselin | parent. | 100 | ML | 13,20 | H |
|
| 96.18 | B05BA10 | kombinace s obsahem aminokyselin | parent. | 100 | ML | 61,83 | H |
| 72160 | AMINO-MEL 3,5% G | inf 6x1000ml | LPD | A |
| 72159 | AMINO-MEL 3,5% G | inf 10x500ml | LPD | A |
| 72162 | AMINO-MEL 5% G | inf 6x1000ml | LPD | A |
| 72163 | AMINO-MEL 5% G | inf 10x500ml | LPD | A |
| 72164 | AMINO-MEL 5% G | inf 6x900ml | LPD | A |
| 91305 | NUTRAMIN C | inf 1x500ml | IHO | CZ |
| 96204 | NUTRAMIN U | inf 1x500ml | IHO | CZ |
| 02452 | NUTRIFLEX SPECIAL | inf 5x1000ml | BMB | CH |
| 02453 | NUTRIFLEX SPECIAL | inf 5x1500ml | BMB | CH |
| 02454 | NUTRIFLEX PERI | inf 5x1000ml | BMB | CH |
| 02455 | NUTRIFLEX PERI | inf 5x2000ml | BMB | CH |
| 02456 | NUTRIFLEX SPECIAL BEZ ELEKTROL. | inf 5x1000ml | BMB | CH |
| 02457 | NUTRIFLEX SPECIAL BEZ ELEKTROL. | inf 5x1500ml | BMB | CH |
| 02458 | NUTRIFLEX PLUS | inf 5x1000ml | BMB | CH |
| 02459 | NUTRIFLEX PLUS | inf 5x2000ml | BMB | CH |
| 02460 | NUTRIFLEX BASAL | inf 5x1000ml | BMB | CH |
| 02461 | NUTRIFLEX BASAL | inf 5x2000ml | BMB | CH |
| 02462 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x2000ml | BMB | CH |
| 02463 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x1000ml | BMB | CH |
| 40178 | AMINOPLASMAL 10% E | inf 1x1000ml | BME | D |
| 45377 | AMINOROZTOK NEO SX 4% INFUSIA | inf 1x500ml | IHO | CZ |
| 45383 | AMINOROZTOK NEO SX 8% INFUSIA | inf 1x500ml | IHO | CZ |
| 46010 | SALVIAMIN HEPAR | inf 1x500ml | CTT | F |
| 56624 | NUTRIFLEX BASAL | inf 5x1000ml | VIF | CH |
| 56625 | NUTRIFLEX BASAL | inf 5x2000ml | VIF | CH |
| 56626 | NUTRIFLEX SPECIAL | inf 5x1000ml | VIF | CH |
| 56627 | NUTRIFLEX SPECIAL | inf 5x1500ml | VIF | CH |
| 56628 | NUTRIFLEX PLUS | inf 5x1000ml | VIF | CH |
| 56629 | NUTRIFLEX PLUS | inf 5x2000ml | VIF | CH |
| 56630 | NUTRIFLEX PERI | inf 5x1000ml | VIF | CH |
| 56631 | NUTRIFLEX PERI | inf 5x2000ml | VIF | CH |
| 56632 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x1000ml | VIF | CH |
| 56633 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x2000ml | VIF | CH |
| 56634 | NUTRIFLEX SPECIAL BEZ ELEKTROL. | inf 5x1000ml | VIF | CH |
| 56635 | NUTRIFLEX SPECIAL BEZ ELEKTROL. | inf 5x1500ml | VIF | CH |
| 69641 | ARDEAELYTOSOL ARGE | inf 1x250ml | ARD | CZ |
| 69642 | ARDEAELYTOSOL ARGE | inf 1x500ml | ARD | CZ |
| 69643 | INFUSIO ARGML ARDEAPHARMA | inf 1x250ml | ARD | CZ |
| 69644 | INFUSIO ARGML ARDEAPHARMA | inf 20x250ml | ARD | CZ |
| 72159 | AMINO-MEL 3.5% G | inf 10x500ml | LPD | A |
| 72160 | AMINO-MEL 3.5% G | inf 6x1000ml | LPD | A |
| 72162 | AMINO-MEL 5% G | inf 6x1000ml | LPD | A |
| 72163 | AMINO-MEL 5% G | inf 10x500ml | LPD | A |
| 72164 | AMINO-MEL 5% G | inf 6x900ml | LPD | A |
| 81692 | NUTRAMIN K | inf 10x500ml | VUA | CZ |
| 88988 | ARDEAELYTOSOL ARGE | inf 20x250ml | ARD | CZ |
| 88989 | ARDEAELYTOSOL ARGE | inf 12x500ml | ARD | CZ |
| 97 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (chlorid sodný 0,9%) | parent. | O |
|---|
| 97.1 | B05BB01 | chlorid sodný 0.9% (nad 100 ml do 250 ml včetně) | parent. | 100 | ML | 11,54 | O |
| 43907 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 16x250ml(sklo) | SFR | I |
| 43912 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 30x250ml(vak) | SFR | I |
| 46070 | CHLORID SODNY 0.9% BRAUN | inf 1x250ml(pe) | BMR | E |
| 46080 | CHLORID SODNY 0.9% BRAUN | inf 1x250ml(pe) | BME | CH |
| 57683 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(plast) | BFH | E |
| 70525 | INFUSIO NATRII CHLOR.ISOTON.MVM | inf 1x250ml | MVM | CZ |
| 86047 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x250ml(sklo) | BFF | I |
| 92509 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x250ml(sklo) | SFR | I |
| 92515 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x250ml(vak) | SFR | I |
| 97682 | CHLORID SODNÝ 0.9% BRAUN | inf 1x250ml(plast) | BMM | D |
| 97749 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(sklo) | BFF | I |
| 97752 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(plast) | BFF | I |
| 97.2 | B05BB01 | chlorid sodný 0.9% (do 100 ml v balení včetně) | parent. | 100 | ML | 22,09 | O |
| 43906 | 0,9% SODIUM CHL. IN WATER F. INJ. | inf 49x100ml(sklo) | SFR | I |
| 43906 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 49x100ml(sklo) | SFR | I |
| 46065 | CHLORID SODNY 0.9% BRAUN | inf 1x100ml(sklo) | BMR | E |
| 46075 | CHLORID SODNY 0.9% BRAUN | inf 1x100ml(sklo) | BME | CH |
| 57681 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(plast) | BFH | E |
| 92508 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x100ml(sklo) | SFR | I |
| 96882 | CHLORID SODNÝ 0.9% BRAUN | inf 1x100ml(sklo) | BMM | D |
| 97748 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(sklo) | BFF | I |
| 97751 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(plast) | BFF | I |
| 97.3 | B05BB01 | chlorid sodný 0.9% (nad než 250 ml v balení) | parent. | 100 | ML | 3,81 | O |
| 92513 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x1000ml(pp) | SFR | I |
| 03122 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1000ml(vak i) | BFH | E |
| 03126 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(vak i) | BFH | E |
| 43915 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 4x2000ml(vak) | SFR | I |
| 57673 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(plast) | BFH | E |
| 83698 | SODIUM CHLORIDE I.V.B.P.CORE | inf 1x1000ml 0.9% | CPL | IND |
| 92511 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x1000ml(sklo) | SFR | I |
| 92518 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x2000ml(vak) | SFR | I |
| 92585 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1x3000ml(vak) | IMA | SK |
| 97.4 | B05BB01 | chlorid sodný 0.9% (do 10 ml včetně v jedné ampuli) | parent. | 100 | ML | 42,82 | O |
| 46078 | CHLORID SODNY 0.9% BRAUN | inj 20x10ml | BME | D |
| 98 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (ostatní) | parent. | 92518 |
|---|
| 98.1 | B05BB | roztoky ovlivňující rovnováhu elektrolytů | parent. | 100 | ML | 10,46 | H |
| 75372 | ELO-MEL BASIS MIT GLUCOSE | inf 6x1000ml(sklo) | LPD | A |
| 75374 | ELO-MEL BASIS MIT GLUCOSE | inf 6x1000ml(plast) | LPD | A |
| 75360 | ELO-MEL ISOTON MIT GLUCOSE | inf 6x1000ml(sklo) | LPD | A |
| 75362 | ELO-MEL ISOTON MIT GLUCOSE | inf 6x1000ml(plast) | LPD | A |
| 75370 | ELO-MEL SEMITON MIT GLUCOSE | inf 6x1000ml(plast) | LPD | A |
| 75368 | ELO-MEL SEMITON MIT GLUCOSE | inf 6x1000ml(sklo) | LPD | A |
| 75358 | ELO-MEL ISOTON | inf 6x1000ml(plast) | LPD | A |
| 75356 | ELO-MEL ISOTON | inf 6x1000ml(sklo) | LPD | A |
| 75366 | ELO-MEL OP (POSTOPERATIV) | inf 6x1000ml(plast) | LPD | A |
| 75364 | ELO-MEL OP (POSTOPERATIV) | inf 6x1000ml(sklo) | LPD | A |
| 98.2 | B05BB01 | elektrolyty | parent. | 100 | ML | 8,07 | H |
| 93527 | ARDEAELYTOSOL R 1/1 | inf 1x500ml | ARD | CZ |
| 85112 | ARDEAELYTOSOL R 1/1 | inf 12x500ml | ARD | CZ |
| 83702 | COMPOUND SODIUM LACTAT.B.P.CORE | inf 1x1000ml | CPL | IND |
| 83701 | COMPOUND SODIUM LACTAT.B.P.CORE | inf 1x500ml | CPL | IND |
| 98238 | DARROW'S SOLUTION | inf 1x500ml | BME | D |
| 85896 | INFUSIO DARROWI IMUNA | inf 1x1000ml(vak) | IMA | SK |
| 91841 | PLASMA-LYTE 148 ELECTROLYT.SOL. | inf 10x1000ml | BXT | GB |
| 55617 | INFUSIO RINGERI IMUNA | inf 1x3000ml(vak) | IMA | SK |
| 96889 | RINGERLACTAT DAB 7 BRAUN | inf 1x1000ml(pe) | BME | D |
| 92802 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x2000ml (vak) | MKS | CZ |
| 96892 | RINGER'S INJECTION BRAUN | inf 1x1000ml | BME | D |
| 66833 | PLASMA-LYTE 148 ELECTROLYT.SOL. | inf 1x1000ml | BXT | GB |
| 69440 | RINGER-LOSUNG SALVIA (PLAST) | inf 1x1000ml | CLS | D |
| 92581 | INFUSIO HARTMANNI IMUNA | inf 1x3000ml (vak) | IMA | SK |
| 84545 | INFUSIO RINGER. C. NAT. LACT. IMUNA | inf 1x3000ml (vak) | IMA | SK |
| 69438 | RINGER-LACTAT SALVIA (PLAST) | inf 1x1000ml | CLS | D |
| 92600 | INFUSIO DARROWI IMUNA | inf 1x3000ml (vak) | IMA | SK |
| 97013 | INFUSIO DARROWI INSTITUTE HUMAN | inf 1x500ml | HUA | H |
| 69442 | RINGER-LOSUNG SALVIA (SKLO) | inf 1x1000ml | CLS | D |
| 69439 | RINGER-LACTAT SALVIA (SKLO) | inf 1x1000ml | CLS | D |
| 01695 | NATRII CHLORIDI 10% MEDVIR | inf 1x100ml | VYS | CZ |
| 55616 | INFUSIO RINGERI IMUNA | inf 1x2000ml (vak) | IMA | SK |
| 92778 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x2000ml (vak) | MKS | CZ |
| 96891 | RINGER'S INJECTION BRAUN | inf 1x500ml | BME | D |
| 96888 | RINGERLACTAT DAB 7 BRAUN | inf 1x500ml (pe) | BME | D |
| 92580 | INFUSIO HARTMANNI IMUNA | inf 1x2000ml (vak) | IMA | SK |
| 84554 | INFUSIO RINGER. C. NAT. LACT. IMUNA | inf 1x2000ml (vak) | IMA | SK |
| 69235 | RINGER'S SOLUTION U. S. P. BIEFFE | inf 1x500ml (sklo) | BFF | I |
| 92599 | INFUSIO DARROWI IMUNA | inf 1x2000ml (vak) | IMA | SK |
| 85578 | INFUSIO RINGERI IMUNA | inf 1x1000ml (vak) | IMA | SK |
| 89861 | INFUSIO RINGERI INFUSIA R 1/1 | inf 1x500ml (sklo) | IHO | CZ |
| 72793 | INFUSIO RINGERI IMUNA | inf 1x500ml (sklo) | IMA | SK |
| 84543 | INFUSIO RINGER. C. NAT. LACT. IMUNA | inf 1x1000ml (vak) | IMA | SK |
| 70529 | INFUSIO RINGERI MEDICAMENTA | inf 1x500ml | MVM | CZ |
| 69736 | ARDEALYTOSOL H 1/1 | inf 1x500ml | ARD | CZ |
| 69695 | ARDEALYTOSOL RL 1/1 | inf 1x500ml | ARD | CZ |
| 99168 | INFUSIO HARTMANNI IMUNA | inf 1x500ml (sklo) | IMA | SK |
| 92801 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x1000ml (vak) | MKS | CZ |
| 86486 | ARDEALYTOSOL H 1/1 | inf 12x500ml | ARD | CZ |
| 92775 | INFUSIO DARROWI MEDIEKOS R1/1 | inf 1x2000ml (vak) | MKS | CZ |
| 85887 | INFUSIO HARTMANNI IMUNA | inf 1x1000ml (vak) | IMA | SK |
| 87250 | INFUSIO HARTMANNI INFUSIA H 1/1 | inf 1x500ml (sklo) | IHO | CZ |
| 70524 | INFUSIO HARTMANNI MEDICAMENTA | inf 1x500ml | MVM | CZ |
| 98.3 | B05BB02 | elektrolyty se sacharidy | parent. | 100 | ML | 9,04 | H |
| 12382 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x500ml(sklo) | IMA | SK |
| 12388 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x1000ml(vak) | IMA | SK |
| 12389 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x2000ml(vak) | IMA | SK |
| 12390 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x3000ml(vak) | IMA | SK |
| 12395 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x500ml(sklo) | IMA | SK |
| 12401 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x1000ml(vak) | IMA | SK |
| 12402 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x2000ml(vak) | IMA | SK |
| 12403 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x3000ml(vak) | IMA | SK |
| 56702 | INFUSIO F 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ |
| 56706 | INFUSIO R 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ |
| 62369 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x500ml(sklo) | IMA | SK |
| 69660 | ARDEAELYTOSOL F 1/2 | inf 1x500ml | ARD | CZ |
| 70552 | INFUSIO HRS MEDICAMENTA | inf 1x500ml | MVM | CZ |
| 71732 | INFUSIO NATR.CHL+GLUC.F1/2 MVM | inf 1x500ml | MVM | CZ |
| 71733 | INFUSIO NATR.CHL.+GLUC.F1/3 MVM | inf 1x500ml | MVM | CZ |
| 85566 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x1000ml(vak) | IMA | SK |
| 92624 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x2000ml(vak) | IMA | SK |
| 92625 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x3000ml(vak) | IMA | SK |
| 98.4 | B05BB03 | trometamol | parent. | 100 | ML | 23,02 | H |
| 69698 | ARDEALYTOSOL THAM 1/1 | inf 1x500 ml | ARD | CZ |
| 85176 | ARDEAELYTOSOL THAM 1/1 | inf 1x400ml | ARD | CZ |
| 99 | B05BC | roztoky k osmotické diuréze | parent. | H |
|---|
| 99.1 | B05BC01 | mannitol (koncentrace do 10% včetně, nad 250 ml v jednom balení) | parent. | 100 | ML | 12,17 | H |
| 31365 | MANNISOL A INFUSION-HUMAN | inf 1x500ml | HUA | H |
| 46027 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFH | E |
| 46028 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x1000ml(vak) | BFH | E |
| 55612 | INFUSIO MANNITOLI 10 IMUNA | inf 1x2000ml(vak) | IMA | SK |
| 55613 | INFUSIO MANNITOLI 10 IMUNA | inf 1x3000ml(vak) | IMA | SK |
| 74984 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFF | I |
| 75517 | INFUSIO MANNITOLI 10 IMUNA | inf 1x500ml(sklo) | IMA | SK |
| 85598 | INFUSIO MANNITOLI 10 IMUNA | inf 1x1000ml(vak) | IMA | SK |
| 89155 | INFUSIO MANNITOLI 10% INFUSIA | inf 1x500ml(sklo) | IHO | CZ |
| 97744 | MANNITOL 10%, I.V.INF.BP BIEFFE | inf 1x500ml(sklo) | BFF | I |
| 99.2 | B05BC01 | mannitol (koncentrace do 10% včetně, do 250 ml v jednom balení včetně) | parent. | 100 | ML | 19,31 | H |
| 46026 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFH | E |
| 74983 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFF | I |
| 80494 | INFUSIO MANNITOLI 100 G/L MVM | inf 1x250ml | MVM | CZ |
| 89154 | INFUSIO MANNITOLI 10% INFUSIA | inf 1x250ml(sklo) | IHO | CZ |
| 97743 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(sklo) | BFF | I |
| 99.3 | B05BC01 | mannitol (koncentrace nad 10%, nad 250 ml v jednom balení) | parent. | 100 | ML | 13,78 | H |
| 43765 | 20% MANNITOL IN WATER F.INJ.USP | inf 1x500ml | SFR | I |
| 43766 | 20% MANNITOL IN WATER F.INJ.USP | inf 1x1000ml | SFR | I |
| 44383 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x500ml(sklo) | IHO | CZ |
| 44583 | 20% MANNITOL IN WATER F.INJ.USP | inf 12x500ml | SFR | I |
| 44584 | 20% MANNITOL IN WATER F.INJ.USP | inf 6x1000ml | SFR | I |
| 46025 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFH | E |
| 59743 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x1000ml(vak) | BFH | E |
| 97746 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(sklo) | BFF | I |
| 97747 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFF | I |
| 99.4 | B05BC01 | mannitol (koncentrace nad 10%, do 250 ml v jednom balení včetně) | parent. | 100 | ML | 21,70 | H |
| 43764 | 20% MANNITOL IN WATER F.INJ.USP | inf 1x250ml | SFR | I |
| 44382 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x250ml(sklo) | IHO | CZ |
| 44582 | 20% MANNITOL IN WATER F.INJ.USP | inf 16x250ml | SFR | I |
| 59741 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFH | E |
| 59742 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFF | I |
| 80497 | INFUSIO MANNITOLI 200 G/L MVM | inf 1x250ml | MVM | CZ |
| 97745 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(sklo) | BFF | I |
| 99.5 | B05BC02 | karbamid | parent. | 90 | GM | 1133,11 | H |
| 100 | B05C | roztoky k irigaci | lok. | H |
|---|
| 100.1 | B05CB01 | chlorid sodný | lok. | 1000 | ML | 37,29 | H |
|
| 100.2 | B05CX02 | sorbitol | lok. | 1000 | ML | 37,29 | H |
|
| 100.3 | B05CX03 | glycin | lok. | 1000 | ML | 54,04 | H |
|
| 100.4 | B05CX10 | kombinované roztoky k irigaci | lok. | 1000 | ML | 54,04 | H |
| 101 | B05D | roztoky k peritoneální dialýze | parent. | H |
|---|
| 101.1 | B05DA | přípravky pro peritoneální dialýzu isotonické | parent. | 1000 | ML | 138,72 | H |
|
| 101.2 | B05DB | přípravky pro peritoneální dialýzu hypertonické | parent. | 1000 | ML | 138,72 | H |
| 45631 | GAMBROSOL 10 H SYSTEM 10 | sol 6x1500ml(vak) | NPB | NL |
| 45632 | GAMBROSOL 10 H SYSTEM 10 | sol 6x1500ml(vak) | BJS | I |
| 45633 | GAMBROSOL 10 H SYSTEM 10 | sol 4x2000ml(vak) | NPB | NL |
| 45634 | GAMBROSOL 10 H SYSTEM 10 | sol 4x2000ml(vak) | BJS | I |
| 45635 | GAMBROSOL 10 M GEMINI 10 | sol 4x2000ml(vak) | NPB | NL |
| 45636 | GAMBROSOL 10 M GEMINI 10 | sol 4x2000ml(vak) | BJS | I |
| 45637 | GAMBROSOL 10 H SYSTEM 10 | sol 4x2500ml(vak) | NPB | NL |
| 45638 | GAMBROSOL 10 H SYSTEM 10 | sol 4x2500ml(vak) | BJS | I |
| 45639 | GAMBROSOL 10 H SYSTEM 10 | sol 2x4500ml(vak) | NPB | NL |
| 45640 | GAMBROSOL 10 H SYSTEM 10 | sol 2x4500ml(vak) | BJS | I |
| 45643 | GAMBROSOL 10 H GEMINI 10 | sol 4x2000ml(vak) | NPB | NL |
| 45644 | GAMBROSOL 10 H GEMINI 10 | sol 4x2000ml(vak) | BJS | I |
| 45667 | GAMBROSOL 10 M SYSTEM 10 | sol 6x1500ml(vak) | NPB | NL |
| 45668 | GAMBROSOL 10 M SYSTEM 10 | sol 6x1500ml(vak) | BJS | I |
| 45669 | GAMBROSOL 10 M SYSTEM 10 | sol 4x2000ml(vak) | NPB | NL |
| 45670 | GAMBROSOL 10 M SYSTEM 10 | sol 4x2000ml(vak) | BJS | I |
| 45671 | GAMBROSOL 10 M SYSTEM 10 | sol 4x2500ml(vak) | NPB | NL |
| 45672 | GAMBROSOL 10 M SYSTEM 10 | sol 4x2500ml(vak) | BJS | I |
| 45673 | GAMBROSOL 10 M SYSTEM 10 | sol 2x4500ml(vak) | NPB | NL |
| 45674 | GAMBROSOL 10 M SYSTEM 10 | sol 2x4500ml(vak) | BJS | I |
| 45699 | GAMBROSOL 10 L SYSTEM 10 | sol 6x1500ml(vak) | NPB | NL |
| 45700 | GAMBROSOL 10 L SYSTEM 10 | sol 6x1500ml(vak) | BJS | I |
| 45701 | GAMBROSOL 10 L SYSTEM 10 | sol 4x2000ml(vak) | NPB | NL |
| 45702 | GAMBROSOL 10 L SYSTEM 10 | sol 4x2000ml(vak) | BJS | I |
| 45703 | GAMBROSOL 10 L SYSTEM 10 | sol 4x2500ml(vak) | NPB | NL |
| 45704 | GAMBROSOL 10 L SYSTEM 10 | sol 4x2500ml(vak) | BJS | I |
| 45705 | GAMBROSOL 10 L SYSTEM 10 | sol 2x4500ml(vak) | NPB | NL |
| 45706 | GAMBROSOL 10 L SYSTEM 10 | sol 2x4500ml(vak) | BJS | I |
| 45709 | GAMBROSOL 10 L GEMINI 10 | sol 4x2000ml(vak) | NPB | NL |
| 45710 | GAMBROSOL 10 L GEMINI 10 | sol 4x2000ml(vak) | BJS | I |
| 46907 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1x2500ml(vak) | BXI | IRL |
| 46909 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1x5000ml(vak) | BXI | IRL |
| 46916 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x2500ml(vak) | BXI | IRL |
| 46918 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x5000ml(vak) | BXI | IRL |
| 46925 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1x2500ml(vak) | BXI | IRL |
| 46927 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1x5000ml(vak) | BXI | IRL |
| 55846 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x2500ml(vak) | BFF | I |
| 55847 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x2500ml(vak) | BFF | I |
| 55848 | PERITONEAL DIAL.SOL.+DEXTR.2.5% | sol 1x2500ml(vak) | BFF | I |
| 58502 | GAMBROSOL 10 H | sol 6x1500ml(sy10) | GBL | S |
| 58503 | GAMBROSOL 10 H | sol 5x2000ml(sy10) | GBL | S |
| 58504 | GAMBROSOL 10 H | sol 4x2500ml(sy10) | GBL | S |
| 58505 | GAMBROSOL 10 H | sol 3x3000ml(sy10) | GBL | S |
| 58506 | GAMBROSOL 10 H | sol 2x4500ml(sy10) | GBL | S |
| 58507 | GAMBROSOL 10 H | sol 2x5000ml(sy10) | GBL | S |
| 58515 | GAMBROSOL 10 H | sol 4x2500ml(ge10) | GBL | S |
| 58532 | GAMBROSOL 10 M | sol 4x2500ml(ge10) | GBL | S |
| 58542 | GAMBROSOL 10 M | sol 6x1500ml(sy10) | GBL | S |
| 58543 | GAMBROSOL 10 M | sol 5x2000ml(sy10) | GBL | S |
| 58544 | GAMBROSOL 10 M | sol 4x2500ml(sy10) | GBL | S |
| 58545 | GAMBROSOL 10 M | sol 3x3000ml(sy10) | GBL | S |
| 58546 | GAMBROSOL 10 M | sol 2x4500ml(sy10) | GBL | S |
| 58547 | GAMBROSOL 10 M | sol 2x5000ml(sy10) | GBL | S |
| 58548 | GAMBROSOL 10 L | sol 2x5000ml(sy10) | GBL | S |
| 58549 | GAMBROSOL 10 L | sol 2x4500ml(sy10) | GBL | S |
| 58550 | GAMBROSOL 10 L | sol 3x3000ml(sy10) | GBL | S |
| 58551 | GAMBROSOL 10 L | sol 4x2500ml(sy10) | GBL | S |
| 58552 | GAMBROSOL 10 L | sol 5x2000ml(sy10) | GBL | S |
| 58553 | GAMBROSOL 10 L | sol 6x1500ml(sy10) | GBL | S |
| 58570 | GAMBROSOL 10 L | sol 4x2500ml(ge10) | GBL | S |
| 65949 | GAMBROSOL 10 M | sol 5x2000ml(sy10) | BJS | I |
| 65950 | GAMBROSOL 10 M | sol 2x5000ml(sy10) | BJS | I |
| 65959 | GAMBROSOL 10 L | sol 2x5000ml(sy10) | BJS | I |
| 65962 | GAMBROSOL 10 L | sol 5x2000ml(sy10) | BJS | I |
| 68460 | GAMBROSOL 10 H | sol 5x2000ml(sy10) | BJS | I |
| 68515 | GAMBROSOL 10 H | sol 2x5000ml(sy10) | BJS | I |
| 69182 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x2000ml(vak) | BFF | I |
| 69183 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x5000ml(vak) | BFF | I |
| 76614 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x2500ml(vak) | BXT | IRL |
| 76616 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x5000ml(vak) | BXT | IRL |
| 76623 | DIANEAL PD 4(+GLUCOSE 2.27%) | sol 1x2500ml(vak) | BXT | IRL |
| 76625 | DIANEAL PD 4(+GLUCOSE 2.27%) | sol 1x5000ml(vak) | BXT | IRL |
| 76632 | DIANEAL PD 4(+GLUCOSE 3.86%) | sol 1x2500ml(vak) | BXT | IRL |
| 76634 | DIANEAL PD 4(+GLUCOSE 3.86%) | sol 1x5000ml(vak) | BXT | IRL |
| 85923 | PERITONEAL DIAL.SOL.+DEXTR.2.5% | sol 1x2000ml(vak) | BFF | I |
| 85924 | PERITONEAL DIALSOL+DEXTR.2.5% | sol 1x5000ml(vak) | BFF | I |
| 85925 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x2000ml(vak) | BFF | I |
| 85926 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x5000ml(vak) | BFF | I |
| 102 | B05X | přídavky do nitrožilně podávaných roztoků (hydrogenuhličitan sodný) | parent. | O |
|---|
| 102.1 | B05XA02 | hydrogenuhličitan sodný (do 20 ml v jedné ampuli včetně) | parent. | 100 | ML | 124,74 | O |
| 00524 | NATRIUM HYDROGENCARBONIC.LECIVA | inj 6x20ml 4.2% | LEX | CZ |
| 55448 | NATRIUM HYDROGENCAR.LECIVA 4.2% | inj 10x10ml | LEX | CZ |
| 102.2 | B05XA02 | hydrogenuhličitan sodný (nad 20 ml v jedné ampuli) | parent. | 100 | ML | 11,00 | O |
| 31352 | ALKALIGEN-INSTITUTE HUMAN | inf 1x400ml | HUA | H |
| 103 | B05X | přídavky do nitrožilně podávaných roztoků (ostatní) | parent. | H |
|---|
| 103.1 | B05XA01 | chlorid draselný (koncentrace 7,45%) | parent. | 100 | ML | 17,40 | H |
| 70523 | INFUSIO KALII CHLORATI CONC.MVM | inf 1x250ml | MVM | CZ |
| 103.2 | B05XA03 | chlorid sodný (koncentrace do 5,85% včetně) | parent | 100 | ML | 22,88 | H |
| 69727 | ARDEAELYTOSOL NATRIUMCHLOR.5.85 | inf 1x200ml | ARD | CZ |
| 103.3 | B05XA03 | chlorid sodný (koncentrace nad 5,85%) | parent. | 100 | ML | 24,93 | H |
| 87726 | ARDEAELYTOSOL NATRIUMCHLOR.10% | inf 1x200ml | ARD | CZ |
| 01695 | NATRII CHLORIDI 10% MEDVIR | inf 1x100ml | VYS | CZ |
| 103.4 | B05XA04 | chlorid amonný | parent. | 100 | ML | 11,68 | H |
| 86596 | ARDEAELYTOSOL AMMONCL 1/1 | inf 12x500ml | ARD | CZ |
| 69576 | ARDEAELYTOSOL AMMONCL 1/1 | inf 1x500ml | ARD | CZ |
| 103.5 | B05XA06 | fosforečnan draselný, vč. kombinací | parent. | 100 | ML | 52,35 | H |
|
| 103.6 | B05XA30 | kombinace elektrolytů (stopové prvky) | parent. | 10 | ML | 12,46 | H |
| 72998 | SOLUTIO SHILS I.ARDEAPHARMA | inf 1x50ml | ARD | CZ |
| 103.7 | B05XA31 | elektrolyty v kombinaci s jinými léčivy | parent. | 100 | ML | 127,87 | H |
|
| 103.8 | B05XB01 | chlorid argininu (koncentrace 21%) | parent. | 100 | ML | 257,49 | H |
| 69597 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x500ml | ARD | CZ |
| 86799 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x400ml | ARD | CZ |
| 69596 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x300ml | ARD | CZ |
| 86798 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x250ml | ARD | CZ |
| 86797 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x200ml | ARD | CZ |
| 103.9 | B05XB02 | alanylglutamin | parent. | 1 | ML | 4,39 | H |
|
| 103.10 | B05XC | vitamíny | parent. | 1 | DF | 43,99 | H |
|
| 103.11 | B05XX | ostatní i.v. roztoky | parent. | 100 | ML | 7,63 | H |
| 104 | B05Z | roztoky k hemodialýze a hemofiltraci | lok. | H |
|---|
| 104.1 | B05Z | hemodialytika a hemofiltráty | lok. | 1000 | ML | 166,19 | H |
| 87560 | ARDEADIALYSOL MAX I | inf 1x250ml | ARD | CZ |
| 87562 | ARDEADIALYSOL MAX I | inf 1x300ml | ARD | CZ |
| 87576 | ARDEADIALYSOL MAX I | inf 1x400ml | ARD | CZ |
| 69646 | ARDEADIALYSOL MAX I | inf 1x500ml | ARD | CZ |
| 87612 | ARDEADIALYSOL MAX II | inf 1x250ml | ARD | CZ |
| 87613 | ARDEADIALYSOL MAX II | inf 1x300ml | ARD | CZ |
| 87614 | ARDEADIALYSOL MAX II | inf 1x400ml | ARD | CZ |
| 69649 | ARDEADIALYSOL MAX II | inf 1x500ml | ARD | CZ |
| 104.2 | B05ZA | hemodialytika, koncentráty | lok. | 1000 | ML | 125,72 | H |
|
| 104.3 | B05ZB | hemofiltráty | lok. | 1000 | ML | 166,19 | H |
| 105 | C01AA | kardioglykosidy z náprstníku | p.o. | |
|---|
| 105.1 | C01AA02 | acetyldigoxin | p.o. | 0.5 | MG | 1,03 | |
|
| 105.2 | C01AA04 | digitoxin | p.o. | 0.1 | MG | 1,03 | |
|
| 105.3 | C01AA05 | digoxin | p.o. | 0.25 | MG | 1,19 | |
| 00705 | DIGOXIN | gtt 1x10ml 0.5mg/ml | GNO | CZ |
| 03542 | DIGOXIN 0.250 LECIVA | tbl 30x0.25mg | LEX | CZ |
| 83318 | DIGOXIN 0.125 LECIVA | tbl 30x0.125mg | LEX | CZ |
| 105.4 | C01AA08 | metildigoxin | p.o. | 0.2 | MG | 1,03 | |
| 106 | C01AA | kardioglykosidy z náprstníku | parent. | |
|---|
| 106.1 | C01AA05 | digoxin | parent. | 0.25 | MG | 6,99 | |
| 00435 | DIGOXIN SPOFA | inj 10x2ml/0.5mg | SPX | CZ |
| 106.2 | C01AA08 | metildigoxin | parent. | 0.2 | MG | 6,99 | |
| |
| 106.3 | C01AC01 | g-strofantin | parent. | 0.25 | MG | 23,46 | |
| 107 | C01BA | antiarytmika, třída la | p.o. | |
|---|
| 107.1 | C01B | ipratropium | p.o. | 30 | MG | 53,77 | |
| | |
| 107.2 | C01BA | detajmii bitartras | p.o. | 75 | MG | 14,39 | |
| 23113 | TACHMALCOR | drg 50x25mg | VAD | D |
| 107.3 | C01BA01 | chinidin | p.o. | 1.2 | GM | 19,36 | |
| 70549 | TBL.CHINIDINI SULFURICI 0.2 MVM | tbl 1000x0.2gm | MVM | CZ |
| 107.4 | C01BA01 | chinidin (retardované lékové formy) | p.o. | 1.2 | GM | 27,27 | |
|
| 107.5 | C01BA02 | prokainamid | p.o. | 3 | GM | 38,61 | |
|
| 107.6 | C01BA03 | disopyramid | p.o. | 0.4 | GM | 12,37 | |
|
| 107.7 | C01BA08 | prajmalin | p.o. | 30 | MG | 14,08 | |
| 90992 | NEO-GILURYTMAL | tbl obd 50x20mg | SVP | D |
| 108 | C01BA | antiarytmika, třída la | parent. | O |
|---|
| 108.1 | C01B | ipratropium | parent. | 3 | MG | 782,94 | O |
|
| 108.2 | C01BA02 | prokainamid | parent. | 3 | GM | 251,87 | O |
|
| 108.3 | C01BA03 | disopyramid | parent. | 0.4 | GM | 251,87 | O |
|
| 108.4 | C01BA05 | ajmalin | parent. | 0.3 | GM | 251,87 | O |
| 99356 | GILURYTMAL 10 I.V. | inj 5x10ml/50mg | GIU | D |
| 109 | C01BB | antiarytmika, třída Ib | p.o. | |
|---|
| 109.1 | C01BB02 | mexiletin | p.o. | 0.8 | GM | 9,68 | |
| 93311 | KATEN RETARD | tbl 50x400mg | SLO | SK |
| 109.2 | C01BB03 | tocainid | p.o. | 1.2 | GM | 10,22 | |
| 110 | C01BB | antiarytmika, třída Ib | parent. | O/INT,KAR |
|---|
| 110.1 | C01BB01 | lidokain | parent. | 1 | ML | 1,22 | O/INT, KAR |
| 30767 | LIDOCAIN 2% | inj 100x2ml/40mg | EGI | H |
| 110.2 | C01BB02 | mexiletin | parent. | 0.8 | GM | 351,64 | O/INT, KAR |
|
| 110.3 | C01BB03 | tocainid | parent. | 1.2 | GM | 351,64 | O/INT, KAR |
| 111 | C01BC | antiarytmika, třída Ic | p.o. | |
|---|
| 111.1 | C01BC03 | propafenon (méně než 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 17,16 | |
| 76761 | RYTMONORM 10 MG | tbl obd 500x10mg | KNO | D |
| 111.2 | C01BC03 | propafenon (od 100 mg do 150 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 6,70 | |
| 12188 | PROFENORM 150 MG | tbl obd 50x150mg | PMP | CZ |
| 53536 | PROPAFENON AL 150 | tbl. obd. 100x150mg | APA | D |
| 53534 | PROPAFENON AL 150 | tbl. obd.20x150mg | APA | D |
| 111.3 | C01BC03 | propafenon (nad 150 mg v jedné tabletě) | p.o. | 0.3 | GM | 5,70 | |
| 112 | C01BC | antiarytmika, třída Ic | parent. | O/INT,KAR |
|---|
| 112.1 | C01BC03 | propafenon | parent. | 0.3 | GM | 176,65 | O/INT, KAR |
| 91275 | PROLEKOFEN | inj 10x10ml/35mg | LEK | SLO |
| 112.2 | C01BC07 | lorcainid | parent. | 0.2 | GM | 139,01 | O/INT, KAR |
| 113 | C01BD | antiarytmika, třída III | p.o. | |
|---|
| 113.1 | C01BD01 | amiodaron | p.o. | 0.2 | GM | 4,20 | |
| 59655 | AMIOKORDIN | tbl 60x200 mg | KRK | SLO |
| 59284 | AMIOHEXAL 200 | tbl 20x200mg | SFS | D |
| 59285 | AMIOHEXAL 200 | tbl 50x200mg | SFS | D |
| 59286 | AMIOHEXAL 200 | tbl 100x200mg | SFS | D |
| 114 | C01BD | antiarytmika, třída III a adenosin | parent. | O/INT,KAR |
|---|
| 114.1 | C01BD01 | amiodaron | parent. | 0.2 | GM | 19,94 | O/INT, KAR |
| 96600 | SEDACORON | inj 5x3ml/150mg | EBW | A |
| 114.2 | C01BD02 | bretylium tosilát | parent. | 100 | MG | 139,01 | O/INT, KAR |
|
| 114.3 | C01EB10 | adenosin | parent. | 15 | MG | 728,30 | O/INT, KAR |
| 91615 | ADENOCOR | inj 6x2ml/6mg | SWI | F |
| 115 | C01CA | adrenergní a dopaminergní léčiva (norepinefrin a dopamin) | parent. | O |
|---|
| 115.1 | C01CA03 | norepinefrin | parent. | 6 | MG | 76,00 | O |
| 00536 | NORADRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ |
| 115.2 | C01CA04 | dopamin | parent. | 0.5 | GM | 109,39 | O |
| 04380 | TENSAMIN | inj 10x5ml | LEX | CZ |
| 116 | C01CA | adrenergní a dopaminergní léčiva (ostatní) | parent. | H |
|---|
| 116.1 | C01CA02 | isoprenalin | parent. | 90 | MG | 15620,16 | H |
|
| 116.2 | C01CA05 | norfenefrin | parent. | 25 | MG | 23,76 | H |
|
| 116.3 | C01CA07 | dobutamin | parent. | 0.5 | GM | 350,71 | H |
| 86762 | DOBUJECT | inf 5x5ml/250mg | LOY | SF |
| 92483 | DOBUDAMIN LACHEMA 250 | inj sic 1x250 mg | LCM | CZ |
| 01639 | DOBUTAMIN GIULINI | inj sic 10x250mg | WAU | D |
| 59267 | DOBUTAMIN LACHEMA 250 | inj sic 10x250mg | LCM | CZ |
| 84361 | DOBUTAMIN GIULINI | inj sic 1x250mg | WAU | D |
| 116.4 | C01CA09 | metaraminol | parent. | 50 | MG | 191,26 | H |
|
| 116.5 | C01CA10 | metoxamin | parent. | 30 | MG | 40,91 | H |
|
| 116.6 | C01CA11 | mepentermin | parent. | 30 | MG | 101,67 | H |
|
| 116.7 | C01CA17 | midodrin | parent. | 7.5 | MG | 83,44 | H |
|
| 116.8 | C01CA24 | epinefrin (lékové formy autoinjektoru) | parent. | 1 | DF | 684,31 | P |
Medicinal product containing epinephrine in autoinjector formulations is prescribed by an allergologist and a clinical immunologist in patients with a history of anaphylactic shock caused by an insect allergy.
| 116.9 | C01CA24 | epinefrin | parent. | 0.5 | MG | 4,50 | O |
| 00362 | ADRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ |
| 116.10 | C01CA14 | dopexamin | parent. | 500 | MG | 109,39 | H |
| 117 | C01CE | léčiva ze skupiny inhibitorů fosfodiesterázy | parent. | X |
|---|
| 117.1 | C01CE01 | amrinon | parent. | 0.5 | GM | 4146,65 | X |
| 91980 | WINCORAM | inj 10x20ml 5mg/ml | SWI | F |
| 117.2 | C01CE02 | milrinon | parent. | 50 | MG | 3980,00 | X |
| 118 | C01DA | vazodilatancia ze skupiny organických nitrátů | p.o. | |
|---|
| 118.1 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tablet) | p.o. | 5 | MG | 2,00 | |
|
| 118.2 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tobolek s peletami) | p.o. | 5 | MG | 3,00 | |
|
| 118.3 | C01DA02 | glycerol trinitrát (nad 2,5 mg v jedné tabletě) | p.o. | 5 | MG | 2,12 | |
| 31089 | NITROMINT 2.6MG | tbl ret 60x2.6mg | EGI | H |
| 118.4 | C01DA08 | isosorbid dinitrát (do 20 mg v jedné tabletě včetně) | p.o. | 60 | MG | 3,50 | |
| 02405 | DINISAN RETARD 20MG | cps ret 30x20mg | ETS | F |
| 118.5 | C01DA08 | isosorbid dinitrát (nad 80 mg v jedné tabletě) | p.o. | 60 | MG | 4,20 | |
| 91591 | CARDIKET RETARD 120 | cps ret 20x120mg | SWP | D |
| 118.6 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) retardované lékové formy | p.o. | 60 | MG | 2,50 | |
| 02379 | DINISAN RETARD 40MG | cps ret 30x40mg | ETS | F |
| 118.7 | C01DA14 | isosorbid mononitrát do 20 mg včetně v jedné tabletě | p.o. | 40 | MG | 2,75 | |
| 76402 | SORBIMON 20MG | tbl 100x20mg | MCK | D |
| 76401 | SORBIMON 20MG | tbl 50x20mg | MCK | D |
| 96190 | MONOSAN 20MG | tbl 30x20mg | PMP | CZ |
| 45821 | MONOSAN 20MG | tbl 500x20mg | PMP | CZ |
| 61467 | ISMN AL 20 | tbl 100x20mg | APA | D |
| 76400 | SORBIMON 20MG | tbl 20x20mg | MCK | D |
| 118.8 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) neretardované lékové formy | p.o. | 60 | MG | 1,25 | |
|
| 118.9 | C01DA14 | isosorbid mononitrát nad 20 mg v jedné tabletě | p.o. | 40 | MG | 2,49 | |
| 76405 | SORBIMON 40MG | tbl 100x40mg | MCK | D |
| 76403 | SORBIMON 40MG | tbl 20x40mg | MCK | D |
| 76404 | SORBIMON 40MG | tbl 50x40mg | MCK | D |
| 61469 | ISMN AL 40 | tbl 100x40 mg | APA | D |
| 45822 | MONOSAN 40MG | tbl 500x40mg | PMP | CZ |
| 96191 | MONOSAN 40MG | tbl 30x40mg | PMP | CZ |
| 119 | C01DA | vazodilatancia ze skupiny organických nitrátů | parent. | H |
|---|
| 119.1 | C01DA02 | glycerol trinitrát | parent. | 2.5 | MG | 13,59 | H |
| 04348 | NITRO-MACK | inj 10x5ml/5mg | MAC | D |
| 119.2 | C01DA08 | isosorbid dinitrát | parent. | 20 | MG | 123,96 | H |
| 120 | C01DA | vazodilatancia ze skupiny organických nitrátů | spr. | |
|---|
| 120.1 | C01DA02 | glycerol trinitrát | spr. | 5 | DF | 2,59 | |
| 60032 | MAYCOR NITROSPRAY-PUMPSPRAY | spr 1x11.8gm=14.5ml | PDA | D |
| 31407 | NITROMINT | aer dos 1x10gm | EGY | H |
| 53139 | NITRILEX | aer 1x14gm/205davek | GNO | CZ |
| 120.2 | C01DA08 | isosorbid dinitrát (mimo přípravků určených k transdermální aplikaci) | spr. | 20 | MG | 8,80 | |
| 121 | C01DA | vazodilatancia ze skupiny organických nitrátů | sublng. | |
|---|
| 121.1 | C01DA02 | glycerol trinitrát | sublng. | 2.5 | MG | 6,11 | |
| 00231 | NITROGLYCERIN SLOVAKOFARMA | tbl 20x0.5mg | SLO | SK |
| 121.2 | C01DA08 | isosorbid dinitrát | sublng. | 20 | MG | 3,03 | |
| 122 | C01DX | ostatní vazodilatancia | p.o. | |
|---|
| 122.1 | C01DX03 | oxifedrin | p.o. | 40 | MG | 4,79 | |
|
| 122.2 | C01DX12 | molsidomin (do 2 mg v jedné tabletě včetně) | p.o. | 6 | MG | 4,46 | |
| 49557 | MOLSIHEXAL 2MG | tbl 60x2mg | SFS | D |
| 86441 | MOLSIHEXAL 2MG | tbl 60x2mg | HEX | D |
| 76154 | CORVATON | tbl 30x2mg | HBS | SK |
| 122.3 | C01DX12 | molsidomin (nad 2 do 4 mg v jedné tabletě včetně) | p.o. | 6 | MG | 2,72 | |
| 49552 | MOLSIHEXAL 4MG | tbl 30x4mg | SFS | D |
| 49558 | MOLSIHEXAL 4MG | tbl 60x4mg | SFS | D |
| 83474 | MOLSIHEXAL 4MG | tbl 30x4mg | HEX | D |
| 86442 | MOLSIHEXAL 4MG | tbl 60x4mg | HEX | D |
| 76155 | CORVATON FORTE | tbl 30x4mg | HBS | SK |
| 122.4 | C01DX12 | molsidomin (nad 4 mg v jedné tabletě) | p.o. | 6 | MG | 2,10 | |
| 49560 | MOLSIHEXAL RETARD | tbl ret 30x8mg | HEX | D |
| 49561 | MOLSIHEXAL RETARD | tbl ret 60x8mg | HEX | D |
| 49559 | MOLSIHEXAL RETARD | tbl ret 100x8mg | HEX | D |
| 86443 | MOLSIHEXAL RETARD | tbl ret 60x8mg | HEX | D |
| 122.5 | C01EB15 | trimetazidin | p.o. | 40 | MG | 7,23 | L/INT, KAR |
| 123 | C01DX | ostatní vazodilatancia | parent. | H |
|---|
| 123.1 | C01DX03 | oxifedrin | parent. | 40 | MG | 13,78 | H |
|
| 123.2 | C01DX12 | molsidomin | parent. | 6 | MG | 105,38 | H |
| 87732 | CORVATON | inj 10x1ml/2mg | HOE | D |
| 124 | C01EA | prostaglandiny | parent. | X |
|---|
| 124.1 | C01EA01 | alprostadil | parent. | 0,5 | MG | 3100,00 | X |
| 92305 | ALPROSTAN | inf 10x0.2ml/100rg | LEX | CZ |
| 70426 | KARON | inj 0.2ml/100rg+sol | LEX | CZ |
| 61219 | PROSTIN VR | inj 1x1 ml/0.5mg | UPJ | B |
| 124.2 | C01EA01 | alprostadil (vázaný na cyklodextrin) | parent. | 20 | RG | 647,95 | X |
| 91731 | PROSTAVASIN | inj sic 10x20rg | SWP | D |
| 125 | C02 | antihypertenziva působící na centrální alfa-2 receptory a jejich kombinace s diuretiky | p.o. | |
|---|
| 125.1 | C02AB01 | methyldopa (levotočivá) | p.o. | 1 | GM | 7,28 | |
| 01328 | DOPEGYT | tbl 50x250mg | EGI | H |
| 125.2 | C02AC01 | klonidin | p.o. | 0.45 | MG | 9,14 | |
|
| 125.3 | C02AC02 | guanfacin | p.o. | 3 | MG | 9,14 | |
| |
| 125.4 | C02AC05 | moxonidin do 0,2 mg v 1 tabletě včetně | p.o. | 0.3 | MG | 9,14 | |
|
| 1125.5 | C02AC05 | moxonidin nad 0,2 mg v 1 tabletě | p.o. | 0.3 | MG | 8,68 | |
|
| 125.6 | C02LA51 | reserpin a diuretika | p.o. | 1 | DF | 1,56 | |
| 02629 | CRYSTEPIN | drg 30 | LEX | CZ |
| 125.7 | C02LB01 | methyldopa/hydrochlorothiazid (do 15 mg v jedné tabletě včetně) | p.o. | 3 | DF | 4,94 | |
| |
| 125.8 | C02LB01 | methyldopa/hydrochlorothiazid (nad 15 mg v jedné tabletě) | p.o. | 2 | DF | 3,42 | |
| |
| 125.9 | C02AC06 | rilmenidin | p.o. | 1 | MG | 8,68 | |
| 126 | C02A | antihypertenziva působící na centrální alfa-2 receptory | parent. | H |
|---|
| 126.1 | C02AC01 | klonidin | parent. | 0.45 | MG | 70,09 | H |
| 92074 | CATAPRESAN | inj 5x1 ml/0.15mg | BGP | D |
| 11823 | CATAPRESAN | inj 5x1 ml/0.15mg | BOE | D |
| 127 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | p.o. | |
|---|
| 127.1 | C02CA | metazosin | p.o. | 20 | MG | 5,96 | |
| |
| 127.2 | C02CA01 | prazosin (do 1 mg v jedné tabletě včetně) | p.o. | 5 | MG | 12,59 | |
| 94315 | DEPRAZOLIN MITE | tbl 10x1mg | LEX | CZ |
| 58259 | DEPRAZOLIN MITE | tbl 15x1mg | LEX | CZ |
| 127.3 | C02CA01 | prazosin (nad 1 mg v jedné tabletě) | p.o. | 5 | MG | 3,18 | |
| 88173 | DEPRAZOLIN | tbl 30x2mg | LEX | CZ |
| 127.4 | C02CA06 | urapidil | p.o. | 50 | MG | 6,89 | |
|
| 127.5 | C02CA04 | doxazosin-retardované formy do 4 mg v jedné tabletě včetně | p.o. | 4 | MG | 20,33 | L/URN |
|
| 127.6 | C02CA04 | doxazosin-retardované formy nad 4 mg v jedné tabletě | p.o. | 4 | MG | 11,00 | L/URN |
|
| 127.7 | C02CA04 | doxazosin – neretardované formy | p.o. | 4 | MG | 18,10 | L/URN |
| 45214 | ZOXON 2 | tbl 30x2mg | LEX | CZ |
| 45215 | ZOXON 4 | tbl 30x4mg | LEX | CZ |
| 64799 | KAMIREN 1 | tbl 30x1mg | KRK | SLO |
| 64798 | KAMIREN 2 | tbl 30x2mg | KRK | SLO |
| 64797 | KAMIREN 4 | tbl 30x4mg | KRK | SLO |
| 128 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | parent. | O |
|---|
| 128.1 | C02CA06 | urapidil | parent. | 50 | MG | 221,16 | O |
| 90763 | EBRANTIL I.V.25 | inj 5x5ml/25mg | BGL | D |
| 90765 | EBRANTIL I.V.50 | inj 5x10ml/50mg | BGL | D |
| 129 | C02D | antihypertenziva působící přímou vazodilataci | p.o. | |
|---|
| 129.1 | C02DB01 | dihydralazin | p.o. | 75 | MG | 2,00 | |
|
| 129.2 | C02DB03 | endralazin | p.o. | 10 | MG | 9,43 | |
| |
| 129.3 | C02DC01 | minoxidil | p.o. | 20 | MG | 20,14 | L/INT,KAR |
| 130 | C02D | antihypertenziva působící přímou vazodilataci | parent. | H |
|---|
| 130.1 | C02DA01 | diazoxid | parent. | 300 | MG | 283,99 | H |
| | |
| 130.2 | C02DB01 | dihydralazin | parent. | 25 | MG | 30,40 | H |
| 90484 | NEPRESOL | inj 5x25mg+solv. | CGC | CH |
| 130.3 | C02DD01 | nitroprusid sodný | parent. | 50 | MG | 273,97 | H |
| 131 | C03AA | thiazidová diuretika | p.o. | |
|---|
| 131.1 | C03AA03 | hydrochlorothiazid | p.o. | 25 | MG | 0,90 | |
| 00168 | HYDROCHLOROTHIAZID LECIVA | tbl 20x25mg | LEX | CZ |
| 132 | C03B | sulfonamidová diuretika a antihypertenziva | p.o. | |
|---|
| 132.1 | C03BA | metipamid | p.o. | 2.5 | MG | 1,03 | |
| 94810 | HYPOTYLIN | tbl 30x2.5mg | LEX | CZ |
| 132.2 | C03BA04 | chlortalidon | p.o. | 25 | MG | 0,59 | |
| 83551 | URANDIL | tbl 30x50mg(blistr.) | LEX | CZ |
| 132.3 | C03BA10 | xipamid | p.o. | 20 | MG | 1,03 | |
|
| 132.4 | C03BA11 | indapamid | p.o. | 2.5 | MG | 1,12 | |
| 96696 | INDAP | cps 30x2.5mg | PMP | CZ |
| 132.5 | C03B | cikletanin | p.o. | 50 | MG | 1,03 | |
|
| 132.6 | C03BA11 | indapamid s řízeným uvolňováním | p.o. | 1,5 | MG | 1,12 | |
| 133 | C03CA | kličková diuretika | p.o. | |
|---|
| 133.1 | C03CA01 | furosemid (méně než 125 mg v jedné tabletě) | p.o. | 40 | MG | 0,88 | |
| 98219 | FURON 40MG | tbl 50x40mg | MCK | D |
| 56347 | APO-FUROSEMIDE 40MG | tbl 100x40mg | APT | CND |
| 96738 | APO-FUROSEMIDE 80MG | tbl 100x80mg | APT | CND |
| 02079 | FUROSEMID SLOVAKOFARMA | tbl 2x10x40mg | SLO | SK |
| 97935 | FURSEMID | tbl 100x40mg | BLU | CHO |
| 96328 | FURSEMID | tbl 12x40mg | BLU | CHO |
| 76031 | FURSEMID | tbl 48x40mg | BLU | CHO |
| 133.2 | C03CA01 | furosemid (125 mg a více v jedné tabletě) | p.o. | 40 | MG | 1,08 | |
| 02785 | FUROSEMID SLOVAKOFARMA FORTE | tbl 10x250mg | SLO | SK |
| 56815 | FURORESE 500 | tbl 100x500mg | FST | D |
| 56814 | FURORESE 500 | tbl 50x500mg | FST | D |
| 56812 | FURORESE 250 | tbl 100x250mg | FST | D |
| 56807 | FURORESE 125 | tbl 30x125mg | FST | D |
| 56808 | FURORESE 125 | tbl 50x125mg | FST | D |
| 56809 | FURORESE 125 | tbl 100x125mg | FST | D |
| 56810 | FURORESE 250 | tbl 20x250mg | FST | D |
| 56811 | FURORESE 250 | tbl 50x250mg | FST | D |
| 68632 | FURORESE 500 | tbl 20x500mg | FST | D |
| 133.3 | C03CA04 | torasemid (do 10 mg v jedné tabletě včetně) | p.o. | 15 | MG | 0,88 | |
|
| 133.4 | C03CA04 | torasemid (nad 10 mg v jedné tabletě) | p.o. | 15 | MG | 1,08 | |
| 134 | C03CA | kličková diuretika | parent. | O |
|---|
| 134.1 | C03CA01 | furosemid (méně než 125 mg v jedné ampuli) | parent. | 40 | MG | 15,04 | O |
| 02133 | FUROSEMID BIOTIKA | inj 5x2ml/20mg | BTA | SK |
| 134.2 | C03CA01 | furosemid (125 mg a více v jedné ampuli) | parent. | 40 | MG | 7,36 | O |
| 99333 | FUROSEMID BIOTIKA FORTE | inj 10x10ml/125mg | HBS | SK |
| 134.3 | C03CA04 | torasemid (do 10 mg v jedné ampuli včetně) | parent. | 15 | MG | 16,03 | O |
|
| 134.4 | C03CA04 | torasemid (nad 10 mg v jedné ampuli) | parent. | 15 | MG | 7,72 | O |
|
| 134.5 | C03C | kyselina etakrynová | parent. | 50 | MG | 543,63 | O |
| 135 | C03D | kalium šetřící diuretika | p.o. | |
|---|
| 135.1 | C03DA01 | spironolakton | p.o. | 75 | MG | 4,84 | |
| 96361 | XENALON-50 | tbl obd 20x50mg | MHA | CH |
| 96362 | XENALON-100 | tbl obd 20x100mg | MHA | CH |
| 135.2 | C03DB01 | amilorid | p.o. | 10 | MG | 1,56 | |
| 87662 | AMICLARAN | tbl 50x5mg | SLO | SK |
| 135.3 | C03DB02 | triamteren | p.o. | 100 | MG | 1,22 | |
| 136 | C03EA | kombinace thiazidových a kalium šetřících diuretik | p.o. | |
|---|
| 136.1 | C03EA | středně silná diuretika a kalium šetřící látky | p.o. | 1 | DF | 1,17 | |
| 88518 | AMICLOTON | tbl 30 | SLO | SK |
| 136.2 | C03EA01 | hydrochlorothiazid a kalium šetřící látky | p.o. | 0.5 | DF | 0,54 | |
| 83717 | AMILORID HCT AL | tbl 50 | APA | D |
| 83718 | AMILORID HCT AL | tbl 100 | APA | D |
| 76380 | RHEFLUIN | tbl 30 | LEX | CZ |
| 89125 | LORADUR MITE | tbl 50x2.5mg/25mg | MCK | A |
| 136.3 | C03EA14 | spironolakton/butizid | p.o. | 1 | DF | 9,78 | |
| 137 | C04AB | periferní vazodilatancia ze skupiny derivátů imidazolu | parent. | O |
|---|
| 137.1 | C04AB01 | fentolamin | parent. | 10 | MG | 20,82 | O |
|
| 137.2 | C04AB02 | tolazolin | parent. | 75 | MG | 83,14 | O |
| 00440 | DIVASCOL | inj 10x1ml/10mg | SPX | CZ |
| 138 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | p.o. | |
|---|
| 138.1 | C04AC01 | kyselina nikotinová | p.o. | 0.2 | GM | 0,44 | |
|
| 138.2 | C04AD04 | etophyllin nikotinát | p.o. | 0.3 | GM | 1,65 | |
| 00243 | OXYPHYLLIN | tbl 50x100mg | SLO | SK |
| 138.3 | C04AD02 | xantinol nikotinát | p.o. | 0.9 | GM | 4,57 | |
|
| 138.4 | C04AD03 | pentoxifyllin (do 100 mg v jedné tabletě včetně) | p.o. | 1 | GM | 4,57 | |
|
| 138.5 | C04AD03 | pentoxifyllin (nad 100 mg do 400 mg v jedné tabletě včetně) | p.o. | 1 | GM | 7,10 | |
| 66513 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 30x400mg | APA | D |
| 89991 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 50x400mg | APA | D |
| 89992 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 100x400mg | APA | D |
| 54247 | APO-PENTOXIFYLLINE SR | tbl ret 100x400mg | APT | CND |
| 53479 | TRENTAL 400 | tbl flm 20x400mg | HBS | SK |
| 53480 | TRENTAL 400 | tbl flm 100x400mg | HBS | SK |
| 138.6 | C04AD03 | pentoxifyllin (nad 400 mg v jedné tabletě) | p.o. | 1 | GM | 7,90 | |
| 97702 | PENTOMER RETARD 600MG | tbl obd 20x600mg | MCK | D |
| 49600 | PENTOHEXAL 600 | tbl ret 30x600mg | SFS | D |
| 49601 | PENTOHEXAL 600 | tbl ret 50x600mg | SFS | D |
| 139 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | parent. | |
|---|
| 139.1 | C04AC | olamin nikotinát | parent. | 0.9 | GM | 20,04 | |
| |
| 139.2 | C04AD | etophyllin/theophyllin | parent. | 0.3 | GM | 11,05 | |
| 57351 | OXANTIL | inj 5x2 ml | HBS | SK |
| 139.3 | C04AD02 | xantinol nikotinát | parent. | 0.9 | GM | 4,25 | |
| |
| 139.4 | C04AD03 | pentoxifyllin | parent. | 0.3 | GM | 28,40 | |
| 53200 | AGAPURIN | inj 5x5ml/100mg | SLO | SK |
| 69241 | PENTILIN 100 | inj 5x5ml/100mg | KRK | SLO |
| 43709 | TRENTAL | inf 10x15ml/300mg | HBS | SK |
| 49603 | PENTOHEXAL 300 | inf 10x15ml/300mg | PHH | D |
| 140 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | p.o. | |
|---|
| 140.1 | C04AE01 | hydrogenované ergotové alkaloidy | p.o. | 3 | MG | 2,08 | |
|
| 140.2 | C04AE02 | nicergolin | p.o. | 30 | MG | 8,50 | |
|
| 140.3 | C04AE54 | dihydroergokristin, kombinace | p.o. | 2 | ML | 1,79 | |
| 88088 | ERSILAN | gtt 50ml | GNO | CZ |
| 141 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | parent. | |
|---|
| 141.1 | C04AE01 | hydrogenované ergotové alkaloidy | parent. | 3 | MG | 69,21 |
| 142 | C04AX | jiná periferní vasodilatancia | p.o. | |
|---|
| 142.1 | C04AX | jiná periferní vasodilatancia | p.o. | 3 | DF | 5,72 | |
| | |
| 142.2 | C04AX02 | fenoxybenzamin | p.o. | 30 | MG | 15,54 | |
| | |
| 142.3 | C04AX19 | sulkotidil | p.o. | 0.3 | GM | 5,72 | |
| | | |
| 142.4 | C04AX20 | buflomedil | p.o. | 0.6 | GM | 5,72 | |
| | |
| 142.5 | C04AX21 | naftidrofuryl | p.o. | 0.2 | GM | 5,72 | |
| 97026 | ENELBIN 100 RETARD | tbl ret 50x100mg | LEX | CZ |
| 66015 | ENELBIN 100 RETARD | tbl ret 100x100mg | LEX | CZ |
| 143 | C04AX | jiná periferní vasodilatancia | parent. | |
|---|
| 143.1 | C04AX | jiná periferní vasodilatancia | parent. | 2 | DF | 14,86 | |
| |
| 143.2 | C04AX11 | bencyklan | parent. | 0.6 | GM | 51,52 | |
| |
| 143.3 | C04AX21 | naftidrofuryl | parent. | 0.2 | GM | 51,52 | |
| 98049 | ENELBIN | inj 10x5ml/40mg | LEX | CZ |
| 144 | C05AD | antihemorhoidalia obsahující lokální anestetika | lok. | |
|---|
| 144.1 | C05AD | přípravky obsahující lokální anestetika (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
|
| 144.2 | C05AD | přípravky obsahující lokální anestetika (lékové formy mastí) | lok. | 1 | GM | 0,81 | |
|
| 144.3 | C05AD01 | lidokain (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
|
| 144.4 | C05AD01 | lidokain (lékové formy mastí) | lok. | 1 | GM | 0,81 | |
|
| 144.5 | C05AD04 | cinchokain (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
|
| 144.6 | C05AD04 | cinchokain (lékové formy mastí) | lok. | 1 | GM | 0,81 | |
| 00832 | AVIRIL H | ung 1x30gm | LEX | CZ |
| 145 | C05AX | jiná antihemorrhoidalia k zevnímu použití | lok. | |
|---|
| 145.1 | C05AX02 | bismutové přípravky, kombinace (lékové formy mastí) | lok. | 1 | GM | 0,78 | |
|
| 145.2 | C05AX02 | bismutové přípravky, kombinace (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
|
| 145.3 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy mastí) | lok. | 1 | GM | 0,78 | |
|
| 145.4 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
| 146 | C05BA | lokální léčiva s heparinem nebo heparinoidy k zevnímu použití | lok. | |
|---|
| 146.1 | C05BA01 | organo-heparinoidy | lok. | 1 | GM | 0,83 | |
| 03575 | HEPAROID LECIVA | ung 1x30gm | LEX | CZ |
| 146.2 | C05BA03 | heparin k zevnímu použití | lok. | 1 | GM | 0,83 | |
| 86042 | HEPARIN AL SALBE 30000 | ung 1x100gm | APA | D |
| 86044 | HEPARIN AL GEL 30000 | gel 1x100gm | APA | D |
| 146.3 | C05BA53 | heparin, kombinace k zevnímu použití | lok. | 1 | GM | 0,83 | |
| 147 | C05CA | kapiláry stabilizující léčiva ze skupiny flavonoidů | p.o. | |
|---|
| 147.1 | C05CA51 | rutosidy (kombinace, pevné lékové formy) | p.o. | 3 | DF | 1,37 | |
| 96303 | ASCORUTIN | tbl obd 50 | SLO | SK |
| 147.2 | C05CA51 | rutosidy (kombinace, tekuté lékové formy) | p.o. | 2 | ML | 3,03 | |
| 02635 | ANAVENOL | gtt 1x25ml | GNO | CZ |
| 147.3 | C05CA04 | troxerutin | p.o. | 0.9 | GM | 4,50 | |
|
| 147.4 | C05CA53 | diosmin, kombinace | p.o. | 2 | DF | 6,52 | |
|
| 147.5 | C05CA54 | troxerutin, kombinace | p.o. | 2 | DF | 6,52 | |
| 148 | C05 | jiné kapiláry stabilizující látky | p.o. | |
|---|
| 148.1 | C05BX01 | dobesilat vápenatý | p.o. | 0.75 | GM | 6,52 | |
|
| 148.2 | C05CX | jiné kapiláry stabilizující látky (escin) | p.o. | 60 | MG | 6,52 | |
| 94327 | YELLON | cps 30x20mg | SLO | SK |
| 148.3 | C05CX01 | tribenosid | p.o. | 0.6 | GM | 4,50 | |
| 149 | C05 | jiné kapiláry stabilizující látky | parent. | H |
|---|
| 149.1 | C05CX | jiné kapiláry stabilizující látky (escin) | parent. | 5 | MG | 54,26 | H |
|
| 149.2 | C05BB02 | polidokanol (do 0,5% včetně) | parent. | 1 | ML | 14,38 | O |
| 08512 | AETHOXYSKLEROL 0,5% | inj 1x30ml 0,5% | KRS | D |
| 08510 | AETHOXYSKLEROL 0,5% | inj 5x2ml 0.5% | KRS | D |
| 149.3 | C05BB02 | polidokanol (nad 0,5 do 1 % včetně) | parent. | 1 | ML | 16,55 | O |
| 20034 | AETHOXYSKLEROL 1% | inj 1x30ml 1% | KRS | D |
| 20033 | AETHOXYSKLEROL 1% | inj 5x2ml 1% | KRS | D |
| 149.4 | C05BB02 | polidokanol (nad 1% do 3 % včetně) | parent. | 1 | ML | 18,43 | O |
| 08511 | AETHOXYSKLEROL 2% | inj 5x2ml 2% | KRS | D |
| 02529 | AETHOXYSKLEROL 3% | inj 5x2ml 3% | KRS | D |
| 149.5 | C05BB02 | polidokanol (více než 3 %) | parent. | 1 | ML | 19,94 | O |
| 90799 | AETHOXYSKLEROL 4% | inj 5x2ml 4% | KRS | D |
| 150 | C07AA | beta-blokátory, bez beta-1 selektivity (sotalol) | p.o. | L/KAR,INT |
|---|
| 150.1 | C07AA07 | Sotalol | p.o. | 0.16 | GM | 5,12 | L/KAR,INT |
| 83671 | SOTAHEXAL | tbl 100x160mg | HEX | D |
| 151 | C07AA | beta-blokátory, bez beta-1 selektivity (ostatní) | p.o. | |
|---|
| 151.1 | C07AA | metipranolol (do 5 mg včetně v 1 tabletě) | p.o. | 10 | MG | 0,78 | |
|
| 151.2 | C07AA | metipranolol (nad 5 do 10 mg včetně v 1 tabletě) | p.o. | 10 | MG | 0,75 | |
| 02483 | TRIMEPRANOL | tbl 50x10mg | SLO | SK |
| 151.3 | C07AA | metipranolol (nad 10 mg v 1 tabletě) | p.o. | 10 | MG | 0,29 | |
| 02484 | TRIMEPRANOL | tbl 50x40mg | SLO | SK |
| 151.4 | C07AA02 | Oxprenolol | p.o. | 0.1 | GM | 2,74 | |
|
| 151.5 | C07AA03 | pindolol | p.o. | 15 | MG | 2,74 | |
|
| 151.6 | C07AA05 | propranolol | p.o. | 0.16 | GM | 2,74 | |
|
| 151.7 | C07AA12 | nadolol. | p.o. | 0.16 | GM | 2,74 | |
|
| 151.8 | C07AA16 | tertatolol | p.o. | 5 | MG | 2,74 | |
|
| 151.9 | C07AA17 | bopindolol | p.o. | 1 | MG | 4,30 | |
| 96998 | SANDONORM | tbl 30x1mg | LEX | CZ |
| 151.10 | C07AA23 | penbutolol | p.o. | 40 | MG | 2,74 | |
|
| 151.11 | C07AA27 | kloranolol | p.o. | 20 | MG | 2,74 | |
| 152 | C07AA | beta-blokátory, bez beta-1 selektivity | parent. | O |
|---|
| 152.1 | C07AA | metipranolol | parent. | 10 | MG | 62,70 | O |
| 85886 | TRIMEPRANOL | inj 10x1ml/1mg | HBS | SK |
| 152.2 | C07AA | talinolol | parent. | 50 | MG | 93,65 | O |
|
| 152.3 | C07AA02 | oxprenolol | parent. | 0.1 | GM | 99,13 | O |
|
| 152.4 | C07AA03 | pindolol | parent. | 15 | MG | 99,13 | O |
|
| 152.5 | C07AA07 | sotalol | parent. | 0.16 | GM | 900,64 | O |
| 153 | C07AB | beta-blokátory, s beta-1 selektivitou | p.o. | |
|---|
| 153.1 | C07AB02 | metoprolol (do 0,05 GM včetně v jedné tabletě) | p.o. | 0.15 | GM | 2,93 | |
| 96753 | APO-METOPROLOL 50 | tbl 100x50mg | APT | CND |
| 50080 | VASOCARDIN 50 | tbl 50x50mg - blistr | SLO | SK |
| 54150 | EGILOK 25MG | tbl 60x25mg | EGI | H |
| 54151 | EGILOK 50MG | tbl 60x50mg | EGI | H |
| 54152 | EGILOK 50MG | tbl 200x50mg | EGI | H |
| 153.2 | C07AB02 | metoprolol (nad 0,05 GM v jedné tabletě) | p.o. | 0.15 | GM | 2,74 | |
| 45555 | BETALOC 100MG | tbl 100x100mg | APN | S |
| 45592 | VASOCARDIN 100 | tbl 50x100mg-blistr | SLO | SK |
| 59894 | EGILOK 100MG | tbl 200x100mg | EGI | H |
| 59893 | EGILOK 100MG | tbl 60x100mg | EGI | H |
| 153.3 | C07AB02 | metoprolol - retardované lékové formy | p.o. | 0.15 | GM | 3,52 | |
| 46980 | BETALOC SR 200 MG | tbl ret 100x200 mg | APN | S |
| 46981 | BETALOC SR 200 MG | tbl ret 30x200 mg | APN | S |
| 153.4 | C07AB02 | metoprolol (léková forma tablet y s řízeným uvolňováním ) do 25 mg v jedné tabletě včetně | p.o. | 0.15 | GM | 35,20 | P |
Metoprolol succinate up to 25 mg is administered by an internist or cardiologist to treat heart failure, especially advanced stages, and is intended only for the introduction of treatment for an essential period of time and can be prescribed in up to 3 packs per patient. The indication of the treatment of hypertension cannot be covered by health insurance.
| 153.5 | C07AB02 | metoprolol (léková forma tablety s řízeným uvolňováním ) nad 25 mg v jedné tabletě | p.o. | 0.15 | GM | 5,12 | |
|
| 153.6 | C07AB03 | atenolol do 50 mg v jedné tabletě včetně | p.o. | 75 | MG | 3,35 | |
| 62856 | ATENOBENE 50MG | tbl obd 20x50mg | MCK | D |
| 62857 | ATENOBENE 50MG | tbl obd 50x50mg | MCK | D |
| 72987 | CATENOL 50 | tbl 100x50mg | CAD | IND |
| 83638 | ATEHEXAL 25 | tbl obd 30x25mg | HEX | D |
| 83639 | ATEHEXAL 25 | tbl obd 50x25mg | HEX | D |
| 83640 | ATEHEXAL 25 | tbl obd 100x25mg | HEX | D |
| 83643 | ATEHEXAL 50 | tbl obd 50x50mg | HEX | D |
| 83644 | ATEHEXAL 50 | tbl obd 100x50mg | HEX | D |
| 89257 | ATENOLOL AL 50 | tbl obd 100x50mg | APA | D |
| 89254 | ATENOLOL AL 25 | tbl obd 100x25mg | APA | D |
| 75001 | APO-ATENOL 50MG | tbl 100x50mg | APT | CND |
| 153.7 | C07AB03 | atenolol nad 50 mg v jedné tabletě | p.o. | 75 | MG | 3,10 | |
| 72988 | CATENOL 100 | tbl 100x100mg | CAD | IND |
| 45208 | CATENOL 100 | tbl 100x100mg | CAI | IND |
| 83648 | ATEHEXAL 100. | tbl obd 100x100mg | HEX | D |
| 83648 | ATEHEXAL 100 | tbl obd 100x100mg | HEX | D |
| 83646 | ATEHEXAL 100 | tbl obd 30x100mg | HEX | D |
| 83647 | ATEHEXAL 100 | tbl obd 50x100mg | HEX | D |
| 89259 | ATENOLOL AL 100 | tbl obd 50x100mg | APA | D |
| 89260 | ATENOLOL AL 100 | tbl obd 100x100mg | APA | D |
| 96445 | COROTENOL 100 | tbl obd 30x100mg | MHA | CH |
| 62860 | ATENOBENE 100MG | tbl obd 50x100mg | MCK | D |
| 75003 | APO-ATENOL 100MG | tbl 100x100mg | APT | CND |
| 153.8 | C07AB04 | acebutolol | p.o. | 0.4 | GM | 5,12 | |
|
| 153.9 | C07AB05 | betaxolol | p.o. | 20 | MG | 5,12 | |
|
| 153.10 | C07AB07 | bisoprolol | p.o. | 10 | MG | 5,12 | |
|
| 153.11 | C07AB08 | Celiprolol | p.o. | 0.2 | GM | 5,12 | |
| 59761 | TENOLOC 200 | tbl obd 30x20mg | LEX | CZ |
| 153.12 | C07AB12 | nebivolol | p.o. | 5 | MG | 5,12 | |
| 154 | C07AB | beta-blokátory, s beta-1 selektivitou | parent | O |
|---|
| 154.1 | C07AB02 | metoprolol | parent. | 0.15 | GM | 1398,18 | O |
|
| 154.2 | C07AB03 | atenolol | parent. | 75 | MG | 1878,19 | O |
| 65387 | TENORMIN | inj 10x10ml/5mg | ZNC | GB |
| 154.3 | C07AB04 | acebutolol | parent. | 0.4 | GM | 1398,18 | O |
|
| 154.4 | C07AB09 | esmolol | parent. | 2,5 | GM | 4836,19 | H |
| 58412 | BREVIBLOC 250MG/ML | inf cnc sol 1x100ml | BXT | GB |
| 155 | C07AG | alfa, beta-blokátory | p.o. | L/KAR,INT |
|---|
Carvediol is administered by an intern or cardiologist to treat heart failure, especially advanced stages. 6.25 mg carvediol is intended only for the introduction of treatment for an essential period of time and can be prescribed in up to 3 packs per patient. The target dose of carvediol in this indication is 25-50 mg daily. The indication of the treatment of hypertension cannot be covered by health insurance.
| 155.1 | C07AG01 | labetalol | p.o. | 0.6 | GM | 19,50 | L/KAR,INT |
| 87669 | TRANDATE | tbl 250x200mg | GLA | GB |
| 155.2 | C07AG02 | karvedilol (do 6,25 mg v 1 tabletě včetně) | p.o. | 37.5 | MG | 46,00 | P |
|
| 155.3 | C07AG02 | karvedilol (nad 6,25 mg v 1 tabletě) | p.o. | 37.5 | MG | 21,00 | P |
| 156 | C07AG | alfa, beta-blokátory | parent. | H |
|---|
| 156.1 | C07AG01 | labetalol | parent. | 0.6 | GM | 1027,60 | H |
| 45145 | TRANDATE | inj 5x20ml/100mg | MEH | GB |
| 157 | C07F | beta-blokátory v kombinaci s jinými antihypertenzivy | p.o. | |
| 157.1 | C07CB03 | atenolol a jiná diuretika | p.o. | 1 | DF | 4,34 | |
| 76715 | TENORETIC | tbl obd 28 | ZNC | GB |
| 157.2 | C07CA17 | bopindolol a thiazidy | p.o. | 1 | DF | 4,34 | |
|
| 157.3 | C07FA | beta-blokátory, neselektivní, a jiná antihypertens. | p.o. | 0.5 | DF | 0,73 | |
| 76981 | TRIMECRYTON | tbl 30(blistr) | LEX | CZ |
| 157.4 | C07BB07 | bisoprolol a thiazidy | p.o. | 1 | DF | 3,71 | |
| 158 | C08CA | antagonisté vápníku dihydropyridinové řady | p.o. | |
| 158.1 | C08CA01 | amlodipin | p.o. | 5 | MG | 7,22 | |
|
| 158.2 | C08CA02 | felodipin | p.o. | 5 | MG | 5,53 | |
|
| 158.3 | C08CA03 | isradipin | p.o. | 5 | MG | 5,28 | |
|
| 158.4 | C08CA03 | isradipin (retardované lékové formy) | p.o. | 5 | MG | 5,53 | |
|
| 158.5 | C08CA05 | nifedipin | p.o. | 30 | MG | 1,56 | |
|
| 158.6 | C08CA05 | nifedipin (retardované lékové formy s obsahem 20 mg) | p.o. | 30 | MG | 2,10 | |
| 91692 | NIFECARD RETARD | tbl ret 30x20mg | LEK | SLO |
| 65381 | NIFEHEXAL 20 RETARD | tbl obd 50x20mg | HEX | D |
| 65382 | NIFEHEXAL 20 RETARD | tbl obd 100x20mg | HEX | D |
| 93460 | CORDIPIN RETARD | tbl ret 30x20mg | KRK | SLO |
| 158.7 | C08CA05 | nifedipin (retardované lékové formy s obsahem 40 mg) | p.o. | 30 | MG | 1,37 | |
| 65383 | NIFEHEXAL 40 RETARD | tbl obd 30x40mg | HEX | D |
| 65384 | NIFEHEXAL 40 RETARD | tbl obd 50x40mg | HEX | D |
| 65385 | NIFEHEXAL 40 RETARD | tbl obd 100x40mg | HEX | D |
| 158.8 | C08CA05 | nifedipin (lékové formy s retardací 24 hodin) | p.o. | 1 | DF | 5,77 | |
| 03033 | CORDIPIN XL | tbl ret 30x40mg | KRK | SLO |
| 55910 | CORDIPIN XL | tbl ret 20x40mg | KRK | SLO |
| 158.9 | C08CA06 | nimodipin | p.o. | 0.3 | GM | 136,08 | X |
| 94189 | DILCEREN | tbl obd 50x30mg | SLO | SK |
| 158.10 | C08CA07 | nisoldipin | p.o. | 20 | MG | 5,53 | |
|
| 158.11 | C08CA08 | nitrendipin | p.o. | 20 | MG | 5,53 | |
| 69305 | UNIPRES 10 | tbl 20x10mg | KRK | SLO |
| 03079 | UNIPRES 10 | tbl 30x10mg | KRK | SLO |
| 03078 | UNIPRES 20 | tbl 30x20mg | KRK | SLO |
| 69306 | UNIPRES 20 | tbl 20x20mg | KRK | SLO |
| 83082 | LUSOPRESS | tbl 28x20mg | LUS | I |
| 158.12 | C08CA09 | lacidipin | p.o. | 4 | MG | 7,22 | |
| 59912 | LACIPIL 4MG | tbl obd 28x4mg | GLA | E |
| 158.13 | C08CA10 | nilvadipin | p.o. | 8 | MG | 6,50 | |
|
| 158.14 | C08CX01 | mibefradil | p.o. | 50 | MG | 13,20 | L/INT,KAR |
| 159 | C08CA | antagonisté vápníku dihydropyridinové řady | parent. | H |
| 159.1 | C08CA03 | isradipin | parent. | 5 | MG | 3074,59 | H |
|
| 159.2 | C08CA05 | nifedipin | parent. | 30 | MG | 3074,59 | H |
|
| 159.3 | C08CA06 | nimodipin | parent. | 50 | MG | 3438,25 | X |
| 88858 | NIMOTOP S | inf 1x50ml/10mg | BAY | D |
| 94535 | NIMOTOP S | inf 5x50ml/10mg | BAY | D |
| 160 | C08DA | antagonisté vápníku fenylalkylaminové řady | p.o. | |
|---|
| 160.1 | C08DA01 | verapamil neretardované lékové formy do 240 mg v jedné tabletě včetně | p.o. | 0.24 | GM | 5,00 | |
| 56152 | VERAHEXAL 40 | tbl obd 30x40mg | FST | D |
| 56153 | VERAHEXAL 40 | tbl obd 50x40mg | FST | D |
| 56154 | VERAHEXAL 40 | tbl obd 100x40mg | FST | D |
| 56155 | VERAHEXAL 80 | tbl obd 30x80mg | FST | D |
| 56156 | VERAHEXAL 80 | tbl obd 50x80mg | FST | D |
| 56157 | VERAHEXAL 80 | tbl obd 100x80mg | FST | D |
| 56158 | VERAHEXAL 120 | tbl obd 30x120mg | FST | D |
| 56159 | VERAHEXAL 120 | tbl obd 50x120mg | FST | D |
| 56160 | VERAHEXAL 120 | tbl obd 100x120mg | FST | D |
| 77034 | VERAPAMIL AL 40 | tbl obd 50x40mg | APA | D |
| 77035 | VERAPAMIL AL 40 | tbl obd 100x40mg | APA | D |
| 77036 | VERAPAMIL AL 80 | tbl obd 50x80mg | APA | D |
| 77037 | VERAPAMIL AL 80 | tbl obd 100x80mg | APA | D |
| 86045 | VERAPAMIL AL 120 | tbl obd 50x120mg | APA | D |
| 86046 | VERAPAMIL AL 120 | tbl obd 100x120mg | APA | D |
| 99305 | VERAPAMIL 40-SLOVAKOFARMA | tbl obd 30x40mg | SLO | SK |
| 99306 | VERAPAMIL 80-SLOVAKOFARMA | tbl obd 30x80mg | SLO | SK |
| 160.2 | C08DA01 | verapamil (retardované lékové formy s obsahem 240 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 5,77 | |
| 43877 | VEROGALID ER 240MG | tbl ret 30x240mg | GNO | CZ |
| 43879 | VEROGALID ER 240MG | tbl ret 100x240mg | GNO | CZ |
| 56164 | VERAHEXAL RR | tbl ret 30x240mg | FST | D |
| 56165 | VERAHEXAL RR | tbl ret 50x240mg | FST | D |
| 56166 | VERAHEXAL RR | tbl ret 100x240mg | FST | D |
| 93679 | LEKOPTIN RETARD | tbl obd 20x240mg | LEK | SLO |
| 160.3 | C08DA02 | gallopamil | p.o. | 0.1 | GM | 5,00 | |
| 161 | C08DA | antagonisté vápníku fenylalkylaminové řady | parent. | H |
|---|
| 161.1 | C08DA01 | verapamil | parent. | 0.24 | GM | 360,71 | H |
| 09210 | LEKOPTIN | inj 50x2ml/5mg | LEK | SLO |
| 162 | C08DB | antagonisté vápníku benzothiazepinové řady | p.o. | |
|---|
| 162.1 | C08DB01 | diltiazem | p.o. | 0.24 | GM | 5,28 | |
| 93186 | BLOCALCIN | tbl 50x60mg | LCM | CZ |
| 94321 | BLOCALCIN 90 RETARD | tbl ret 30x90mg | LCM | CZ |
| 94314 | DIACORDIN 60 | tbl 50x60mg | LEX | CZ |
| 93711 | DIACORDIN 90 RETARD | tbl 30x90mg | LEX | CZ |
| 162.2 | C08DB01 | diltiazem (retardované lékové formy s obsahem 120 mg a více) | p.o. | 0.24 | GM | 5,77 | |
| 76736 | DIACORDIN 120 RETARD | tbl ret 30x120mg | LEX | CZ |
| 58752 | DIACORDIN 240 SR | cps ret 30x240mg | LEX | CZ |
| 163 | C08DB | antagonisté vápníku benzothiazepinové řady | parent. | H |
|---|
| 163.1 | C08DB01 | diltiazem | parent. | 25 | MG | 319,18 | H |
| 164 | C09AA | inhibitory angiotenzin konvertujícího enzymu | p.o. | |
|---|
| 164.1 | C09AA01 | kaptopril (do 12,5 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,52 | |
| 31385 | TENSIOMIN 12.5MG | tbl 30x12.5mg | EGI | H |
| 47282 | TENSIOMIN 12.5MG | tbl 200x12.5mg | EGI | H |
| 49564 | TENSIOMIN 12.5MG | tbl 90x12.5mg | EGI | H |
| 56200 | CAPOTEN 12.5MG | tbl 90x12.5mg | BMS | AUS |
| 96903 | APO-CAPTO | tbl 100x12.5mg | APT | CND |
| 164.2 | C09AA01 | kaptopril (nad 12,5 mg do 25 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,25 | |
| 31215 | TENSIOMIN 25MG | tbl 30x25mg | EGI | H |
| 47283 | TENSIOMIN 25MG | tbl 200x25mg | EGI | H |
| 49562 | TENSIOMIN 25MG | tbl 90x25mg | EGI | H |
| 68839 | APO-CAPTO 25MG | tbl 100x25mg | APT | CND |
| 90975 | KATOPIL | tbl 40x25mg | GLN | YU |
| 59379 | CAPTOPRIL 25 SVUS | tbl 30x25mg | SVS | CZ |
| 59380 | CAPTOPRIL 25 SVUS | tbl 50x25mg | SVS | CZ |
| 59381 | CAPTOPRIL 25 SVUS | tbl 100x25mg | SVS | CZ |
| 164.3 | C09AA01 | kaptopril (nad 25 mg v 1 tabletě) | p.o. | 50 | MG | 4,00 | |
| 31216 | TENSIOMIN 50MG | tbl 20x50mg | EGI | H |
| 47284 | TENSIOMIN 50MG | tbl 200x50mg | EGI | H |
| 49563 | TENSIOMIN 50MG | tbl 90x50mg | EGI | H |
| 90976 | KATOPIL | tbl 40x50mg | GLN | YU |
| 164.4 | C09AA02 | enalapril hydrogenmaleát (do 5 mg v jedné tabletě včetně) | p.o. | 10 | MG | 5,62 | |
| 45273 | ENAP 5 MG | tbl 30x5 mg | KRK | SLO |
| 55637 | ENALAPRIL LACHEMA 5 | tbl 100x5 mg | LCM | CZ |
| 59916 | ENALAPRIL LACHEMA 5 | tbl 60x5 mg | LCM | CZ |
| 85927 | ENALAPRIL LACHEMA 5 | tbl 20x5 mg | LCM | CZ |
| 83508 | EDNYT 5 MG | tbl 100x5 mg | GED | H |
| 83503 | APO-ENALAPRIL 5 MG | tbl 100x5 mg | APQ | MEX |
| 83505 | EDNYT 2.5MG | tbl 28x2.5mg | GED | H |
| 83507 | EDNYT 5MG | tbl 28x5mg | GED | H |
| 84514 | ACETENSIL 5MG | tbl 10x5mg | ANO | E |
| 84515 | ACETENSIL 5MG | tbl 60x5mg | ANO | E |
| 164.5 | C09AA02 | enalapril hydrogenmaleát (nad 5 do 10 mg v jedné tabletě včetně) | p.o. | 10 | MG | 4,32 | |
| 83510 | EDNYT 10 MG | tbl 100x 10 mg | GED | H |
| 55638 | ENALAPRIL LACHEMA 10 | tbl 100x10mg | LCM | CZ |
| 59917 | ENALAPRIL LACHEMA 10 | tbl 60x10mg | LCM | CZ |
| 83509 | EDNYT 10MG | tbl 28x10mg | GED | H |
| 92576 | ENALAPRIL LACHEMA 10 | tbl 20x10mg | LCM | CZ |
| 59642 | ENAP 10MG | tbl 100x10mg | KRK | SLO |
| 45274 | ENAP 10MG | tbl 30x10mg | KRK | SLO |
| 64839 | APO-ENALAPRIL 10MG | tbl 100x10mg | APQ | MEX |
| 164.6 | C09AA02 | enalapril hydrogenmaleát (nad 10 mg v jedné tabletě) | p.o. | 10 | MG | 3,40 | |
| 55639 | ENALAPRIL LACHEMA 20 | tbl 100x20mg | LCM | CZ |
| 84516 | ACETENSIL 20MG | tbl 28x20mg | ANO | E |
| 85928 | ENALAPRIL LACHEMA 20 | tbl 20x20mg | LCM | CZ |
| 83511 | EDNYT 20MG | tbl 28x20mg | GED | H |
| 45275 | ENAP 20MG | tbl 30x20mg | KRK | SLO |
| 59641 | ENAP 20MG | tbl 100x20 | KRK | SLO |
| 64840 | APO-ENALAPRIL 20MG | tbl 100x20mg | APQ | MEX |
| 164.7 | C09AA03 | lisinopril | p.o. | 10 | MG | 6,26 | |
| 67561 | DAPRIL 5 | tbl 30x5mg | MOE | CY |
| 67562 | DAPRIL 10 | tbl 30x10mg | MOE | CY |
| 67563 | DAPRIL 20 | tbl 20x20mg | MOE | CY |
| 164.8 | C09AA04 | perindopril | p.o. | 4 | MG | 7,25 | |
|
| 164.9 | C09AA05 | ramipril | p.o. | 2.5 | MG | 7,25 | |
| 56978 | TRITACE 2.5 | tbl 50x2.5mg | HBS | SK |
| 56982 | TRITACE 5 | tbl 50x5mg | HBS | SK |
| 56974 | TRITACE 1.25 | tbl 50x1.25mg | HBS | SK |
| 56973 | TRITACE 1.25 | tbl 30x1.25mg | HBS | SK |
| 56981 | TRITACE 5 | tbl 30x5mg | HBS | SK |
| 56977 | TRITACE 2.5 | tbl 30x2.5mg | HBS | SK |
| 164.10 | C09AA06 | quinapril | p.o. | 15 | MG | 7,25 | |
|
| 164.11 | C09AA07 | benazepril | p.o. | 7.5 | MG | 7,25 | |
|
| 164.12 | C09AA08 | cilazapril | p.o. | 2.5 | MG | 7,25 | |
|
| 164.13 | C09AA09 | fosinopril | p.o. | 1 | DF | 7,25 | |
|
| 164.14 | C09AA10 | trandolapril | p.o. | 2 | MG | 7,25 | |
|
| 164.15 | C09AA11 | spirapril | p.o. | 6 | MG | 7,25 | |
|
| 164.16 | C09AA12 | delapril | p.o. | 30 | MG | 7,25 | |
|
| 164.17 | C09AA13 | moexipril | p.o. | 15 | MG | 7,25 | |
| 165 | C09AA | inhibitory angiotenzin konvertujícího enzymu | parent. | H |
|---|
| 165.1 | C09AA02 | enalaprilát | parent. | 1.25 | MG | 27,76 | H |
| 62597 | ENAP I.V. | inj 5x1ml/1.25mg | KRK | SLO |
| 166 | C09BA | inhibitory angiotenzin konvertujícího enzymu v kombinaci s diuretiky | p.o. | |
|---|
| 166.1 | C09BA01 | kaptopril a diuretika | p.o. | 1 | DF | 4,78 | |
| 53242 | CAPTOHEXAL COMP.25/25 | tbl 20x25mg/25mg | SFS | D |
| 53243 | CAPTOHEXAL COMP.25/25 | tbl 50x25mg/25mg | SFS | D |
| 53245 | CAPTOHEXAL COMP.25/25 | tbl 100x25mg/25mg | SFS | D |
| 53246 | CAPTOHEXAL COMP.50/25 | tbl 20x50mg/25mg | SFS | D |
| 53248 | CAPTOHEXAL COMP.50/25 | tbl 50x50mg/25mg | SFS | D |
| 53249 | CAPTOHEXAL COMP.50/25 | tbl 100x50mg/25mg | SFS | D |
| 53250 | CAPTOHEXAL COMP.25/12.5 | tbl 20x25mg/12.5mg | SFS | D |
| 53251 | CAPTOHEXAL COMP.25/12.5 | tbl 50x25mg/12.5mg | SFS | D |
| 53252 | CAPTOHEXAL COMP.25/12.5 | tbl 100x25mg/12.5mg | SFS | D |
| 166.2 | C09BA02 | enalapril a diuretika | p.o. | 1 | DF | 5,22 | |
| 55429 | ENAP-HL | tbl 30 | KRK | SLO |
| 66506 | ENAP-H | tbl 30 | KRK | SLO |
| 166.3 | C09BA06 | quinapril a diuretika | p.o. | 1 | DF | 5,28 | |
|
| 166.4 | C09BA07 | benazepril a diuretika | p.o. | 1 | DF | 5,06 | |
|
| 166.5 | C09BB05 | felodipin a ramipril | p.o. | 1 | DF | 10,50 | |
|
| 166.6 | C09BB10 | trandolapril/verapamil | p.o. | 1 | DF | 11,10 | |
| 167 | C09CA | antagonisté angiotensinu II | p.o. | Z |
|---|
| 167.1 | C09CA01 | losartan | p.o. | 50 | MG | 22,00 | Z |
|
| 167.2 | C09CA02 | eprosartan | p.o. | 600 | MG | 22,00 | Z |
|
| 167.3 | C09CA03 | valsartan | p.o. | 80 | MG | 22,00 | Z |
| 56240 | DIOVAN 160 | cps 28x160mg | NPA | CH |
| 167.4 | C09CA04 | irbesartan | p.o. | 150 | MG | 22,00 | Z |
| 53657 | APROVEL 300MG | tbl 28x300mg | SWI | F |
| 167.5 | C09CA06 | kandesartan | p.o. | 8 | MG | 22,00 | Z |
| 53389 | ATACAND 16 MG | tbl 28x16mg | APN | S |
| 167.6 | C09CA07 | telmisartan | p.o. | 40 | MG | 22,00 | Z |
| 64087 | PRITOR 80 | tbl 28x80 | GXW | I |
| 64801 | PRITOR 40MG | tbl 28x40mg | GXW | I |
| 167.7 | C09DA01 | losartan v kombinaci s thiazidy | p.o. | 1 | DF | 22,40 | Z |
|
| 167.8 | C09DA06 | kandesartan v kombinaci s thiazidy | p.o. | 1 | DF | 22,40 | Z |
| 168 | C10AA | hypolipidemika ze skupiny statinů | p.o. | P |
|---|
Simvastatin, lovastatin: treatment of patients with manifested atherosclerosis (secondary prevention) with isolated hypercholesterolaemia or mixed hyperlipidaemia with predominant hypercholesterolaemia, can be prescribed only one hypolipidemic (cannot be combined with statins and fibrates)
Treatment with atorvastatin, cerivastatin, fluvastatin and pravastatin is performed by a cardiologist, an intern, a diabetic or a physician working in a clinic for lipid metabolism disorders:
a) Treatment of patients with familial hypercholesterolaemia
b) Treatment of patients with manifested atherosclerosis (secondary prevention) with isolated hypercholesterolaemia or combined hyperlipidaemia with predominant hypercholesterolaemia
(c) treatment of patients with accumulation of risk factors (high risk of cardiovascular events expressed as an absolute 10-year risk of 10% or more) with isolated hypercholesterolaemia or combined hyperlipidaemia with predominant hypercholesterolaemia
| 168.1 | C10AA01 | simvastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,50 | P |
| 59727 | SIMGAL 10MG | tbl obd 28x10mg | GNO | CZ |
| 66024 | SIMVOR 10MG | tbl obd 30x10mg | RXY | IND |
| 58136 | VASILIP 10 | tbl obd 28x10mg | KRK | SLO |
| 168.2 | C10AA01 | simvastatin (nad 10 do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 18,50 | P |
| 66026 | SIMVOR 20MG | tbl obd 30x20mg | RXY | IND |
| 59728 | SIMGAL 20MG | tbl obd 28x20mg | GNO | CZ |
| 58064 | VASILIP 20 | tbl obd 28x20mg | KRK | SLO |
| 168.3 | C10AA01 | simvastatin (nad 20 mg v jedné tabletě) | p.o. | 1 | DF | 32,56 | P |
| 66028 | SIMVOR 40MG | tbl obd 30x40mg | RXY | IND |
| 59729 | SIMGAL 40MG | tbl obd 28x40mg | GNO | CZ |
| 168.4 | C10AA02 | lovastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,50 | P |
| 01300 | APO-LOVASTATIN 20 | tbl 30x20mg | APT | CND |
| 53286 | APO-LOVASTATIN 20 | tbl 100x20mg | APT | CND |
| 45184 | HOLETAR | tbl 20x20mg | KRK | SLO |
| 58799 | HOLETAR 20 | tbl 30x20mg | KRK | SLO |
| 53506 | MEDOSTATIN 20MG | tbl 30x20mg | MOE | CY |
| 53507 | MEDOSTATIN 20MG | tbl 100x20mg | MOE | CY |
| 59800 | LOVACARD 20 | tbl 28x20mg | LEX | CZ |
| 168.5 | C10AA02 | lovastatin (nad 20 mg v jedné tabletě do 40 mg v jedné tabletě včetně) | p.o. | 1 | DF | 18,50 | P |
| 59799 | LOVACARD 40 | tbl 28x40mg | LEX | CZ |
| 01254 | APO-LOVASTATIN 40 | tbl 30x40mg | APT | CND |
| 53287 | APO-LOVASTATIN 40 | tbl 100x40mg | APT | CND |
| 168.6 | C10AA03 | pravastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,50 | P |
|
| 168.7 | C10AA03 | pravastatin (nad 10 mg do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 18,50 | P |
|
| 168.8 | C10AA03 | pravastatin (nad 20 mg v jedné tabletě ) | p.o. | 1 | DF | 25,90 | P |
|
| 168.9 | C10AA04 | fluvastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,50 | P |
|
| 168.10 | C10AA04 | fluvastatin (nad 20 mg do 40 MGv jedné tabletě včetně) | p.o. | 1 | DF | 18,50 | P |
|
| 168.11 | C10AA04 | fluvastatin (nad 40 MGv jedné tabletě ) | p.o. | 1 | DF | 25,90 | P |
|
| 168.12 | C10AA05 | atorvastatin (do 10 MG včetně v jedné tabletě) | p.o. | 1 | DF | 25,90 | P |
|
| 168.13 | C10AA05 | atorvastatin (nad 10 MG do 20 MG v jedné tabletě včetně) | p.o. | 1 | DF | 42,73 | P |
|
| 168.14 | C10AA05 | atorvastatin (nad 20 MG do 40 MG v jedné tabletě včetně) | p.o. | 1 | DF | 70,50 | P |
|
| 168.15 | C10AA06 | cerivastatin (do 0,10 MG včetně v jedné tabletě) | p.o. | 1 | DF | 10,50 | P |
|
| 168.16 | C10AA06 | cerivastatin (nad 0,10 do 0,20 MG včetně v jedné tabletě) | p.o. | 1 | DF | 19,55 | P |
|
| 168.17 | C10AA06 | cerivastatin (nad 0,20 MG v jedné tabletědo 0,30 MG v jedné tabletě včetně) | p.o. | 1 | DF | 25,90 | P |
|
| 168.18 | C10AA06 | cerivastatin ( nad 0,30 MG v jedné tabletě ) | p.o. | 1 | DF | 31,60 | P |
| 169 | C10A | hypolipidemika ze skupiny fibrátů a některých dalších skupin | p.o. | |
|---|
| 169.1 | C10AB | etofylin klofibrát | p.o. | 0.5 | GM | 4,79 | |
| 49609 | DUOLIP FORTE | tbl 100x500mg | MCK | A |
| 49608 | DUOLIP FORTE | tbl 30x500mg | MCK | A |
| 169.2 | C10AB02 | bezafibrát | p.o. | 0.6 | GM | 8,50 | |
| 21569 | REGADRIN B | drg 50x200mg | BCE | D |
| 169.3 | C10AB04 | gemfibrozil | p.o. | 1.2 | GM | 8,50 | |
| 53941 | INNOGEM 300MG | cps 100x300mg | EGI | H |
| 96574 | GEVILON | tbl obd 30x450mg | LEX | CZ |
| 44651 | APO-GEMFIBROZIL 600 | tbl obd 100x600mg | APT | CND |
| 76222 | IPOLIPID | cps 250 | MOE | CY |
| 76224 | IPOLIPID | cps 1000 | MOE | CY |
| 76223 | IPOLIPID | cps 500 | MOE | CY |
| 67026 | IPOLIPID | cps 50 | MOE | CY |
| 76221 | IPOLIPID | cps 100 | MOE | CY |
| 169.4 | C10AB05 | fenofibrát | p.o. | 0.3 | GM | 8,41 | |
| 85813 | LIPANTHYL | cps 50x100mg | FFR | F |
| 97669 | LIPANTHYL 100 | cps 50x100mg | LCM | CZ |
| 169.5 | C10AB05 | fenofibrát (mikronisované lékové formy) | p.o. | 1 | DF | 10,50 | |
| 45295 | FENOFIBRATE PHARMAVIT SR 250MG | cps 30x250mg | ETP | F |
| 45296 | FENOFIBRATE PHARMAVIT SR 250MG | cps 30x250mg | PLF | H |
| 76502 | LIPANTHYL 200 M | cps 30x200mg | FFR | F |
| 92327 | LIPANTHYL 200 M | cps 30x200mg | LCM | CZ |
| 169.6 | C10AB08 | ciprofibrát | p.o. | 0.1 | GM | 8,50 | |
|
| 169.7 | C10AD06 | acipimox | p.o. | 500 | MG | 11,73 | |
| 170 | C10AC | hypolipidemika ze skupiny pryskyřic | p.o. | P |
|---|
Treatment is performed by a cardiologist, an intern or a physician working in a treatment centre for lipid disorders:
(a) the treatment of patients with high cholesterol hyperlipoproteinaemia;
(b) treatment of patients with pruritus during biliary cirrhosis.
| 170.1 | C10AC01 | cholestyramin | p.o. | 14 | GM | 31,09 | P |
| 94031 | VASOSAN P | plv 1x400gm | FOP | D |
| 94033 | VASOSAN S | plv 1x400gm | FOP | D |
| 170.2 | C10AC02 | colestipol | p.o. | 20 | GM | 59,39 | P |
| 94764 | COLESTID | plv 50x5gm | UPJ | B |
| 171 | D01AA | antimykotika pro lokální podání ze skupiny antibiotik | lok. | |
| 171.1 | D01AA01 | nystatin | lok. | 1 | GM | 2,54 | |
| 01069 | FUNGICIDIN LECIVA | ung 1x10gm | LEX | CZ |
| 171.2 | D01AA02 | natamycin | lok. | 1 | GM | 1,96 | |
| 172 | D01AC | antimykotika pro lokální podání ze skupiny derivátu imidazolu | lok. | |
|---|
| 172.1 | D01AC01 | klotrimazol do 20 g včetně | lok. | 1 | GM | 1,96 | |
| 86262 | CANESTEN | crm 1x20gm | LEX | CZ |
| 65484 | CLOTRIMAZOL AL 1% | crm 1x20gm 1% | APA | D |
| 93483 | CLOTRIMAZOLUM POLFA | crm 20gm 1% | POL | PL |
| 172.2 | D01AC01 | klotrimazol nad 20 g | lok. | 1 | GM | 1,65 | |
|
| 172.3 | D01AC02 | mikonazol | lok. | 1 | GM | 1,96 | |
|
| 172.4 | D01AC03 | ekonazol lékové formy krému | lok. | 1 | GM | 1,96 | |
|
| 172.5 | D01AC03 | ekonazol (lékové formy tekuté, lipogelu a pasty) | lok. | 1 | GM | 3,52 | |
|
| 172.6 | D01AC05 | isokonazol | lok. | 1 | ML | 1,96 | |
|
| 172.7 | D01AC08 | ketokonazol | lok. | 1 | GM | 1,96 | |
|
| 172.8 | D01AC10 | bifonazol | lok. | 1 | GM | 2,49 | |
|
| 172.9 | D01AC11 | oxikonazol | lok. | 1 | GM | 2,49 | |
| 99248 | MYFUNGAR | crm 1x30gm | LEX | CZ |
| 172.10 | D01AC12 | fenticonazol | lok. | 1 | GM | 1,96 | |
|
| 172.11 | D01AC16 | flutrimazol | lok. | 1 | GM | 5,88 | |
| 53457 | MICETAL | crm 1x15gm 1% | MCI | CZ |
| 53905 | MICETAL | spr 1x30ml 1% | MCI | CZ |
| 172.12 | D01AC20 | kombinace | lok. | 1 | GM | 1,96 | |
|
| 172.13 | D01AC51 | clotrimazol/urea | lok. | 1 | GM | 1,96 | |
|
| 172.14 | D01AC60 | bifonazol, kombinace | lok. | 1 | GM | 29,33 | P |
Treatment is administered by a dermatologist in onychomycosis, supported by culture testing and documented contraindication to the use of systemic antifungal therapy.
| 172.15 | D01AC14 | sertakonazol | lok. | 1 | GM | 2,49 | |
|
| 172.16 | D01AC01 | klotrimazol tekuté lékové formy | lok. | 1 | GM | 2,54 | |
| 173 | D01AE | antimykotika pro lokální podání ostatních skupin | lok. | |
|---|
| 173.1 | D01AE | jiná antimykotika k zevnímu použití (nitroethanoldodecylsulfonat) | lok. | 1 | ML | 0,83 | |
| 00799 | NITROFUNGIN | liq 1x25ml | GNO | CZ |
| 02772 | MYCO-DECIDIN | liq 25ml | GNO | CZ |
| 173.2 | D01AE04 | kyselina undecylenová | lok. | 1 | GM | 0,93 | |
| 00871 | MYKOSEPTIN | ung 1x30gm | LEX | CZ |
| 173.3 | D01AE14 | ciclopirox | lok. | 1 | GM | 3,91 | |
| 76150 | BATRAFEN | crm 1x20gm | HBS | SK |
| 76152 | BATRAFEN | liq 1x20ml | HBS | SK |
| 173.4 | D01AE15 | terbinafin | lok. | 1 | GM | 3,91 | |
|
| 173.5 | D01AE16 | amorolfin | lok. | 1 | GM | 3,91 | |
|
| 173.6 | D01AE18 | tolnaftat | lok. | 1 | GM | 1,96 | |
|
| 173.7 | D01AE19 | tolciklát | lok. | 1 | GM | 1,96 | |
|
| 173.8 | D01AE20 | kombinace antimykotik (tolnaftat/cetrimid) | lok. | 1 | GM | 1,96 | |
|
| 173.9 | D01AE20 | kombinace antimykotik (ostatní kombinace) | lok. | 1 | GM | 0,64 | |
|
| 173.10 | D01AE | naftini hydrochlorid | lok. | 1 | GM | 2,93 | |
| 174 | D01BA | antimykotika pro celkové podání | p.o. | P |
|---|
Treatment with terbinafine is performed by dermatologist:
(a) severe forms of dermatomycosis of selected dermatophytes based on culture or microscopic examination
(b) heavy forms of nail mycosis, if at least one of the following conditions applies:
• Disability of the whole nail plate
• Disability of at least four nail plates so that each of them has a disability that affects more than 30% for the free edge of the nail in a proximal direction
• thumbnail involvement of the lower limb
A positive microscopic finding and mycological culture sampling are a condition for initiating treatment ad (b).
| 174.1 | D01BA01 | griseofulvin | p.o. | 0.5 | GM | 9,97 | |
|
| 174.2 | D01BA02 | terbinafin | p.o. | 0.25 | GM | 64,00 | P |
| 175 | D02AB | emolliencia obsahující oxid zinečnatý | lok. | |
|---|
| 175.1 | D02AB | přípravky obsahující oxid zinečnatý (do 120 g v jednom balení včetně) | lok. | 1 | GM | 0,78 | |
| 54249 | SUSPENSIO ZINCI OXYDATI HERBAC. | sus 1x100gm | HEO | CZ |
| 176 | D02AC | emolliencia obsahující měkký parafin a tukové produkty | lok. | L/DER,PDD |
|---|
| 176.1 | D02AC | měkký parafin a tukové produkty (do 250 ml v 1 balení včetně) - tekuté lékové formy | lok. | 1 | ML | 0,59 | L/DER,PDD |
|
| 176.2 | D02AC | měkký parafin s polydekanolem (do 250 ml v 1 balení včetně) | lok. | 1 | ML | 0,65 | L/DER,PDD |
|
| 176.3 | D02AC | měkký parafin a tukové produkty (nad 250 ml v 1 balení) - tekuté lékové formy | lok. | 1 | ML | 0,43 | L/DER,PDD |
|
| 176.4 | D02AC | měkký parafin s polydekanolem (nad 250 ml v 1 balení) | lok. | 1 | ML | 0,47 | L/DER,PDD |
|
| 176.5 | D02AC | měkký parafin a tukové produkty (do 250 gm v 1 balení včetně) | lok. | 1 | GM | 0,59 | L/DER,PDD |
|
| 176.6 | D02AC | měkký parafin a tukové produkty (nad 250 gm v 1 balení) | lok. | 1 | GM | 0,43 | L/DER,PDD |
|
| 176.7 | D02AE01 | měkký parafin a tukové produkty s obsahem močoviny -tekuté lékové formy | lok. | 1 | ML | 0,50 | L/DER,PDD |
| 97152 | EXCIPIAL U LIPOLOTIO | lot 1x200ml | SEG | CH |
| 97153 | EXCIPIAL U HYDROLOTIO | lot 1x200ml | SEG | CH |
| 177 | D02AX | jiná emolliencia a protektiva | lok. | |
|---|
| 177.1 | D02AX | jiná emolliencia a protektiva (do 50 g v balení včetně) | lok. | 1 | GM | 1,71 | |
| 00891 | POLYSAN | pst 1x50gm | SLO | SK |
| 177.2 | D02AX | jiná emolliencia a protektiva (nad 50 g v balení) | lok. | 1 | GM | 0,64 | |
| 04192 | POLYSAN | pst 1x650gm | SLO | SK |
| 88603 | POLYSAN CUM OLEUM HELIANTI GLO | ung 1x900gm | GAO | CZ |
| 177.3 | D03AX | jiná léčiva podporující tvorbu jizev (chlorofyl) | lok. | 1 | ML | 0,49 | |
|
| 177.4 | D03AX02 | dextranomer | lok. | 1 | GM | 3,91 | |
|
| 177.5 | D03AX | jiná léčiva podporující zajizvení (kombinace celulosa + karboxycelulosa, na obsah karboxycelulosy) | lok. | 1 | GM | 15,40 | |
| 93561 | SYSTOGEN | plv.ads.1x20GM | IHO | CZ |
| 177.6 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy gelu) | lok. | 1 | GM | 1,42 | |
|
| 177.7 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy roztoku) | lok. | 1 | ML | 3,91 | |
| 178 | D03BA | proteolytické enzymy | lok. | P |
|---|
Treatment is performed by a surgeon, orthopaedic surgeon, gynecologist, otorhinolaryngologist or dermatologist:
(a) the treatment of leg ulcers,
(b) treatment of necrotic post-injury or post-operative wounds;
(c) treatment of necrotic wounds and decubits.
| 178.1 | D03BA | proteolytické enzymy (chymotrypsin) | lok. | 1 | GM | 79,28 | P |
|
| 178.2 | D03BA | proteolytické enzymy (kolagenáza - do 10 GM v jednom balení včetně) | lok. | 1 | GM | 18,57 | P |
|
| 178.3 | D03BA | proteolytické enzymy (plasmin/deoxiribonukleáza) | lok. | 1 | GM | 13,69 | P |
| 42261 | FIBROLAN | ung 1x100gm | PDA | D |
| 42262 | FIBROLAN | ung 1x25gm | PDA | D |
| 62518 | FIBROLAN | ung 1x50gm | PDA | D |
| 178.4 | D03BA | proteolytické enzymy (trypsin/chymotrypsin) | lok. | 1 | GM | 28,84 | P |
|
| 178.5 | D03BA | proteolytické enzymy (kolagenáza - nad 10 GM v jednom balení) | lok. | 1 | GM | 16,62 | P |
|
| 178.6 | D04AB01 | lidokain (lékové formy spreje, koncentrace 10%) | lok. | 1 | GM | 2,10 | O |
| 179 | D05AA | antipsoriatika ze skupiny dehtů a derivátů vitaminu D | lok. | |
Treatment of vitamin derivatives D in local pharmaceutical forms is operated by dermatologist:
(a) treatment for torpid localized psoriasis not responding to standard therapy of up to 100 g per week.
(b) in other cases only after approval by the medical insurance undertaking's medical examiner.
| 179.1 | D05AA | dehty (odbarvený dehet) | lok. | 1 | GM | 1,17 | |
|
| 179.2 | D05AA | dehty | lok. | 1 | GM | 0,73 | |
| 00889 | PITYOL | ung 1x30gm | LEX | CZ |
| 66262 | SALOXYL | ung 1x30gm | HEO | CZ |
| 66502 | ICHTOXYL | ung 1x30gm | HEO | CZ |
| 85950 | SUSPENSIO VISNEVSKI+PICE LIQUID | sus 1x1000gm | HEO | CZ |
| 179.3 | D05AD02 | methoxalen (0,15 % koncentrace) | lok. | 1 | ML | 4,30 | |
| 90618 | OXSORALEN | liq 1x50ml 0.15% | GER | A |
| 179.4 | D05AC01 | dithranol | lok. | 1 | GM | 3,91 | |
|
| 179.5 | D05AX02 | kalcipotriol | lok. | 1 | GM | 11,00 | P |
|
| 179.6 | D05AX04 | tacalcitol | lok. | 1 | GM | 18,00 | P |
| 180 | D05BB | retinoidy pro celkové podání | p.o. | P |
Treatment is performed by dermatologist:
(a) treatment for severe generalised forms of psoriasis not responding to other treatments;
b) other severe forms of keratinisation disorder not responding to any other treatment only after prior approval by a revision physician
| 180.1 | D05BB01 | etretinát | p.o. | 35 | MG | 81,14 | P |
|
| 180.2 | D05BB02 | acitretin | p.o. | 35 | MG | 81,14 | P |
| 76660 | NEOTIGASON ROCHE 10MG | cps 30x10mg | HLR | CH |
| 76661 | NEOTIGASON ROCHE 25MG | cps 30x25mg | HLR | CH |
| 180.3 | D05BA02 | methoxalen | p.o. | 10 | MG | 4,06 | L/DER |
| 03733 | OXSORALEN | cps 50x10mg | GER | A |
| 181 | D06AX | antibiotika k zevnímu použití | lok. | |
|---|
| 181.1 | D06AA | tetracyklin a deriváty | lok. | 1 | GM | 2,93 | |
|
| 181.2 | D06AX | neomycin/bacitracin (k přípravě roztoku) | lok. | 1 | ML | 3,91 | |
| 55759 | PAMYCON NA PRIPRAVU KAPEK | plv 1x1lahv | BTA | SK |
| 181.3 | D06AX | neomycin/bacitracin (zásyp do 2 g včetně) | lok. | 1 | GM | 13,69 | |
| 01062 | FRAMYKOIN | plv ads 1x2gm | IHO | CZ |
| 181.4 | D06AX | neomycin/bacitracin (zásyp nad 2 do 5 g v jednom balení včetně) | lok. | 1 | GM | 7,63 | |
|
| 181.5 | D06AX | neomycin/bacitracin (mast) | lok. | 1 | GM | 2,93 | |
| 01066 | FRAMYKOIN | ung 1x10gm | LEX | CZ |
| 181.6 | D06AX | primycin | lok. | 1 | GM | 2,44 | |
|
| 181.7 | D06AX02 | chloramfenikol | lok. | 1 | GM | 2,88 | |
|
| 181.8 | D06AX09 | mupirocin (do 5 g v jednom balení včetně) | lok. | 1 | GM | 8,31 | |
|
| 181.9 | D06AX09 | mupirocin (nad 5 g v jednom balení) | lok. | 1 | GM | 5,18 | |
|
| 181.10 | D06AX | neomycin/bacitracin (zásyp nad 5 g v jednom balení) | lok. | 1 | GM | 2,44 | |
| 182 | D06BA | sulfonamidy s obsahem stříbrných solí k lokálnímu podání | lok. | L/DER,CHI |
|---|
| 182.1 | D06BA | sulfathiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1 | GM | 1,08 | L/DER, CHI |
|
| 182.2 | D06BA | sulfathiazin stříbrný (nad 50 g v jednom balení) | lok. | 1 | GM | 0,98 | L/DER, CHI |
|
| 182.3 | D06BA01 | sulfadiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1 | GM | 1,32 | L/DER, CHI |
|
| 182.4 | D06BA01 | sulfadiazin stříbrný (nad 50 g v jednom balení) | lok. | 1 | GM | 1,12 | L/DER, CHI |
|
| 182.5 | D06BA02 | sulfathiazol | lok. | 1 | GM | 1,03 | |
| 00899 | SULFATHIAZOL NEO-SLOVAKOFARMA | ung 1x20gm 5% | SLO | SK |
| 182.6 | D06BA03 | mafenid | lok. | 1 | GM | 0,98 | L/DER, CHI |
|
| 182.7 | D06BA51 | sulfadiazin stříbrný v kombinaci (léková forma náplasti) | lok. | 100 | CM2 | 13,49 | L/DER, CHI |
|
| 182.8 | D06BA51 | sulfadiazin stříbrný v kombinaci (léková forma krému) | lok. | 1 | GM | 2,25 | L/DER, CHI |
| 183 | D07AA | kortikosteroidy třídy I, slabě účinné | lok. | |
|---|
| 183.1 | D07AA02 | hydrokortison | lok. | 1 | GM | 3,16 | |
| 00858 | HYDROCORTISON LECIVA | ung 1x10gm 1% | LEX | CZ |
| 183.2 | D07AA03 | prednisolon | lok. | 1 | GM | 3,32 | |
| 184 | D07AB | kortikosteroidy třídy II, středně účinné | lok. | |
|---|
| 184.1 | D07AB01 | klobetazon | lok. | 1 | GM | 3,32 | |
|
| 184.2 | D07AB02 | hydrokortison butyrát | lok. | 1 | GM | 3,32 | |
| 09310 | LOCOID 0.1% | ung 1x30gm 0.1% | YEU | NL |
| 09305 | LOCOID 0.1% | crm 1x30gm 0.1% | YEU | NL |
| 09307 | LOCOID 0.1% LOTION | lot 1x30ml | YEU | NL |
| 62047 | LOCOID LIPOCREAM | crm 1x30gm 0.1% | YEU | NL |
| 184.3 | D07AB03 | flumetason | lok. | 1 | GM | 3,32 | |
|
| 184.4 | D07AB07 | flupredniden | lok. | 1 | GM | 3,32 | |
|
| 184.5 | D07AB09 | triamcinolon (lékové formy mastí a krémů) | lok. | 1 | GM | 2,44 | |
| 02828 | TRIAMCINOLON LECIVA | crm 1x10gm 0.1% | LEX | CZ |
| 02829 | TRIAMCINOLON LECIVA | ung 1x10gm 0.1% | LEX | CZ |
| 184.6 | D07AB09 | triamcinolon (lékové formy lotia) | lok. | 1 | ML | 2,83 | |
| 02826 | TRIAMCINOLON-GALENA | lot 1x15gm | GNO | CZ |
| 66167 | TRIAMCINOLON-GALENA | lot 1x30gm | GNO | CZ |
| 184.7 | D07AB09 | triamcinolon (lékové formy spreje) | lok. | 1 | GM | 0,73 | |
|
| 184.8 | D07AB09 | triamcinolon (lékové formy tinktury) | lok. | 1 | ML | 0,98 | |
|
| 184.9 | D07AB19 | dexamethason acetát | lok. | 1 | GM | 3,09 | |
| 02415 | DEXAMETHAZON LECIVA | crm 10gm 0.01% | LEX | CZ |
| 01965 | DEXAMETHAZON LECIVA | ung 1x10gm 0.025% | LEX | CZ |
| 185 | D07AC | kortikosteroidy třídy III, účinné (fluorované) | lok. | |
|---|
| 185.1 | D07AC01 | betamethason dipropionát | lok. | 1 | GM | 2,49 | |
| 80204 | BELODERM | ung 1x30gm 0.05% | BLU | CHO |
| 80206 | BELODERM | crm 1x30gm 0.05% | BLU | CHO |
| 88489 | KUTERID | crm 20gm | LEK | SLO |
| 88495 | KUTERID | ung 20gm | LEK | SLO |
| 98032 | DIPROSONE | ung 1x30gm | SCH | B |
| 98034 | DIPROSONE | crm 1x30gm | SCH | B |
| 185.2 | D07AC01 | betamethason valerát | lok. | 1 | GM | 3,32 | |
|
| 185.3 | D07AC02 | fluklorolon | lok. | 1 | GM | 3,32 | |
|
| 185.4 | D07AC04 | fluocinolon gel | lok. | 1 | GM | 2,44 | |
| 04156 | GELARGIN | gel 1x25gm | LEX | CZ |
| 185.5 | D07AC04 | fluocinolon mast a krém (koncentrace do 0,025% včetně). | lok. | 1 | GM | 2,93 | |
| 92285 | GELARGIN | ung 1x20gm/5mg | LEX | CZ |
| 185.6 | D07AC04 | fluocinolon mast a krém (koncentrace nad 0,025%) | ok. | 1 | GM | 3,91 | |
|
| 185.7 | D07AC04 | fluocinolon lotio (koncentrace do 0,025% včetně) | lok. | 1 | GM | 2,93 | |
|
| 185.8 | D07AC04 | fluocinolon lotio (koncentrace nad 0,025%) | lok. | 1 | GM | 3,91 | |
| 44743 | GELARGIN FORTE LOT | lot1x50GM/100MG | LEX | CZ |
| 185.9 | D07AC06 | diflukortolon | lok. | 1 | GM | 3,42 | |
|
| 185.10 | D07AC08 | fluocinonid | lok. | 1 | GM | 2,93 | |
|
| 185.11 | D07AC12 | halometason | lok. | 1 | GM | 3,27 | |
|
| 185.12 | D07AC17 | flutikason | lok. | 1 | GM | 3,42 | |
| 186 | D07AC | kortikosteroidy třídy III, účinné (nefluorované) | lok. | L/DER,ALG, PDD |
|---|
| 186.1 | D07AC09 | budesonid | lok. | 1 | GM | 3,18 | L/DER |
|
| 186.2 | D07AC13 | mometazon do 10g v 1 balení včetně | lok. | 1 | GM | 6,70 | L/DER, ALG, PDD |
|
| 186.3 | D07AC13 | mometazon nad 10g v jednom balení | lok. | 1 | GM | 5,00 | L/DER, ALG, PDD |
| 76975 | ELOCOM | ung 1x15 gm 0,1% | SCH | B |
| 81693 | ELOCOM | crm 1x15 gm 0,1% | SCH | B |
| 88856 | ELOCOM | lot 1x20 ml | SCH | B |
| 186.4 | D07AC14 | methylprednisoni aceponas | lok. | 1 | GM | 5,87 | L/DER, ALG, PDD |
|
| 186.5 | D07AC18 | prednikarbat (do 10 g v 1 balení včetně) | lok. | 1 | GM | 6,70 | L/DER, ALG, PDD |
| 83154 | DERMATOP | crm 1x10gm 2.5mg/gm | HBS | SK |
| 83156 | DERMATOP | ung 1x10gm 2.5mg/gm | HBS | SK |
| 186.6 | D07AC18 | prednikarbat (nad 10 g v 1 balení) | lok. | 1 | GM | 5,87 | L/DER, ALG, PDD |
| 187 | D07AD | kortikosteroidy třídy IV, vysoce účinné | lok. | L/DER |
|---|
| 187.1 | D07AD01 | klobetasol | lok. | 1 | GM | 4,40 | L/DER |
|
| 187.2 | D07AD02 | halcinonid | lok. | 1 | ML | 4,64 | L/DER |
| 97019 | BETACORTON | liq 1x25ml | SEG | CH |
| 97020 | BETACORTON | liq 1x100ml | SEG | CH |
| 188 | D07BB | kortikosteroidy, středně účinné, kombinace s antiseptiky | lok. | |
|---|
| 188.1 | D07BA01 | prednisolon/cloroxin | lok. | 1 | GM | 1,96 | |
|
| 188.2 | D07BB01 | flumetason a antiseptika | lok. | 1 | GM | 3,32 | |
|
| 188.3 | D07BB03 | triamcinolon a antiseptika (lékové formy pěny) | lok. | 1 | GM | 1,42 | |
| 02975 | TRIAMCINOLON | spm 40gm | GNO | CZ |
| 188.4 | D07BB03 | triamcinolon a antiseptika (lékové formy spreje) | lok. | 1 | GM | 0,59 | |
|
| 188.5 | D07BB03 | triamcinolon a antiseptika (lékové formy tinktury) | lok. | 1 | ML | 1,53 | |
|
| 188.6 | D07BB03 | triamcinolon a antiseptika (lékové formy mastí a krémů) | lok. | 1 | GM | 1,81 | |
| 04178 | TRIAMCINOLON E LECIVA | ung 1x20gm | LEX | CZ |
| 188.7 | D07BA01 | prednisolon/hexamidin diisothionát | lok. | 1 | GM | 1,96 | |
|
| 188.8 | D07CC01 | betamethason a gentamycin | lok. | 1 | GM | 2,50 | L/DER |
| 189 | D07X | kortikosteroidy, jiné kombinace | lok. | |
|---|
| 189.1 | D07XA01 | hydrokortison | lok. | 1 | ML | 1,96 | |
|
| 189.2 | D07XA02 | prednisolon/kyselina salicylová | lok. | 1 | ML | 1,32 | |
|
| 189.3 | D07XB01 | flumetason/dehet | lok. | 1 | GM | 4,40 | |
| 09297 | LOCACORTEN TAR | ung 1x60gm | CGC | CH |
| 189.4 | D07XB01 | flumethason pivalat/kyselina salicylová | lok. | 1 | GM | 2,93 | |
|
| 189.5 | D07XB02 | triamcinolon | lok. | 1 | GM | 1,81 | |
| 04160 | TRIAMCINOLON S LECIVA | ung 1x30gm | LEX | CZ |
| 189.6 | D07XC | diflucortolon/isoconasol | lok. | 1 | GM | 2,69 | |
|
| 189.7 | D07XC01 | betamethason (lékové formy mastí a krémů) | lok. | 1 | GM | 2,69 | |
| 85864 | BELOSALIC | ung 1x30gm | BLU | CHO |
| 98072 | DIPROSALIC | ung 1x15 gm | SCH | B |
| 189.8 | D07XC01 | betamethason (lékové formy tinktur) | lok. | 1 | ML | 2,69 | |
| 31334 | DIPROSALIC | liq 1x30 ml | SCH | B |
| 189.9 | D07XD | halcinonid/kyselina salicylová | lok. | 1 | ML | 3,57 | |
|
| 189.10 | D07XD | halcinonid/močovina | lok. | 1 | GM | 3,57 | |
|
| 189.11 | D07CA01 | hydrocortison a antibiotika (lékové formy mastí a krémů) | lok. | 1 | GM | 1,96 | |
|
| 189.12 | D07CA01 | hydrocortison a antibiotika (tekuté lékové formy) | lok. | 1 | ML | 1,96 | |
| 190 | D08A | antiseptika a desinficiencia | lok. | |
|---|
| 190.1 | D08AC02 | chlorhexidin | lok. | 1000 | ML | 178,70 | |
|
| 190.2 | D08AD | kyselina boritá (lékové formy mastí) | lok. | 1 | GM | 0,68 | |
|
| 190.3 | D08AD | kyselina boritá (lékové formy roztoků) | lok. | 10 | GM | 1,32 | |
|
| 190.4 | D08AG02 | polyvidon-jód (do 200 ml včetně roztoku v jednom balení) | lok. | 1 | ML | 0,98 | |
| 62318 | BETADINE (CHIRURG.) | liq 1x120ml | EGI | H |
| 02981 | JODISOL ROZTOK | liq 1x80gm | LDN | CZ |
| 96605 | JODISOL SPRAY S MECH.ROZPRASOV. | spr 1x75gm | LDN | CZ |
| 46054 | BRAUNOL 2000 | liq 1x100ml | BMB | CH |
| 190.5 | D08AG02 | polyvidon-jód (nad 200 ml roztoku v jednom balení) | lok. | 1 | ML | 0,49 | |
| 02983 | JODISOL ROZTOK | liq 1x760gm | LDN | CZ |
| 80553 | BRAUNOL 2000 | liq 1x1000ml | BMB | CH |
| 46056 | BRAUNOL 2000 | liq 1x500ml | BMB | CH |
| 62319 | BETADINE (CHIRURG.) | liq 1x1000ml | EGI | H |
| 62317 | BETADINE | liq 1x1000ml | EGI | H |
| 190.6 | D08AG02 | polyvidon-jód (do 200 g masti v jednom balení včetně) | lok. | 1 | GM | 1,96 | |
| 84421 | BRAUNOVIDON MAST | ung 100gm (pe tuba) | BMB | CH |
| 190.7 | D08AG02 | polyvidon-jód nad 200 g masti v jednom balení) | lok. | 1 | GM | 0,98 | |
| 46052 | BRAUNOVIDON MAST | ung 250gm (pe nad.) | BMB | CH |
| 84422 | BRAUNOVIDON MAST | ung 250gm (pe tuba) | BMB | CH |
| 190.8 | D08AH | kloroxin | lok. | 1 | GM | 0,78 | |
| 03008 | ENDIARON | pst 1x30gm 5% | LEX | CZ |
| 190.9 | D08AJ | bromid benzododecinia (tinktura a roztok do 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,29 | |
| 00739 | AJATIN TINCTURA | tct 1x50ml 1% | SLO | SK |
| 190.10 | D08AJ | bromid benzododecinia (tinktura a roztok nad 50 ml v jednom balení) | lok. | 1 | ML | 0,29 | H |
|
| 190.11 | D08AJ | chlorid karbetopendecinia (tinktura 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,29 | |
| 191 | D08AX | jiná antiseptika a desinficiencia | lok. | H |
|---|
| 191.1 | D08AX | hexamidin/chlorhexidin | lok. | 1 | ML | 121,37 | H |
|
| 191.2 | D08AX | noxytiolin | lok. | 2.5 | GM | 492,11 | H |
|
| 191.3 | D08AX | noxytiolin/tetrakain | lok. | 2.5 | GM | 492,11 | H |
|
| 191.4 | D08AX | taurolidin | lok. | 1 | GM | 94,48 | H |
| 93242 | TAUROLIN | gel 1x50gm/1.75gm | GSO | CH |
| 192 | D10A | lokálně podávaná léčiva k léčbě akne | lok. | |
|---|
| 192.1 | D10AD01 | tretinoin (lékové formy krémů a gelů do koncentrace 0,05% včetně) | lok. | 1 | GM | 3,96 | |
| 98205 | LOCACID | crm 1x30gm 0.05% | PFB | F |
| 97573 | RETIN A | crm 1x30gm 0.025% | CIL | CH |
| 03740 | RETIN A | crm 1x30gm 0.05% | CIL | CH |
| 192.2 | D10AD01 | tretinoin (lékové formy krémů a gelů koncentrace nad 0.05%) | lok. | 1 | GM | 4,40 | |
|
| 192.3 | D10AD01 | tretinoin (lékové formy roztoků do koncentrace 0,05% včetně) | lok. | 1 | ML | 4,11 | |
|
| 192.4 | D10AD01 | tretinoin (lékové formy roztoků koncentrace nad 0,05%) | lok. | 1 | ML | 4,40 | |
|
| 192.5 | D10AE01 | benzoyl peroxid (lékové formy krémů a gelů) | lok. | 1 | GM | 1,42 | |
|
| 192.6 | D10AE01 | benzoyl peroxid (lékové formy roztoků a lotií) | lok. | 1 | ML | 0,39 | |
| 91816 | INOXITAN | lot 100ml 50mg/ml | GNO | CZ |
| 192.7 | D10AE01 | benzoyl peroxid (koncentrace 20%) | lok. | 1 | ML | 2,54 | |
|
| 192.8 | D10AF01 | klindamycin | lok. | 1 | ML | 1,96 | |
|
| 192.9 | D10AF02 | erythromycin (lékové formy krémů a mastí) | lok. | 1 | GM | 2,93 | |
|
| 192.10 | D10AF02 | erythromycin (lékové formy roztoků) do 60 ml včetně v jednom balení | lok. | 1 | ML | 2,17 | |
| 98204 | ERYFLUID | sol 1x30ml | PFB | F |
| 192.11 | D10AF52 | erythromycin v kombinaci | lok. | 1 | ML | 2,93 | |
|
| 192.12 | D10AX03 | kyselina azelaová | lok. | 1 | GM | 1,96 | |
|
| 192.13 | D10AF02 | erythromycin (lékové formy roztoků) nad 60 ml v jednom balení | lok. | 1 | ML | 1,75 | |
| 75285 | ERYFLUID | sol 1x100ml | PFB | F |
| 193 | D10B | celkově podávaná léčiva k léčbě akné | p.o. | X |
|---|
| 193.1 | D10BA01 | isotretinoin (do 10 MG včetně v jedné kapsli ) | p.o. | 30 | MG | 83,53 | X |
| 11685 | ROACCUTANE ROCHE | cps 30x10mg | HLR | CH |
| 193.2 | D10BA01 | isotretinoin (nad 10 MG v jedné kapsli) | p.o. | 30 | MG | 75,39 | X |
| 91843 | ROACCUTANE ROCHE | cps 30x20mg | HLR | CH |
| 194 | D11AX | jiná dermatologika | lok. | L/DER |
|---|
| 194.1 | D11AX | celulóza (lékové formy zásypů) | lok. | 1 | GM | 9,78 | L/DER |
|
| 194.2 | D11AX | fluorouracil (lékové formy roztoků) | lok. | 1 | ML | 16,86 | L/DER |
| 60890 | VERRUMAL | liq 1x13ml | HEM | D |
| 194.3 | D11AX | fluorouracil (lékové formy mastí) | lok. | 1 | GM | 13,15 | L/DER, ONK |
| 195 | G01AA | vaginálně podávaná antimykotika a antibiotika | vag. | |
|---|
Treatment with vaginal clindamycin is performed by a gynaecologist:
(a) the treatment of bacterial vaginosis during pregnancy,
(b) vaginitis with evidence of bacterial strains sensitivity to clindamycin.
| 195.1 | G01AA01 | nystatin | vag. | 100 | KU | 0,98 | |
|
| 195.2 | G01AA02 | natamycin (lékové formy s obsahem méně než 100 mg) | vag. | 25 | MG | 4,11 | |
|
| 195.3 | G01AA02 | natamycin (lékové formy s obsahem 100 mg) | vag. | 25 | MG | 7,14 | |
| 78213 | PIMAFUCIN | glo vag 3x100mg | YEU | NL |
| 195.4 | G01AA10 | klindamycin (lékové formy krémů) | vag. | 1 | GM | 11,00 | P |
| 195.5 | G01AA51 | nystatin kombinace s neomycinem a polymyxinem | vag. | 1 | DF | 10,90 | |
|
| 195.6 | G01AA51 | nystatin kombinace s nifuratelem (lékové formy vag. čípků ) | vag. | 1 | DF | 17,60 | |
|
| 195.7 | G01AA51 | nystatin kombinace s nifuratelem (lékové formy vag. krémů ) | vag. | 5 | GM | 35,19 | |
| 196 | G01AF | vaginálně podávané imidazolové deriváty | vag. | |
|---|
| 196.1 | G01AF20 | kombinace imidazolových derivátů - mikonazol a metronidazol ( lékové formy vag. tablet) | vag. | 1 | DF | 6,35 | |
|
| 196.2 | G01AF01 | metronidazol | vag. | 0.5 | GM | 3,71 | |
| 66787 | MEDAZOL | tbl vag 10 | BLU | CHO |
| 196.3 | G01AF02 | klotrimazol (lékové formy vaginálních tablet) | vag. | 0.1 | GM | 8,70 | |
| 62862 | CANDIBENE 100MG | tbl vag 6x100mg | MCK | D |
| 62863 | CANDIBENE 200MG | tbl vag 3x200mg | MCK | D |
| 65483 | CLOTRIMAZOL AL 100 | tbl vag 6x100mg+apl | HHC | D |
| 66549 | CLOTRIMAZOL AL 200 | tbl vag 3x200mg+apl | HHC | D |
| 93484 | CLOTRIMAZOLUM POLFA | tbl vag 6x100mg | POL | PL |
| 58254 | CLOTRIMAZOLUM GW | tbl vag 6x100mg | GWP | PL |
| 196.4 | G01AF02 | klotrimazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 13,39 | |
| 68917 | JENAMAZOL 2% | crm vag 20gm+aplik. | VJP | D |
| 196.5 | G01AF04 | mikonazol | vag. | 0.1 | GM | 8,70 | |
|
| 196.6 | G01AF05 | ekonazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 13,39 | |
|
| 196.7 | G01AF05 | ekonazol (lékové formy vaginálních tablet, globulí a čípků) | vag. | 0.1 | GM | 31,58 | |
| 06095 | GYNO-PEVARYL 50 | glo vag 15x50mg | CIL | CH |
| 196.8 | G01AF11 | ketoconazol | vag. | 0.4 | GM | 13,44 | |
|
| 196.9 | G01AF12 | fenticonazol | vag. | 0.1 | GM | 13,44 | |
|
| 196.10 | G01AF17 | oxikonazol | vag. | 0.6 | GM | 109,90 | |
| 99250 | GYNO-MYFUNGAR | tbl vag 1x600mg | LEX | CZ |
| 196.11 | G01AG02 | terkonazol (lékové formy vaginálních krémů) | vag. | 80 | MG | 13,49 | |
|
| 196.12 | G01AG02 | terkonazol (lékové formy vaginálních tablet) | vag. | 80 | MG | 31,28 | |
| 197 | G01AX | vaginálně podávaná jiná antiinfektiva a antiseptika | vag. | |
|---|
| 197.1 | G01AX | laktobacillus | vag. | 1 | DF | 10,26 | |
|
| 197.2 | G01AX | nifuratel/nystatin (lékové formy vaginálních čípků) | vag. | 1 | DF | 17,60 | |
|
| 197.3 | G01AX | nifuratel/nystatin (lékové formy vaginálních krémů) | vag. | 5 | GM | 35,19 | |
|
| 197.4 | G01AX | nitrofurantoin | vag. | 0.2 | GM | 2,79 | |
| 03629 | FURANTOIN LECIVA | tbl vag 30x100mg | LEX | CZ |
| 197.5 | G01AX03 | polykresulen | vag. | 90 | MG | 0,35 | |
| 41965 | VAGOTHYL | sol 1x50gm | POL | PL |
| 197.6 | G01AX05 | nifuratel | p.o. | 0.6 | GM | 15,64 | L/GYN, URN |
|
| 197.7 | G01AX11 | polyvidon-jód (vaginální čípky) | vag. | 0.2 | GM | 8,94 | |
|
| 197.8 | G01AX11 | polyvidon-jód (vaginální gel) | vag. | 0.2 | GM | 6,16 | |
|
| 197.9 | G01AX12 | ciklopirox (vaginální krém - do 40 GM včetně v jednom balení) | vag. | 1 | GM | 4,69 | |
| 76153 | BATRAFEN | crm vag 40gm+6xapl. | HBS | SK |
| 197.10 | G01AX12 | ciklopirox (vaginální krém - nad 40 GM v jednom balení) | vag. | 1 | GM | 3,11 | |
|
| 197.11 | G01AX | sulfathiazol | vag. | 1 | DF | 6,60 | |
|
| 197.12 | G01AX | jiná antiinfektiva a antiseptika (tetraboritan sodný) | vag. | 1 | DF | 6,40 | |
|
| 197.13 | G01AX12 | ciclopirox (vaginální roztok) | vag. | 1 | DF | 17,60 | |
|
| 197.14 | G01AX12 | ciclopirox (vaginální čípky) | vag. | 1 | DF | 31,28 | |
| 58711 | DAFNEGIN | sup vag 6x100mg | MON | I |
| 197.15 | G01AX14 | laktobacilus a estriol - vaginální tablety | vag. | 1 | DF | 16,13 | |
|
| 197.16 | G02CC03 | benzydamin hydrochlorid | vag. | 1 | DF | 8,00 | |
| 198 | G02AB | uterotonika ze skupiny námelových alkaloidů | p.o. | |
|---|
| 198.1 | G02AB02 | ergotové alkaloidy | p.o. | 0.2 | MG | 1,12 | |
|
| 198.2 | G02AB03 | ergometrin | p.o. | 0.2 | MG | 1,12 | |
| 199 | G02AB | uterotonika ze skupiny námelových alkaloidů | parent. | |
|---|
| 199.1 | G02AB01 | methylergometrin | parent. | 0.2 | MG | 17,21 | |
| 00509 | METHYLERGOMETRIN SPOFA | inj 5x1ml/0.2mg | SPX | CZ |
| 199.2 | G02AB03 | ergometrin | parent. | 0.2 | MG | 9,38 | |
| 200 | G02AD | uterotonika ze skupiny prostaglandinů | p.o. | H |
|---|
| 200.1 | G02AD02 | dinoproston | p.o. | 0.5 | MG | 95,31 | H |
| 86287 | PROSTIN E2 | tbl 10x0.5mg | UPJ | GB |
| 201 | G02AD | uterotonika ze skupiny prostaglandinů | vag. | K/P |
|---|
Treatment is administered by a gynecologist:
(a) preinduction of childbirth upon termination of pregnancy,
(b) induction of abortion within 24 weeks of pregnancy for genetic reasons;
(c) induction of childbirth (including stillbirth) after 24 weeks of pregnancy,
(d) in the postpartum period in the case of severe metrorhagia.
| 201.1 | G02AD02 | dinoproston (do 0,5 mg v jedné dávce včetně) | vag. | 1 | DF | 770,00 | K/P |
|
| 201.2 | G02AD02 | dinoproston (nad 2 mg v jedné dávce) | vag. | 1 | DF | 432,53 | K/P |
|
| 201.3 | G02AD02 | dinoproston (nad 0,5 do 2 mg v jedné dávce včetně) | vag. | 1 | DF | 1111,90 | K/P |
|
| 201.4 | G02AD02 | dinoproston (pesar) | vag. | 1 | DF | 2200,00 | K/P |
| 202 | G02AD | uterotonika ze skupiny prostaglandinů | parent. | K/P |
|---|
Treatment is administered by a gynecologist:
(a) preinduction of childbirth upon termination of pregnancy,
(b) induction of abortion within 24 weeks of pregnancy for genetic reasons;
(c) induction of childbirth (including stillbirth) after 24 weeks of pregnancy,
(d) in the postpartum period in the case of severe metrorhagia.
| 202.1 | G02AD01 | dinoprost | parent. | 25 | MG | 651,85 | K/P |
|
| 202.2 | G02AD02 | dinoproston | parent. | 0.5 | MG | 389,86 | K/P |
| 67188 | PROSTIN E2 SS 1MG/ML | inj 1x0.75ml | UPJ | B |
| 67189 | PROSTIN E2 SS 10MG/ML | inj 1x0.5ml | UPJ | B |
| 202.3 | G02AD04 | karboprost | parent. | 0.25 | MG | 675,61 | K/P |
|
| 202.4 | G02AD05 | sulproston | parent. | 0.5 | MG | 651,85 | K/P |
| 203 | G02CA | tokolytika ze skupiny beta-sympatomimetik | p.o. | P |
Treatment is administered by a gynecologist:
only as a continuation of parenteral use of tocolytics.
| 203.1 | G02CA | hexoprenalin | p.o. | 1.5 | MG | 10,80 | P |
| 75173 | GYNIPRAL 0.5MG | tbl 20x0.5mg | HNP | A |
| 203.2 | G02CA01 | ritodrin | p.o. | 40 | MG | 23,66 | P |
|
| 203.3 | G02CA03 | fenoterol | p.o. | 20 | MG | 23,66 | P |
| 21391 | PARTUSISTEN | tbl 50x5mg | BOE | D |
| 204 | G02CA | tokolytika ze skupiny beta-sympatomimetik | parent. | U/P |
|---|
Treatment is administered by a gynecologist:
(a) initiation of tocolytic therapy after 20 weeks of pregnancy,
(b) the treatment of birth dystocia;
(c) intrapartic acute tocolysis.
| 204.1 | G02CA | hexoprenalin | parent. | 25 | RG | 45,36 | U/P |
| 75464 | GYNIPRAL 25RG KONCENTR.ZUR INF. | inf 5x5ml/25rg | HNP | A |
| 75463 | GYNIPRAL 10RG/2ML | inj 5x2ml/10rg | HNP | A |
| 204.2 | G02CA01 | ritodrin | parent. | 40 | MG | 45,36 | U/P |
|
| 204.3 | G02CA03 | fenoterol | parent. | 0.5 | MG | 45,36 | U/P |
|
| 204.4 | G02CX01 | atosiban infuse | parent. | 1 | DF | 3500,00 | H |
|
| 204.5 | G02CX01 | atosiban injekce | parent. | 1 | DF | 1.300,00 | H |
| 205 | G02CB | inhibitory prolaktinu | p.o. | |
The intolerance and lack of efficacy of other dopaminergic agonists (terguride and bromocriptin) in patients with hyperprolactinaemia and prolactin-secerating adenomas and in patients with acromegaly who are sensitive to this treatment.
| 205.1 | G02CB | tergurid | p.o. | 1 | MG | 5,46 | |
| 91979 | MYSALFON | tbl obd 30x0.5mg | LEX | CZ |
| 205.2 | G02CB01 | bromokriptin | p.o. | 5 | MG | 14,22 | |
| 67512 | MEDOCRIPTINE | tbl 30x2.5mg | MOE | CY |
| 67515 | MEDOCRIPTINE | tbl 1000x2.5mg | MOE | CY |
| 67514 | MEDOCRIPTINE | tbl 500x2.5mg | MOE | CY |
| 97673 | SEROCRYPTIN | tbl 30x2.5mg | SRO | I |
| 205.3 | G02CB02 | lisurid | p.o. | 0.6 | MG | 2,49 | |
|
| 205.4 | G02CB03 | kabergolin | p.o. | 70 | RG | 27,08 | P |
|
| 205.5 | G02CB04 | quinagolid | p.o. | 75 | RG | 27,08 | Z |
| 206 | G03B | androgeny | p.o. | L/END,ONK,GYN,SEX |
|---|
| 206.1 | G03BA03 | testosteron | p.o. | 0.12 | GM | 27,37 | L/END,ONK,GYN, SEX,URN |
|
| 206.2 | G03BB01 | mesterolon | p.o. | 50 | MG | 20,04 | L/END,ONK,GYN, SEX,URN |
| 09591 | PROVIRON 25 | tbl 20x25mg | SAG | D |
| 09592 | PROVIRON 25 | tbl 50x25mg | SAG | D |
| 207 | G03B | androgeny | parent. | L/END,ONK,GYN,SEX |
|---|
| 207.1 | G03BA03 | testosteron | parent. | 18 | MG | 8,11 | L/END,ONK,GYN, SEX,URN |
| 00373 | AGOVIRIN-DEPOT | inj 5x2ml/50mg | BTA | SK |
| 208 | G03CA | přirozené a semisyntetické estrogeny | p.o. | P |
|---|
Estradiol, treatment is performed by a gynaecologist, sexologist or endocrinologist:
(a) replacement treatment for women after premature menopause;
b) treatment of postmenopausal vegetative and estrogen-deficiency syndrome.
Estriol, treatment is performed by a gynecologist, urologist, sexologist or endocrinologist:
treatment of postmenopausal vegetative and estrogen-deficiency syndrome.
| 208.1 | G03CA | přirozené a semisyntetické estrogeny prosté, mestranol | p.o. | 0.15 | MG | 3,76 | P |
|
| 208.2 | G03CA57 | přírodní konj. estrogeny (do 625 RG včetně v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 6,00 | P |
| 83387 | OESTROFEMINAL 0.6 | cps 21x0.6mg | MAC | D |
| 208.3 | G03CA03 | estradiol (do 1 mg v jedné tabletě včetně) | p.o. | 2 | MG | 9,00 | P |
| 208.4 | G03CA03 | estradiol (nad 1 mg do 2 mg v jedné tabletě včetně) | p.o. | 2 | MG | 6,00 | P |
|
| 208.5 | G03CA03 | estradiol (nad 2 mg v jedné tabletě) | p.o. | 2 | MG | 4,40 | P |
|
| 208.6 | G03CA03 | estradiol (s uvolněním méně než 50 RG/den, v rámci 28. denního cyklu) | transd. | 1 | DF | 4,40 | P |
|
| 208.7 | G03CA03 | estradiol (s uvolněním od 50 do 99 RG včetně /den, v rámci 28. denního cyklu) | transd. | 1 | DF | 6,00 | P |
| 57473 | DERMESTRIL-SEPTEM 50 | tts emp 4x5mg | LHM | D |
| 208.8 | G03CA03 | estradiol (s uvolněním 100 a více RG/den, v rámci 28. denního cyklu) | transd. | 1 | DF | 9,00 | P |
|
| 208.9 | G03CA03 | estradiol (lékové formy gelů) | transd. | 1,5 | MG | 5,87 | P |
| 76922 | OESTROGEL | gel 1x80gm | LBE | F |
| 208.10 | G03CA03 | estradiol | vag. | 25 | RG | 5,87 | P |
|
| 208.11 | G03CA04 | estriol | p.o. | 2 | MG | 6,00 | P |
|
| 208.12 | G03CA04 | estriol (lékové formy vaginálních krémů) | vag. | 0.2 | MG | 3,08 | P |
| 97170 | OVESTIN | crm 15gm+aplikator | ORG | NL |
| 98182 | OVESTIN | crm vag 1x 15gm+aplikator | ORG | IRL |
| 208.13 | G03CA04 | estriol (lékové formy vaginálních tablet, do 0,5 mg včetně) | vag. | 0.2 | MG | 5,87 | P |
|
| 208.14 | G03CA04 | estriol (lékové formy vaginálních tablet, nad 0,5 mg) | vag. | 0.2 | MG | 1,22 | P |
| 097590 | ORTHOGYNEST D | sub vag 6 | CIL | CH |
| 208.15 | G03CA57 | přírodní konj. estrogeny (nad 625 RG v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 4,34 | P |
| 09467 | OESTROFEMINAL 1.25 | cps 21x1.25mg | MAC | D |
| 208.16 | G03CA03 | estradiol (lékové formy vaginálních krémů) | vag. | 0.2 | MG | 3,08 | P |
| 209 | G03CA | přirozené a semisyntetické estrogeny | parent. | |
|---|
| 209.1 | G03CA03 | estradiol | parent. | 1 | MG | 4,35 | |
| 00364 | AGOFOLLIN | inj 5x1ml/5mg | BTA | SK |
| 00365 | AGOFOLLIN-DEPOT | inj 1x2ml/10mg | BTA | SK |
| 56188 | AGOFOLLIN DEPOT | inj 5x2ml/10mg | BTA | SK |
| 209.2 | G03CA03 | estradiol valerat | parent. | 1 | MG | 2,40 | |
| 00529 | NEOFOLLIN | inj 5x1ml/5mg | BTA | SK |
| 209.3 | G03CA03 | estradiol implantát | parent. | 1 | DF | 1095,00 | |
|
| 209.4 | G03CA04 | estriol | parent. | 2 | MG | 4,30 | |
| 210 | G03D | progestiny | p.o. | L/GYN,URN,END,INT, SEX |
|---|
| 210.1 | G03DA02 | medroxyprogesteron | p.o. | 5 | MG | 3,62 | L/GYN,URN,END, INT,SEX |
|
| 210.2 | G03DA04 | progesteron | p.o. | 0.3 | GM | 17,40 | L/GYN,URN,END, INT,SEX |
|
| 210.3 | G03DB01 | dydrogesteron | p.o. | 10 | MG | 3,81 | L/GYN,URN,END, INT,SEX |
|
| 210.4 | G03DC02 | norethisteron | p.o. | 5 | MG | 2,88 | L/GYN,URN,END, INT,SEX |
| 01939 | NORETHISTERON SLOVAKOFARMA | tbl 30x5mg | SLO | SK |
| 210.5 | G03DC03 | lynestrenol | p.o. | 5 | MG | 2,88 | L/GYN,URN,END, INT,SEX |
|
| 210.6 | G03DC05 | tibolon | p.o. | 2.5 | MG | 18,00 | P |
Treatment with tibolone is performed by a gynecologist for the treatment of oestrogen deficiency syndrome where other hormonal agents are contraindicated or where the patient objectively hates other hormonal agents.
| 211 | G03D | progestiny | parent. | L/GYN,URN,SEX |
| 211.1 | G03DA03 | hydroxyprogesteron | parent. | 10 | MG | 1,76 | L/GYN,URN,SEX |
| 00531 | NEOLUTIN FORTE | inj 5x1 ml/125mg | SPX | CZ |
| 211.2 | G03DA04 | progesteron (depotní lékové formy) | parent. | 5 | MG | 4,01 | L/GYN,URN,SEX |
| 00367 | AGOLUTIN-DEPOT | inj 1x2ml/50mg | BTA | SK |
| 211.3 | G03DA04 | progesteron | parent. | 5 | MG | 1,08 | L/GYN,URN,SEX |
| 02094 | AGOLUTIN | inj 5x2ml/60mg | BTA | SK |
| 212 | G03E | androgeny a ženské pohlavní hormony | parent. | L/GYN,END,SEX |
| 212.1 | G03EA02 | testosteron a estrogen | parent. | 1 | DF | 22,34 | L/GYN,END,SEX |
| 00464 | FOLIVIRIN | inj 5x2ml | BTA | SK |
| 212.2 | G03EA03 | prasteron enantat/estradiol valerat | parent. | 1 | DF | 73,32 | L/GYN,END,SEX |
| 213 | G03F | progestiny a estrogeny | p.o. | P |
Treatment is administered by a gynaecologist, sexologist or endocrinologist:
treatment of postmenopausal vegetative and estrogen-deficiency syndrome.
| 213.1 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 2 MG estradiolu v jedné tabletě | p.o. | 1 | DF | 6,84 | P |
|
| 213.2 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 1 MG estradiolu v jedné tabletě | p.o. | 1 | DF | 5,50 | P |
|
| 213.3 | G03FA01 | norethisteron a estrogen, fixní kombinace | transd. | 1 | DF | 6,84 | P |
|
| 213.4 | G03FA12 | medroxyprogesteron a estrogen, fixní kombinace | p.o. | 1 | DF | 6,84 | P |
| 53690 | PREMELLA 2.5 | tbl obd 1x28 | WYM | IRL |
| 53691 | PREMELLA 2.5 | tbl obd 3x28 | WYM | IRL |
| 53692 | PREMELLA 5 | tbl obd 1x28 | WYM | IRL |
| 53693 | PREMELLA 5 | tbl obd 3x28 | WYM | IRL |
| 213.5 | G03FB | gestageny a estrogeny, sekvenční přípravky | p.o. | 0.75 | DF | 5,08 | P |
|
| 213.6 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | p.o. | 1 | DF | 6,84 | P |
|
| 213.7 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,84 | P |
|
| 213.8 | G03FB06 | medroxyprogesteron a estrogen, sekvenční přípravky | p.o. | 0.75 | DF | 5,08 | P |
| 54310 | DIVINA | tbl 3x21 (=63) | ORN | DK |
| 54309 | DIVINA | tbl 1x21 | ORN | DK |
| 45182 | CYCLO-PREMELLA | tbl obd 1x28 | WYM | IRL |
| 45183 | CYCLO-PREMELLA | tbl obd 3x28 | WYM | IRL |
| 213.9 | G03FB08 | dydrogesteron a estrogen, sekvenční kombinace | p.o. | 0.75 | DF | 5,08 | P |
|
| 213.10 | G03FB09 | levonorgestrel a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,84 | P |
|
| 213.11 | G03FB09 | levonorgestrel a estrogen, sekvenční kombinace | p.o. | 0,75 | DF | 5,08 | P |
| 67425 | CYCLO-MENORETTE | tbl obd 3x21 (=63) | WYE | D |
| 84582 | CYCLOOSTROGYNAL | drg 21 | ASH | D |
| 84583 | CYCLOOSTROGYNAL | drg 3x21(=63) | ASH | D |
| 213.12 | G03HB01 | cyproteron/estradiol | p.o. | 0.75 | DF | 5,08 | P |
| 214 | G03GA | gonadotrofin (choriový) | parent. | L/GYN,END,PDD,SEX |
| 214.1 | G03GA01 | choriový gonadotrofin (do 500 U v 1 ampuli včetně) | parent. | 250 | U | 24,59 | L/GYN,END,PDD, SEX |
| 10809 | PREGNYL | inj 3x500ut+solv. | ORG | NL |
| 214.2 | G03GA01 | choriový gonadotrofin (nad 500 U do 1500 U v 1 ampuli včetně) | parent. | 250 | U | 15,45 | L/GYN,END,PDD, SEX |
| 11951 | PREGNYL | inj 3x1500ut+solv. | ORG | NL |
| 214.3 | G03GA01 | choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250 | U | 11,05 | L/GYN,END,PDD, SEX |
| 96314 | PREGNYL | inj 3x5000ut+solv. | ORG | NL |
| 215 | G03GA | gonadotrofin (lidský) | parent. | Z |
| 215.1 | G03GA02 | gonadotrofin lidský | parent. | 75 | U | 329,64 | Z |
| 12979 | MENOGON | inj sic 10+10xsolv. | FEI | D |
| 43727 | MERIONAL 75 M.J. | inj sic 1x75ut+solv | IBS | CH |
| 12979 | MENOGON | inj sic 10+10xsolv. | FEI | D |
| 215.2 | G03GA04 | urofollitrofin | parent. | 75 | U | 400,81 | Z |
| 56473 | METRODIN 75 | inj sic 1x75ut+solv | SRO | I |
| 56474 | METRODIN 75 | inj sic 10x75ut+sol | SRO | I |
| 43723 | FOSTIMON 75 M.J. | inj sic 1x75ut+solv | IBS | CH |
| 43724 | FOSTIMON 75 M.J | inj sic 10x75ut+sol | IBS | CH |
| 215.3 | G03GA06 | folitrofin beta | parent. | 75 | U | 733,19 | Z |
|
| 215.4 | G03GA04 | urofollitrofin vysoce čištěný | parent. | 75 | U | 488,79 | Z |
|
| 215.5 | G03GA05 | folitrofin alfa | parent. | 75 | U | 733,19 | Z |
| 216 | G03GB | syntetické stimulátory ovulace | p.o. | L/GYN,END,SEX |
| 216.1 | G03GB02 | klomifen | p.o. | 9 | MG | 1,32 | L/GYN,END,SEX, URN |
| 83672 | CLOMHEXAL 50 | tbl 10x50mg | HEX | D |
| 217 | G03HA | antiandrogeny | p.o. | |
| 217.1 | G03HA01 | cyproteron (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 166,20 | |
| 77006 | ANDROCUR 10MG | tbl 15x10mg | SAG | D |
| 217.2 | G03HA01 | cyproteron (nad 10 mg v jedné tabletě) | p.o. | 0.1 | GM | 61,80 | |
| 97862 | ANDROCUR | tbl 20x50mg | SAG | D |
| 03783 | ANDROCUR | tbl 50x50mg | SAG | D |
| 59354 | ANDROCUR 100 | tbl obd 50x100mg | SUE | F |
| 218 | G03HA | antiandrogeny | parent. | L/PSY,SEX |
| 218.1 | G03HA01 | cyproteron | parent. | 0.1 | GM | 128,06 | L/PSY,SEX,URN |
| 23342 | ANDROCUR-DEPOT | inj 3x3ml/300mg | SAG | D |
| 219 | G03XA | antigonadotrofiny a podobná léčiva | p.o. | L/GYN,END,HEM,ALG,SEX |
| 219.1 | G03XA01 | danazol | p.o. | 0.6 | GM | 83,68 | L/GYN,END,HEM, ALG,SEX |
| 67525 | ANARGIL 100MG | cps 100x100mg | MOE | CY |
| 67526 | ANARGIL 100MG | cps 200x100mg | MOE | CY |
| 67527 | ANARGIL 100MG | cps 500x100mg | MOE | CY |
| 67528 | ANARGIL 200MG | cps 100x200mg | MOE | CY |
| 67529 | ANARGIL 200MG | cps 200x200mg | MOE | CY |
| 67530 | ANARGIL 200MG | cps 500x200mg | MOE | CY |
| 219.2 | G03XA02 | gestrinon | p.o. | 0.7 | MG | 47,36 | L/GYN,END,HEM, ALG,SEX |
|
| 219.3 | G03XC01 | raloxifen | p.o. | 60 | MG | 39,40 | P |
| 84722 | EVISTA | tbl obd 28x60mg | LIL | GB |
Raaloxifene: treatment is performed by an internist, endocrinologist, rhematologist and orthopaedic surgeon: Postmenopausal osteoporosis of women documented densitometric (less than -2,5 SD) or osteoporotic fracture women who have failed hormone replacement therapy (HRT) or for objective reasons HRT cannot be used. Treatment is long-term, lasts at least one year. Treatment beyond one year only in patients with evidence of bone loss
| 220 | G04AB | chinolonová chemoterapeutika močových infekcí | p.o. | |
| 220.1 | G04AB01 | kyselina nalidixová | p.o. | 4 | GM | 8,55 | |
|
| 220.2 | G04AB03 | kyselina pipemidová | p.o. | 0.8 | GM | 19,55 | |
| 221 | G04AC | nitrofuranová chemoterapeutika močových infekcí | p.o. | |
| 221.1 | G04AC02 | nifurtinol | p.o. | 0.16 | GM | 2,58 | |
| 222 | G04BC | rozpouštědla močových kamenů | p.o. | |
| 222.1 | G04BC | rozpouštědla močových kamenů (ve formě prášku) | p.o. | 10 | GM | 5,97 | |
| 02150 | ALKALIT | gra 1x200gm | IHO | CZ |
| 222.2 | G04BC | rozpouštědla močových kamenů (ve formě eff. tablet) | p.o. | 4 | DF | 5,97 | |
| 223 | G04BD | spasmolytika močových cest | p.o. | L/URN,GYN,SEX, GER |
| 223.1 | G04BD02 | flavoxat | p.o. | 0.8 | GM | 13,24 | L/URN,GYN,SEX GER |
|
| 223.2 | G04BD04 | oxybutynin | p.o. | 15 | MG | 13,24 | L/URN,GYN,SEX GER |
| 66791 | DITROPAN | tbl 30x5mg | MDD | F |
| 59104 | UROXAL 5MG | tbl 60x5mg | FFR | F |
| 223.3 | G04BD06 | propiverin (do 5 mg v jedné tabletě včetně) | p.o. | 15 | MG | 12,05 | L/URN,GYN,SEX PDD, GER |
| 66819 | MICTONETTEN | drg 50x5mg | APG | D |
| 92255 | MICTONETTEN | drg 30x5mg | APG | D |
| 66820 | MICTONETTEN | drg 100x5mg | APG | D |
| 223.4 | G04BD06 | propiverin (nad 5 mg v jedné tabletě) | p.o. | 15 | MG | 5,40 | L/URN,GYN,SEX,GER |
| 92254 | MICTONORM | drg 30x15mg | APG | D |
| 66817 | MICTONORM | drg 50x15mg | APG | D |
| 66818 | MICTONORM | drg 100x15mg | APG | D |
| 223.5 | G04BD07 | tolterodin | p.o. | 4 | MG | 30,00 | L/URN,GYN,SEX,GER |
| 224 | G04BX | jiná urologika, k léčbě benigní hyperplasie prostaty | p.o. | L/URN |
| 224.1 | G04CA01 | alfuzosin | p.o. | 7.5 | MG | 21,50 | L/URN |
|
| 224.2 | G04CA01 | alfuzosin (SR nebo retardované formy) | p.o. | 10 | MG | 21,50 | L/URN |
|
| 224.3 | G04CA02 | tamsulosin | p.o. | 0.4 | MG | 21,50 | L/URN |
|
| 224.4 | G04CA03 | terazosin | p.o. | 5 | MG | 18,10 | L/URN |
|
| 224.5 | G04CB01 | finasterid | p.o. | 5 | MG | 21,50 | L/URN |
| 65988 | PENESTER | tbl obd 30x5mg | LEX | CZ |
| 224.6 | G04CX01 | extrakt Pyg. africanum | p.o. | 2 | DF | 17,50 | L/URN |
| 42212 | TADENAN 50MG | cps 30 | DEB | F |
| 224.7 | G04CX02 | extrakt Serenoa repens včetně kombinací | p.o. | 2 | DF | 17,50 | L/URN |
| 57898 | SPALDA SABAL 160MG | cps 200x160mg | KKA | D |
| 57897 | SPALDA SABAL 160MG | cps 120x160mg | KKA | D |
| 57893 | SPALDA SABAL 320MG | cps 60x320mg | KKA | D |
| 57896 | SPALDA SABAL 160MG | cps 60x160mg | KKA | D |
| 57894 | SPALDA SABAL 320MG | cps 120x320mg | KKA | D |
| 57895 | SPALDA SABAL 320MG | cps 200x320mg | KKA | D |
| 07428 | PROSTAKAN MONO | cps 120x160mg | SCE | D |
| 224.8 | G04CX03 | mepartricin | p.o. | 150 | KU | 21,50 | L/URN |
| 55999 | IPERTROFAN 40 | tbl ent 30x40mg | SPA | I |
| 225 | H01A | hormony předního laloku hypofýzy | parent. | |
| 225.1 | H01AA02 | tetrakosaktid (nedepotní lékové formy) | parent. | 0.25 | MG | 59,93 | L/END |
|
| 225.2 | H01AC01 | somatropin | parent. | 2 | U | 765,20 | L/J5 |
| 56362 | ZOMACTON 12 | inj sic 5x12ut+solv | FEI | D |
| 96132 | NORDITROPIN PENSET 12UT | inj sic 1x12ut+solv | NOO | DK |
| 96133 | NORDITROPIN PENSET 24UT | inj sic 1x24ut+solv | NOO | DK |
| 56033 | NORDITROPIN12I.U. | inj sic 1x12ut+solv | NOO | DK |
| 61227 | SAIZEN 10 | inj sic 1x10ut+5ml | SRO | CH |
| 226 | H01BA | vasopresin a jeho deriváty | parent. | H |
| 226.1 | H01BA02 | desmopresin | parent. | 4 | RG | 82,41 | O |
| 04070 | ADIURETIN | inj 5x1ml/4rg | FRL | CZ |
| 226.2 | H01BA04 | terlipresin (do 0,5 mg včetně v jedné ampuli) | parent. | 1 | MG | 301,88 | H |
| 44356 | REMESTYP 0.5 | inj 5x5ml/0.5mg | FRL | CZ |
| 03648 | REMESTYP 0.2 | inj 5x2ml/0.2mg | FRL | CZ |
| 226.3 | H01BA05 | ornipresin | parent. | 5 | U | 27,57 | H |
|
| 226.4 | H01BA04 | terlipresin (nad 0,5 mg v jedné ampuli) | parent. | 1 | MG | 245,27 | H |
| 227 | H01BA | vasopresin a jeho deriváty | lok. | |
| 227.1 | H01BA02 | desmopresin (nosní kapky) | lok. | 25 | RG | 21,86 | |
| 02634 | ADIURETIN SD | gtt nas 1x5ml/0.5mg | FRL | CZ |
| 227.2 | H01BA02 | desmopresin (nosní spray) | lok. | 25 | RG | 21,86 | |
|
| 227.3 | H01BA02 | desmopresin (pevné lékové formy) | p.o. | 400 | RG | 21,86 | |
| 228 | H01BB | oxytocin a jeho deriváty | parent. | H |
| 228.1 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15 | U | 46,95 | H |
| 00543 | OXYTOCIN FERRING-LECIVA | inj 5x2ml/2ut | FRL | CZ |
| 228.2 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15 | U | 21,00 | H |
| 00544 | OXYTOCIN FERRING-LECIVA | inj 5x1ml/5ut | FRL | CZ |
| 229 | H01CA | hormon uvolňující gonadotrofin | lok. | Z |
| 229.1 | H01CA01 | gonadorelin (nasálně) | lok. | 1.2 | MG | 203,34 | Z |
|
| 229.2 | H01CA02 | nafarelin do 4 ml včetně v jednom balení (nasálně) | lok. | 0,4 | MG | 147,61 | Z |
| 45481 | SYNAREL | spr nas 1x4ml | SEA | POR |
| 229.3 | H01CA02 | nafarelin nad 4 ml v jednom balení (nasálně) | lok. | 0,4 | MG | 116,04 | Z |
| 83795 | SYNAREL | spr nas 1x8ml | SEA | POR |
| 229.4 | H01CC01 | ganirelix (antagonista gonadotropin releasing hormonu ) | parent. | 0,25 | MG | 1600,00 | Z |
| 05979 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | NL |
| 05980 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | NL |
| 05981 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | IRL |
| 05982 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | IRL |
| 230 | H01CB | somatostatin a jeho deriváty | parent. | X |
| 230.1 | H01CB01 | somatostatin | parent. | 6 | MG | 7941,40 | X |
| 92109 | SOMATOSTATIN | inj sic 1x250rg+1ml | UCB | B |
| 66824 | SOMATOSTATIN | inj sic 1x3mg+solv. | UCB | B |
| 97824 | STILAMIN | inj sic 1x3mg | SRO | CH |
| 230.2 | H01CB02 | oktreotid | parent. | 1 | MG | 5022,50 | X |
| 93864 | SANDOSTATIN | inj 5x1 ml/0.05mg | SAN | CH |
| 93865 | SANDOSTATIN | inj 5x1 ml/0.1 mg | SAN | CH |
| 93866 | SANDOSTATIN | inj 5x1 ml/0.5mg | SAN | CH |
| 93867 | SANDOSTATIN | inj 1x5ml/1mg-lahv. | SAN | CH |
| 230.3 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 10 MG | parent. | 0,35 7 | MG | 1434,00 | X |
|
| 230.4 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 20 MG | parent. | 0,71 4 | MG | 1912,00 | X |
|
| 230.5 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 30 MG | parent. | 1,07 2 | MG | 2390,00 | X |
|
| 230.6 | H01CB03 | lantreotid | parent. | 2,14 | MG | 1840,57 | X |
| 84701 | SOMATULINE P.R. | inj sic 1x30mg+solv | IPE | F |
| 231 | H02AA | mineralokortikoidy | p.o. | |
| 231.1 | H02AA02 | fludrokortison | p.o. | 0.1 | MG | 4,79 | |
| 23865 | FLUDROCORTISON | tbl 100x0.1 mg | SQH | D |
| 232 | H02AB | glukokortikoidy | p.o. | |
| 232.1 | H02AB01 | betamethason | p.o. | 1.5 | MG | 3,42 | |
|
| 232.2 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.5 | MG | 10,22 | |
| 83994 | FORTECORTIN 4 | tbl 20x4mg | MEC | D |
| 232.3 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.5 | MG | 3,42 | |
| 86698 | DEXAMETHAZON LECIVA | tbl 20x0.5mg-blistr | LEX | CZ |
| 70508 | DEXONA | tbl 100x0.5mg | CAD | IND |
| 232.4 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.5 | MG | 3,42 | |
| 232.5 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.5 | MG | 5,43 | |
| 86606 | MEDROL | tbl 50x16mg(blistr) | UPJ | B |
| 93617 | MEDROL | tbl 50x16mg(lekov.) | UPJ | B |
| 232.6 | H02AB07 | Prednison | p.o. | 10 | MG | 2,62 | |
| 02963 | PREDNISON 20 LECIVA | tbl 20x20mg(blistr) | LEX | CZ |
| 00269 | PREDNISON 5 LECIVA | tbl 20x5mg | LEX | CZ |
| 232.7 | H02AB08 | triamcinolon | p.o. | 7.5 | MG | 2,74 | |
| 00332 | TRIAMCINOLON LECIVA | tbl 20x4mg | LEX | CZ |
| 232.8 | H02AB09 | hydrokortison | p.o. | 30 | MG | 7,33 | |
| 76205 | HYDROCORTISON 10MG JENAPHARM | tbl 20x10mg | VJP | D |
| 232.9 | H02AB10 | kortison | p.o. | 37.5 | MG | 5,72 | |
|
| 232.10 | H02AB07 | prednison (do 10 mg včetně) | p.rect. | 10 | MG | 17,30 | |
|
| 232.11 | H02AB07 | prednison (nad 30 mg) | p.rect. | 10 | MG | 4,59 | |
|
| 232.12 | H02AB07 | prednison (nad 10 do 30 mg včetně) | p.rect. | 10 | MG | 8,16 | |
| 233 | H02AB | glukokortikoidy | parent. | O |
| 233.1 | H02AB | mazipredon | parent. | 30 | MG | 17,79 | O |
| 02125 | DEPERSOLON | inj 3x1ml/30mg | GED | H |
| 233.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.4 | MG | 3,69 | O |
| 89870 | DIPROPHOS | inj 1x1ml | SCH | B |
| 78257 | DIPROPHOS | inj 5x1ml | SCH | F |
| 233.3 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.5 | MG | 24,87 | O |
| 99479 | FORTECORTIN MONO 40(AMPULE) | inj 1x5ml/40mg | MEC | D |
| 233.4 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.5 | MG | 2,54 | O |
| 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY |
| 96108 | DEXONA | inj 6x2ml 4mg/ml | CAD | IND |
| 96109 | DEXONA | inj 8x6x2ml | CAD | IND |
| 01673 | DEXAMED | inj 100x2ml/8mg | MOE | CY |
| 233.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20 | MG | 35,70 | O |
| 09709 | SOLU-MEDROL | inj sic 1x40mg+1ml | UPJ | B |
| 233.6 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20 | MG | 15,25 | O |
|
| 233.7 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20 | MG | 22,11 | O |
| 09711 | SOLU-MEDROL | inj sic 1x500mg+8ml | UPJ | B |
| 233.8 | H02AB06 | prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10 | MG | 17,84 | O |
| 09705 | SOLU-DECORTIN H 50 | inj sic 1x50mg+1ml | MEC | D |
| 233.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10 | MG | 12,51 | O |
| 09707 | SOLU-DECORTIN H 250 | inj sic 1x250mg+2ml | MEC | D |
| 233.10 | H02AB08 | triamcinolon | parent. | 7.5 | MG | 13,64 | O |
| 08006 | KENALOG 10 | inj 1x5ml/50mg | LEX | CZ |
| 02126 | KENALOG 40 | inj 1x5ml/200mg | LEX | CZ |
| 233.11 | H02AB09 | hydrokortison | parent. | 30 | MG | 11,19 | O |
| 06199 | SOLU-CORTEF | inj sic 25x100mg | UPJ | B |
| 00484 | HYDROCORTISON SOLUBILE VUAB | inj 1x100mg | VUA | CZ |
| 234 | H03AA | hormony štítné žlázy | p.o. | |
| 234.1 | H03AA | hormony štítné žlázy | p.o. | 1 | DF | 2,15 | |
| 61161 | JODTHYROX | tbl 100 | MEC | D |
| 61160 | JODTHYROX | tbl 50 | MEC | D |
| 234.2 | H03AA01 | levothyroxin sodný (do 50 RG v 1 tabletě včetně) | p.o. | 0.15 | MG | 1,96 | |
| 47141 | LETROX 50 | tbl 100x50rg | BCE | D |
| 69189 | EUTHYROX 50 | tbl 100x50rg | MEC | D |
| 234.3 | H03AA01 | levothyroxin sodný (nad 50 RG do 100 RG včetně v 1 tabletě) | p.o. | 0.15 | MG | 1,37 | |
| 47144 | LETROX 100 | tbl 100x100rg | BCE | D |
| 97186 | EUTHYROX 100 | tbl 100x100rg | MEC | D |
| 234.4 | H03AA01 | levothyroxin sodný (nad 100 RG v 1 tabletě) | p.o. | 0.15 | MG | 1,12 | |
| 47133 | LETROX 150 | tbl 100x150rg | BCE | D |
| 234.5 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4,40 | |
| 09805 | TERTROXIN | tbl 100x0.02mg | GLA | GB |
| 234.6 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1 | DF | 1,81 | |
| 03875 | THYREOTOM | tbl 60x50rg | BCE | D |
| 234.7 | H03CA | jódová terapie | p.o. | 200 | RG | 1,81 | |
| 61158 | JODID 100 | tbl 100 | MEC | D |
| 61159 | JODID 200 | tbl 100 | MEC | D |
| 235.1 | H03BA02 | propylthiouracil | p.o. | 0.1 | GM | 7,76 | |
| 09577 | PROPYCIL 50 | tbl 100x50mg | KCH | D |
| 09576 | PROPYCIL 50 | tbl 20x50mg | SVP | D |
| 235.2 | H03BB01 | karbimazol | p.o. | 15 | MG | 3,11 | |
| 00066 | CARBIMAZOL SLOVAKOFARMA | tbl 100x5mg | SLO | SK |
| 235.3 | H03BB02 | thiamazol | p.o. | 10 | MG | 2,83 | |
|
| 235.4 | H03BC01 | perchlorát draselný | p.o. | 0.2 | GM | 1,66 | |
| 236 | H03B | thyreostatika | parent. | H |
| 236.1 | H03BB02 | thiamazol | parent. | 10 | MG | 4,50 | H |
| 237 | H04AA | glukagon a jeho deriváty | parent. | L/DIA |
| 237.1 | H04AA01 | glukagon | parent. | 1 | MG | 404,62 | L/DIA |
|
| 237.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1 | MG | 811,39 | L/DIA |
| 83741 | GLUCAGEN 1MG HYPOKIT | inj sic 1mg+strik. | DK |
| 238 | H05BA | kalcitonin | inhal. | L/INT,GYN,ORT,END |
| 238.1 | H05BA01 | kalcitonin (lososí, do 100 U včetně v jedné dávce) | inhal. | 200 | U | 104,13 | L/INT,ORT,END |
| 64662 | TONOCALCIN 100I.U.NOSNÍ SPREJ | spr nas 1x3.5ml | MCI | CZ |
| 238.2 | H05BA01 | kalcitonin (lososí, nad 100 U v jedné dávce) | inhal. | 200 | U | 83,00 | L/INT,ORT,END |
| 10146 | TONOCALCIN 200 I.U.NOSNÍ SPREJ | spr nas 1x3.5ml | MCI | CZ |
| 239 | H05BA | kalcitonin | parent. | L/INT,GYN,ORT,END |
| 239.1 | H05BA01 | kalcitonin (lososí) | parent. | 100 | U | 118,09 | L/INT,ORT,END |
| 89017 | UCECAL 50 I.U. | inj 5x1ml/50ut | UCB | B |
| 239.2 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100 | U | 125,37 | L/INT,ORT, END |
|
| 239.3 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100 | U | 157,39 | L/INT,ORT, END |
| 240 | J01AA | tetracyklinová antibiotika | p.o. | |
| 240.1 | J01AA02 | doxycyklin | p.o. | 0.1 | GM | 4,01 | |
| 90986 | DEOXYMYKOIN | tbl 10x100mg | LEX | CZ |
| 12735 | DOXYHEXAL 200 TABS | tbl 10x200mg | HEX | D |
| 12736 | DOXYHEXAL 200 TABS | tbl 20x200mg | HEX | D |
| 12741 | DOXYHEXAL TABS | tbl 10x100mg | HEX | D |
| 12742 | DOXYHEXAL TABS | tbl 20x100mg | HEX | D |
| 240.2 | J01AA04 | lymecyklin | p.o. | 0.6 | GM | 4,01 | |
| |
| 240.3 | J01AA06 | oxytetracyklin | p.o. | 1 | GM | 4,01 | |
|
| 240.4 | J01AA07 | tetracyklin | p.o. | 1 | GM | 4,01 | |
| |
| 240.5 | J01AA08 | minocyklin | p.o. | 0.2 | GM | 4,01 | |
|
| 240.6 | J01AA52 | doxycyklin v kombinaci s ambroxolem | p.o. | 1 | DF | 7,00 | |
| 241 | J01AA | tetracyklinová antibiotika | parent. | K |
| 241.1 | J01AA02 | doxycyklin | parent. | 0.1 | GM | 94,63 | K |
| 12705 | DOXYHEXAL SF | inj 2x5ml/100mg | HEX | D |
| 12706 | DOXYHEXAL SF | inj 5x5ml/100mg | HEX | D |
| 241.2 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 94,63 | K |
| 242 | J01BA | amfenikolová antibiotika | p.o. | |
| 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 24,73 | |
| 71951 | CHLORAMPHENICOL LECIVA | cps 30x250mg | LEX | CZ |
| 243 | J01BA | amfenikolová antibiotika | parent. | K |
| 243.1 | J01BA01 | chloramfenikol | parent. | 3 | GM | 255,63 | K |
| 97390 | CHLORAMPHENICOL SOLUBILE VUAB | inj sic 1x1gm | VUA | CZ |
| 243.2 | J01BA02 | thiamphenikol | parent. | 1.5 | GM | 176,31 | K |
| 244 | J01CA | aminopenicilinová antibiotika | p.o. | |
| 244.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2 | GM | 14,13 | |
|
| 244.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2 | GM | 17,20 | |
|
| 244.3 | J01CA04 | amoxicilin (pevné lékové formy) do 0,5 GM v 1tabletě včetně | p.o. | 1 | GM | 10,12 | |
| 66368 | OSPAMOX 500MG | tbl obd 12x500mg | BCA | A |
| 66828 | AMOCLEN 250 | cps 30x250mg | LEX | CZ |
| 66829 | AMOCLEN 500 | cps 30x500mg | LEX | CZ |
| 53681 | AMOXICILLIN 250-SLOVAKOFARMA | cps 30x250mg | SLO | SK |
| 53682 | AMOXICILLIN 500-SLOVAKOFARMA | cps 30x500mg | SLO | SK |
| 244.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 GM v 1tabletě | p.o. | 1 | GM | 9,06 | |
| 66370 | OSPAMOX 1000MG | tbl obd 12x1000mg | BCA | A |
| 66369 | OSPAMOX 750MG | tbl obd 12x750mg | BCA | A |
| 44343 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | HCC | D |
| 44333 | AMOXIHEXAL 750 TABS | tbl sol 12x750mg | HHC | D |
| 44334 | AMOXIHEXAL 750 TABS | tbl sol 24x750mg | HHC | D |
| 44335 | AMOXIHEXAL 1000 TABS | tbl sol 12x1000mg | HHC | D |
| 44336 | AMOXIHEXAL 1000 TABS | tbl sol 24x1000mg | HHC | D |
| 244.5 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 GM včetně v 5 mililitrech) | p.o. | 1 | GM | 13,05 | |
| 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL |
| 66366 | OSPAMOX 250MG/5ML | gra sus 1x60ml | BCA | A |
| 66367 | OSPAMOX 375MG/5ML | gra sus 1x60ml | BCA | A |
| 84510 | AMOCLEN 250 | sir sic 1x5gm/100ml | LEX | CZ |
| 244.6 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 GM v 5 mililitrech) | p.o. | 1 | GM | 10,00 | |
|
| 244.7 | J01CA06 | bakampicilin | p.o. | 1.2 | GM | 16,62 | |
| 245 | J01CA | aminopenicilinová antibiotika | parent. | K |
| 245.1 | J01CA01 | ampicilin | parent. | 2 | GM | 27,08 | K |
| 60248 | PENTREXYL | inj sic 50x250mg | BMS | I |
| 246 | J01CA | acylureidová antibiotika | parent. | U/ATB |
| 246.1 | J01CA09 | azlocilin | parent. | 12 | GM | 637,48 | U/ATB |
| 04035 | SECUROPEN | inj sic 5x2gm+20ml | BAY | D |
| 46974 | SECUROPEN 2GM | inj sic 5x2gm | BAY | D |
| 97002 | SECUROPEN | inf 5x5gm | BAY | D |
| 246.2 | J01CA12 | piperacilin | parent. | 14 | GM | 1297,98 | U/ATB |
| 12336 | PIPRAKS | inj sic 1x2gm+10ml | ECZ | TR |
| 246.3 | J01CA13 | tikarcilin | parent. | 15 | GM | 1980,92 | U/ATB |
| 247 | J01CE | na beta-laktamázu citlivé peniciliny | p.o | |
| 247.1 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2 | GM | 19,65 | |
| 45997 | OSPEN 1000 | tbl obd 30x1000ku | BCA | A |
| 45998 | OSPEN 1500 | tbl obd 30x1500ku | BCA | A |
| 49513 | PENBENE | tbl obd 30x1mu | MCK | D |
| 64936 | PENCID 1500 | tbl obd 20x1.5mu | LEX | CZ |
| 64937 | PENCID 1000 | tbl obd 20x1mu | LEX | CZ |
| 65356 | PENBENE | tbl obd 12x1mu | MCK | D |
| 66359 | OSPEN 1000 | tbl obd 12x1000ku | BCA | A |
| 66360 | OSPEN 1500 | tbl obd 12x1500ku | BCA | A |
| 247.2 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2 | GM | 21,02 | |
| 92805 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK |
| 247.3 | J01CE02 | fenoxymethylpenicilin (od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2 | GM | 19,11 | |
| 92806 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-blistr | SLO | SK |
| 247.4 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 14,52 | |
| 56442 | PENCLEN | tbl 30x350mg-blistr | SLO | SK |
| 247.5 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2 | GM | 29,43 | |
| 49549 | OSPEN 400MG | sir 1x150ml | BCA | A |
| 247.6 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2 | GM | 69.99 | |
|
| 247.7 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2 | GM | 26,30 | |
| 248 | J01CE | na beta-laktamázu citlivé peniciliny | parent. | K |
| 248.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.6 | GM | 123,86 | K |
| 01093 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x1mu | BTA | SK |
| 02136 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x500ku | BTA | SK |
| 248.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.6 | GM | 49,32 | K |
| 93405 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x5mu | BTA | SK |
| 248.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2 | MU | 70,63 | K |
|
| 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2 | MU | 32,94 | K |
| 50160 | RETARPEN 2.4 M.U.I. | inj sic 50x2.4mu | BCW | A |
| 248.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2 | MU | 79,58 | K |
|
| 248.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2 | MU | 39,05 | K |
| 01102 | PROKAIN PENICILIN G BIOTIKA | inj 10x1.5mu | BTA | SK |
| 248.7 | J01CE30 | kombinace | parent. | 0.5 | DF | 10,36 | K |
| 02723 | PENDEPON COMPOSITUM | inj 10x1.5mu | BTA | SK |
| 249 | J01CF | vůči beta-laktamáze stabilní peniciliny | p.o. | |
| 249.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
|
| 249.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | |
|
| 249.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
| 02677 | OXACILIN 250 LECIVA | cps 60x250mg | LEX | CZ |
| 76201 | PROSTAPHLIN 500MG | cps 40x500mg | BMS | I |
| 249.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | |
| 250 | J01CF | vůči beta-laktamáze stabilní peniciliny | parent. | K |
| 250.1 | J01CF04 | oxacilin | parent. | 2 | GM | 98,74 | K |
| 92359 | PROSTAPHLIN 1000MG | inj sic 1x1000mg | BMS | I |
| 251 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny | p.o. | |
| 251.1 | J01CR04 | sultamicilin (pevné lékové formy) | p.o. | 1.5 | GM | 83,58 | |
|
| 251.2 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.5 | GM | 80,90 | |
|
| 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 31,80 | |
|
| 251.4 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1 | GM | 28,98 | |
|
| 251.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg v 1 tabletě) | p.o. | 1 | GM | 27,18 | |
| 12494 | AUGMENTIN 1GM | tbl 14x1gm | SKB | GB |
| 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 47,44 | |
| 53567 | CURAM 156.25MG/5ML | plv sus 1x100ml | BCA | A |
| 251.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 31,12 | |
| 84792 | AUGMENTIN DUO | plv sus 1x70ml | SKW | GB |
| 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | U/ATB |
| 252.1 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 2 | GM | 162,17 | U/ATB |
|
| 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 109,88 | U/ATB |
| 97660 | AUGMENTIN 1,2GM | inj sic 5x1.2gm | LEX | CZ |
| 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1820,84 | U/ATB |
|
| 252.4 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14 | GM | 1980,92 | U/ATB |
|
| 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 71,80 | U |
|
| 252.6 | J01DA | cefoperazon a inhibitor beta-laktamázy | parent. | 2 | GM | 397,00 | U/ATB |
| 253 | J01DA | cefalosporinová antibiotika | p.o. | |
| 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 38,13 | |
| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A |
| 06158 | ORACEF | cps 16x500mg | KRK | SLO |
| 66356 | OSPEXIN 500MG | tbl obd 12x500mg | BCA | A |
| 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 44,33 | |
| 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A |
| 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A |
| 253.3 | J01DA06 | cefuroxim axetil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | |
| 76366 | ZINNAT | tbl fc 10x125mg | GLA | I |
| 76367 | ZINNAT | tbl fc 10x250mg | GLA | I |
| 76368 | ZINNAT | tbl fc 10x500mg | GLA | I |
| 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| 96016 | ZINNAT | gra sus 1x50ml | GLA | GB |
| 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 72,88 | |
| 53153 | VERCEF 250 MG | cps 7x3 (blistr) | RXY | IND |
| 69474 | CECLOR RETARD 375MG | tbl obd 10x375mg | LIL | I |
| 253.6 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.5 | GM | 66,03 | |
| 53157 | VERCEF 500 MG | cps 7x3 (blistr) | RXY | IND |
| 69475 | CECLOR RETARD 750MG | tbl obd 10x750mg | LIL | I |
| 45193 | CEC 500 | tbl obd 10x500mg | SFS | D |
| 45194 | CEC 500 | tbl obd 20x500mg | SFS | D |
| 253.7 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.5 | GM | 103,11 | |
| 45195 | CEC SIRUP | plv sus 100ml/2.5gm | SFS | D |
| 253.8 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 86,27 | |
| 53152 | VERCEF250 MG/5ML | plv sus 1x100 ml | RXY | IND |
| 45196 | CEC FORTE SIRUP | plv sus 100ml/5gm | SFS | D |
| 253.9 | J01DA09 | cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 44,00 | |
| 44802 | BIODROXIL | tbl obd 12x1000mg | BCA | A |
| 44799 | BIODROXIL | cps 12x500mg | BCA | A |
| 46752 | CEFADROX TABS | tbl sol 10x1000mg | SFS | D |
| 46753 | CEFADROX TABS | tbl sol 20x1000mg | SFS | D |
| 253.10 | J01DA09 | cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 68,00 | |
| 44807 | BIODROXIL 250MG/5ML | plv sus 1x60ml/3gm | BCA | A |
| 253.11 | J01DA23 | cefixim | p.o. | 0.4 | GM | 107,35 | ATB |
|
| 253.12 | J01DA26 | cefetamet | p.o. | 1 | GM | 107,53 | ATB |
|
| 253.13 | J01DA33 | cefpodoxim | p.o. | 0.4 | GM | 92,35 | ATB |
|
| 253.14 | J01DA39 | ceftibuten | p.o. | 0.4 | GM | 92,35 | ATB |
|
| 253.15 | J01DA41 | cefprozil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | |
|
| 253.16 | J01DA41 | cefprozil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| 254 | J01DA | cefalosporinová antibiotika | parent. | U/ATB P |
Treatment with ceftriaxone in outpatient care is performed by a neurologist, an infectionist, a dermatologist, a pediatrician or a rheumatist:
(a) the oral treatment of bacterial meningitis in children under 18 years of age;
(b) treatment for Lyme disease stage II and III (documented by laboratory examination),
(c) treatment of uncomplicated acute gonorrhea (single intravenous administration of 250 mg ceftriaxone).
| 254.1 | J01DA03 | cefalotin | parent. | 4 | GM | 188,18 | U |
| 85512 | CEFALOTIN BIOTIKA | inj sic 50x1gm | BTA | SK |
| 254.2 | J01DA04 | cefazolin | parent. | 3 | GM | 162,06 | U |
| 02205 | CEFAZOLINE PANPHARMA | inj sic 25x1gm | LPA | F |
| 58092 | CEFAZOLIN BIOCHEMIE 1GM | inj sic 10x1gm | BCA | A |
| 83111 | ORIZOLIN | inj sic 1x1000mg | CAD | IND |
| 84018 | CEFAZOLINE PANPHARMA | inj sic 50x1gm | LPA | F |
| 85510 | VULMIZOLIN | inj sic 50x1gm | BTA | SK |
| 91148 | VULMIZOLIN | inj sic 10x1gm | BTA | SK |
| 254.3 | J01DA05 | cefoxitin | parent. | 6 | GM | 937,79 | U/ATB |
|
| 254.4 | J01DA06 | cefuroxim | parent. | 4 | GM | 497,69 | U/ATB |
| 76360 | ZINACEF AD INJ. | inj sic 1x1.5gm | GLA | I |
| 77044 | ZINACEF AD INJ. | inj sic 1x750mg | GLA | I |
| 83042 | ZINACEF AD INJ. | inj sic 1x750mg+6ml | GLA | I |
| 254.5 | J01DA07 | cefamandol | parent. | 6 | GM | 615,68 | U/ATB |
|
| 254.6 | J01DA10 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6 | GM | 663,29 | U/ATB |
| 94176 | CEFOTAXIME | inj 1x1gm | LEK | SLO |
| 254.7 | J01DA10 | cefotaxim nad 1 g v jedné ampuli | parent. | 6 | GM | 593,68 | U/ATB |
| 94177 | CEFOTAXIME | inj 1x2gm | LEK | SLO |
| 254.8 | J01DA11 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6 | GM | 1736,18 | U/ATB |
| 76355 | FORTUM | inj 1x500mg | GLA | I |
| 83038 | FORTUM | inj 1x500mg+5ml sol | GLA | I |
| 254.9 | J01DA11 | ceftazidim nad 500 mg v jedné ampuli | parent. | 6 | GM | 1739,99 | U/ATB |
| 76353 | FORTUM | inj 1x1gm | GLA | I |
| 83039 | FORTUM | inj 1x1gm+10ml solv | GLA | I |
| 76354 | FORTUM | inj 1x2gm | GLA | I |
| 254.10 | J01DA12 | cefsulodin | parent. | 6 | GM | 615,68 | U/ATB |
|
| 254.11 | J01DA13 | ceftriaxon | parent. | 2 | GM | 654,12 | ambulantně: K/P ústavně: U/ATB |
| 80662 | LENDACIN 1GM | inj sic 5x1gm | LEK | SLO |
| 80663 | LENDACIN 250MG | inj sic 5x250mg | LEK | SLO |
| 87769 | ROCEPHIN ROCHE I.V. STERIL.PLV | inj sic 5x1gm+10ml | HLR | CH |
| 87774 | ROCEPHIN ROCHE I.M. STERIL.PLV | inj sic 5x1gm+3.5ml | HLR | CH |
| 254.12 | J01DA22 | ceftizoxim | parent. | 4 | GM | 615,68 | U/ATB |
| |
| 254.13 | J01DA30 | cefapirin | parent. | 4 | GM | 194,73 | U |
| |
| 254.14 | J01DA32 | cefoperazon | parent. | 6 | GM | 1526,24 | U/ATB |
| |
| 254.15 | J01DA37 | cefpirom | parent. | 4 | GM | 1679,48 | U/ATB |
| 86598 | CEFROM 2GM | inj sic 1x2gm | ROU | F |
| 254.16 | J01DA24 | cefepim | parent. | 4 | GM | 1605,91 | U/ATB |
| 255 | J01DF | monobaktámová antibiotika | parent. | U/ATB |
| 255.1 | J01DF01 | aztreonam | parent. | 4 | GM | 1670,80 | U/ATB |
| 86412 | AZACTAM | inj sic 1x1gm | BMS | I |
| 256 | J01DH | karbapenemová antibiotika | parent | U/ATB |
| 256.1 | J01DH02 | meropenem | parent. | 2 | GM | 2259,20 | U/ATB |
| 83488 | MERONEM 500MG I.M. | inj sic 1x500mg+sol | ZNC | GB |
| 256.2 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2 | GM | 2258,99 | U/ATB |
| 257 | J01EB | krátkodobě působící sulfonamidy | p.o. | |
| 257.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.4 | GM | 12,32 | |
| 89812 | TRIPRIM 100MG | tbl 10x100mg | MCK | D |
| 89813 | TRIPRIM 100MG | tbl 20x100mg | MCK | D |
| 257.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.4 | GM | 9,29 | |
| 89815 | TRIPRIM 200MG | tbl 10x200mg | MCK | D |
| 89816 | TRIPRIM 200MG | tbl 20x200mg | MCK | D |
| 257.3 | J01EB05 | sulfafurazol | p.o. | 4 | GM | 13,64 | |
| 258 | J01EE | sulfonamidy kombinované s trimetoprimem | p.o. | |
| 258.1 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 17,06 | |
|
| 258.2 | J01EE01 | Sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6,84 | |
| 97868 | ORIPRIM | tbl 2x10x480mg | CAD | IND |
| 87758 | ORIPRIM | tbl 10x10x480mg | CAD | IND |
| 75023 | COTRIMOXAZOL AL FORTE | tbl 20x960mg | APA | D |
| 258.3 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22,39 | |
| 97867 | ORIPRIM PRO INFANT. | sus 100ml 240mg/5ml | CAD | IND |
| 91291 | SUMETROLIM | sir 100ml 240mg/5ml | EGI | H |
| 258.4 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
|
| 258.5 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | |
|
| 258.6 | J01EE04 | sulfamonoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
|
| 258.7 | J01EE04 | sulfamonoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | |
|
| 258.8 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
| 259 | J01EE | sulfonamidy kombinované s trimetoprimem | parent. | K |
| 259.1 | J01EE01 | Sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 129,00 | K |
| 91281 | PRIMOTREN I.V. | inj 10x5ml | LEK | SLO |
| 260 | J01FA | makrolidová antibiotika | p.o. | |
| 260.1 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1 | GM | 20,09 | |
|
| 260.2 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1 | GM | 47,31 | |
| 97507 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x60ml | MCK | D |
| 55585 | MEROMYCIN 200MG/5ML | plv sus 1x100ml | MCK | D |
| 97508 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x100ml | MCK | D |
| 55584 | MEROMYCIN 200MG/5ML | plv sus 1x60ml | MCK | D |
| 260.3 | J01FA02 | spiramycin | p.o. | 3 | GM | 48,42 | |
|
| 260.4 | J01FA05 | oleandomycin | p.o. | 1 | GM | 15,36 | |
|
| 260.5 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 43,77 | |
|
| 260.6 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 37,84 | |
|
| 260.7 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2 | GM | 34,05 | |
|
| 260.8 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1 | GM | 42,58 | |
|
| 260.9 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.5 | GM | 48,40 | |
|
| 260.10 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.5 | GM | 70,00 | |
|
| 260.11 | J01FA10 | azithromycin (pevné lékové formy do 125 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 63,77 | |
|
| 260.12 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.25 | GM | 86,60 | |
|
| 260.13 | J01FA13 | dirythromycin | p.o. | 0.5 | GM | 48,42 | |
|
| 260.14 | J01FA10 | azithromycin (pevné lékové formy nad 125 mg v 1 tabletě nebo tobolce) | p.o. | 0.25 | GM | 63,27 | |
|
| 260.15 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5 | DF | 32,16 | |
| 261 | J01FA | makrolidová antibiotika | parent. | K |
| 261.1 | J01FA01 | erythromycin | parent. | 1 | GM | 717,50 | K |
| 88108 | ERYTHROCIN I.V. | inj 1x300mg | ABB | GB |
| 261.2 | J01FA02 | spiramycin | parent. | 4,5 | MU | 663,67 | K |
| 78174 | ROVAMYCINE 1.5MU | inj sic 1x1.5mu | SPC | F |
| 261.3 | J01FA09 | klaritromycin | parent. | 1 | GM | 861,00 | K |
| 262 | J01FF | linkosamidová antibiotika | p.o. | ATB |
| 262.1 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.2 | GM | 55,46 | |
| 03365 | DALACIN C | cps 16x150mg | UPJ | B |
| 83458 | DALACIN C | cps 16x300mg | UPJ | B |
| 262.2 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.2 | GM | 136,53 | |
|
| 262.3 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.8 | GM | 29,08 | ATB |
|
| 262.4 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.8 | GM | 160,62 | ATB |
| 263 | J01FF | linkosamidová antibiotika | parent. | U/ATB |
| 263.1 | J01FF01 | klindamycin (do 0,3 GM včetně v jedné ampuli) | parent. | 1.8 | GM | 598,67 | U/ATB |
|
| 263.2 | J01FF01 | klindamycin (nad 0,3 GM v jedné ampuli) | parent. | 1.8 | GM | 548,92 | U/ATB |
|
| 263.3 | J01FF02 | linkomycin | parent. | 1.8 | GM | 49,17 | U/ATB |
| 83593 | MEDOGLYCIN 600MG | inj 100x2ml/600mg | MOE | CY |
| 67029 | MEDOGLYCIN 600MG | inj 10x2ml/600mg | MOE | CY |
| 264 | J01GA | streptomycin a jeho deriváty | parent. | |
| 264.1 | J01GA01 | streptomycin | parent. | 1 | GM | 119,10 | |
| 59732 | STREPTOMYCIN GRUNENTHAL 1.0 G | inj sic 1x1gm+solv. | GRU | D |
| 265 | J01GB | aminoglykosidová antibiotika | parent. | U/ATB |
| 265.1 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 43,84 | U |
|
| 265.2 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,02 | U |
|
| 265.3 | J01GB03 | gentamicin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 45,18 | U |
| 96413 | GENTAMICIN 40MG LEK | inj 10x2ml/40mg | LEK | SLO |
| 265.4 | J01GB03 | gentamicin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,61 | U |
| 96414 | GENTAMICIN 80MG LEK | inj 10x2ml/80mg | LEK | SLO |
| 265.5 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130 | MG | 2411,98 | U/ATB |
|
| 265.6 | J01GB03 | gentamicin (lékové formy kuliček k impiantaci) | imp. | 1 | DF | 152,06 | U/ATB |
| |
| 265.7 | J01GB05 | neomycin | parent. | 1 | GM | 122,34 | U/ATB |
| |
| 265.8 | J01GB06 | amikacin (do 100 mg v jedné ampuli včetně) | parent. | 1 | GM | 741,01 | U/ATB |
| 12334 | AMIKOZIT 100MG | inj 1x2ml | ECZ | TR |
| 265.9 | J01GB06 | amikacin (nad 100 mg v jedné ampuli) | parent. | 1 | GM | 398,66 | U/ATB |
| 12335 | AMIKOZIT 500MG | inj 1x2ml | ECZ | TR |
| 265.10 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 519,93 | U/ATB |
|
| 265.11 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 304,57 | U/ATB |
| |
| 265.12 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1 | GM | 516,90 | U/ATB |
| |
| 265.13 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1 | GM | 620,27 | U/ATB |
| 266 | J01MA | fluorované chinolony | p.o. | |
For the treatment of sparfloxacin and trovafloxacin, consultation and approval of an antibiotic centre are required.
| 266.1 | J01MA01 | ofloxacin | p.o. | 0.4 | GM | 29,33 | |
| 54391 | TAROFLOX 200 | tbl obd 10x200mg | HBS | SK |
| 55636 | OFLOXIN 200 | tbl obd 10x200mg | LEX | CZ |
| 266.2 | J01MA02 | ciprofloxacin | p.o. | 1 | GM | 29,33 | |
| 44985 | CIPLOX 500 | tbl obd 10x500mg | CIA | IND |
| 44986 | CIPLOX 500 | tbl obd 50x500mg | CIA | IND |
| 44988 | CIPLOX 250 | tbl obd 10x250mg | CIA | IND |
| 44989 | CIPLOX 250 | tbl obd 50x250mg | CIA | IND |
| 53201 | CIPHIN 250 | tbl obd 10x250mg | SLO | SK |
| 53202 | CIPHIN 500 | tbl obd 10x500mg | SLO | SK |
| 53203 | CIPHIN 750 | tbl obd 10x750mg | SLO | SK |
| 53715 | CIFLOXINAL | tbl obd 200x250mg | PMP | CZ |
| 64698 | QUINTOR 250MG | tbl obd 10x250mg | TRT | IND |
| 64699 | QUINTOR 500MG | tbl obd 10x500mg | TRT | IND |
| 69195 | CIPROBID 250 | tbl obd 10x250mg | CAI | IND |
| 69196 | CIPROBID 500 | tbl obd 10x500mg | CAI | IND |
| 80539 | QUINTOR 250MG | tbl obd 50x250mg | TRT | IND |
| 80540 | QUINTOR 500MG | tbl obd 20x500mg | TRT | IND |
| 87104 | CIFLOXINAL | tbl obd 10x250mg | PMP | CZ |
| 87105 | CIFLOXINAL | tbl obd 20x250mg | PMP | CZ |
| 94453 | CIPRINOL 250 | tbl obd 10x250mg | KRK | SLO |
| 96039 | CIPRINOL 500 | tbl obd 10x500mg | KRK | SLO |
| 266.3 | J01MA03 | pefloxacin | p.o. | 0.8 | GM | 29,33 | |
| 94156 | ABAKTAL | tbl obd 10x400mg | LEK | SLO |
| 266.4 | J01MA04 | enoxacin | p.o. | 0.8 | GM | 22,48 | |
|
| 266.5 | J01MA06 | norfloxacin | p.o. | 0.8 | GM | 22,48 | |
| 44087 | GYRABLOCK 400 | tbl obd 30x400mg | MOE | CY |
| 44089 | GYRABLOCK 400 | tbl obd 100x400mg | MOE | CY |
| 44090 | GYRABLOCK 400 | tbl obd 500x400mg | MOE | CY |
| 44091 | GYRABLOCK 400 | tbl obd 1000x400mg | MOE | CY |
| 67015 | GYRABLOCK 400 | tbl obd 14x400mg | MOE | CY |
| 93465 | NOLICIN | tbl 20x400mg | KRK | SLO |
| 266.6 | J01MA07 | lomefloxacin | p.o. | 0.8 | GM | 29,33 | |
|
| 266.7 | J01MA08 | fleroxacin | p.o. | 0.4 | GM | 29,33 | |
|
| 266.8 | J01MA09 | sparfloxacin | p.o. | 0.2 | GM | 29,33 | P |
|
| 266.9 | J01MA | trovafloxacin | p.o. | 0,2 | GM | 29,33 | P |
|
| 266.10 | J01MB05 | kyselina oxolinová | p.o. | 1 | GM | 8,55 | |
| 9101 | DESUROL | tbl. 50 x 2502 mg | LEX | CZ |
| 267 | J01MA | fluorované chinolony | parent. | U/ATB |
| 267.1 | J01MA01 | ofloxacin | parent. | 0.4 | GM | 212,23 | U/ATB |
| 66137 | OFLOXIN INF | inf 1x100ml/200mg | LEX | CZ |
| 267.2 | J01MA02 | ciprofloxacin - infúze | parent. | 0.5 | GM | 212,23 | U/ATB |
|
| 267.3 | J01MA02 | ciprofloxacin - injekce | parent. | 0.5 | GM | 190,00 | U/ATB |
| 96040 | CIPRINOL | inj 5x10ml/100mg | KRK | SLO |
| 267.4 | J01MA03 | pefloxacin | parent. | 0.8 | GM | 93,26 | U/ATB |
|
| 267.5 | J01MA08 | fleroxacin | parent. | 0.4 | GM | 212,23 | U/ATB |
|
| 267.6 | J01MA | trovafloxacin | parent. | 0,2 | GM | 212,23 | U/ATB |
| 268 | J01XA | ostatní antibiotika | parent. | U/ATB |
| 268.1 | J01XA01 | vankomycin | parent. | 2 | GM | 1375,38 | U/ATB |
| 92289 | EDICIN 0.5GM | inj.sicc.1x500mg | LEK | SLO |
| 92290 | EDICIN 1GM | inj.sicc.1x1gm | LEK | SLO |
| 268.2 | J01XA02 | teikoplanin | parent. | 0.4 | GM | 2492,83 | U/ATB |
|
| 268.3 | J01XB01 | kolistin | parent. | 3 | MU | 116,92 | U/ATB |
| 61178 | COLIMYCINE | inj sic 50x1mu | RBE | F |
| 268.4 | J01XB02 | polymyxin | parent. | 0.15 | GM | 103,09 | U/ATB |
|
| 268.5 | J01XX | quinupristin v kombinaci s dalfopristinem | parent | 1 | DF | 2492,00 | U/ATB |
| 54311 | SYNERCID | inf sic 1x150/350mg | AVT | E |
| 269 | J01XB | polymyxinová antibiotika | p.o. | U/ATB |
| 269.1 | J01XB01 | kolistin | p.o. | 3 | MU | 42,82 | U/ATB |
| 86794 | COLIMYCINE | tbl 50x1.5mu | RRO | F |
| 270 | J01XD | imidazolová chemoterapeutika | parent. | U |
| 270.1 | J01XD01 | metronidazol | parent. | 1.5 | GM | 176,89 | U |
| |
| 270.2 | J01XD03 | ornidazol | parent. | 1 | GM | 50,44 | U |
| 96404 | AVRAZOR | inj 5x3ml/500mg | LEX | CZ |
| 270.3 | J01XE01 | nitrofurantoin | p.o. | 0.2 | GM | 2,58 | |
| 271 | J02AA | antimykotická antibiotika | parent. | U |
| 271.1 | J02AA01 | amfotericin | parent. | 35 | MG | 285,31 | U |
| 57548 | AMPHOTERICIN B SQUIBB | inj sic 1x50mg | BMJ | F |
| 271.2 | J02AA01 | amfotericin na tukových nosičích | parent. | 35 | MG | 1597,70 | U/ATB |
| 272 | J02AB | imidazolová antimykotika | p.o. | |
| 272.1 | J02AB02 | ketokonazol | p.o. | 0.2 | GM | 27,37 | |
| 91739 | ORONAZOL | tbl 20x200mg | KRK | SLO |
| 273 | J02AB | imidazolová antimykotika | parent. | U |
| 273.1 | J02AB01 | mikonazol | parent. | 1 | GM | 469,63 | U |
| 274 | J02AC | triazolová antimykotika | p.o. | P |
1. A short-term treatment is performed by a gynaecologist or dermatologist based on culture or microscopic examination:
a) vaginal mycosis not responding to locally administered antifungals
(b) recurrence of vaginal mycosis
2. Multiday treatment is performed by an infectious, haematologist, oncologist, transplant unit specialist or dermatologist:
a) systemic mycosis in immunocompromised patients
(b) severe forms of mucosal and skin mycoses caused by candidates or dermatophytes based on culture or microscopic examination
(c) severe forms of nail mycosis (itraconazole) if at least one of the following conditions applies:
• Disability of the whole nail plate
• Disability of at least four nail plates so that each of them has a disability that affects more than 30% for the free edge of the nail in a proximal direction
• thumbnail involvement of the lower limb
A positive microscopic finding and mycological culture sampling are a condition for initiating treatment ad c).
(d) prophylactic in immunocompromised patients or pre-transplant patients
e) itraconazole liquid formulations - treatment of oral and oesophageal candidiasis and prophylaxis in immunocompromised patients
| 274.1 | J02AC01 | flukonazol ( pevné lékové formy 150 mg v 1 tabletě ) | p.o. | 0.15 | GM | 203,85 | P |
| 59875 | MYCOCYST 150MG | cps 1x150mg | GED | H |
| 274.2 | J02AC01 | flukonazol - ostatní pevné lékové formy jiné než 150 mg v jedné tabletě | p.o. | 0.2 | GM | 262,18 | P |
| 55396 | FLUCONAZOL 50-SLOVAKOFARMA | cps 7x50mg | SLO | SK |
| 55397 | FLUCONAZOL 50-SLOVAKOFARMA | cps 14x50mg | SLO | SK |
| 66032 | MYCOMAX 50 | cps 7x50mg | LEX | CZ |
| 66036 | MYCOMAX 100 | cps 28x100mg | LEX | CZ |
| 66037 | MYCOMAX 100 | cps 7x100mg | LEX | CZ |
| 274.3 | J02AC01 | flukonazol - tekuté lékové formy nad 100 mg v 5 ml sirupu | p.o. | 0.2 | GM | 349,25 | P |
|
| 274.4 | J02AC01 | flukonazol (do 50 mg v 5 ml sirupu včetně) | p.o. | 0.2 | GM | 479,01 | P |
|
| 274.5 | J02AC01 | flukonazol (nad 50 do 100mg v 5 ml sirupu včetně) | p.o. | 0.2 | GM | 436,59 | P |
|
| 274.6 | J02AC02 | itrakonazol (pevné lékové formy do 400 mg včetně v jednom balení) | p.o. | 0.2 | GM | 101,93 | P |
|
| 274.7 | J02AC02 | itrakonazol (pevné lékové formy) nad 400 mg v jednom balení | p.o. | 0.2 | GM | 128,00 | P |
| 94897 | SPORANOX | cps 15x100mg | JAN | B |
| 274.8 | J02AX01 | flucytosin | p.o. | 10 | GM | 858,22 | P |
|
| 274.9 | J02AC02 | itrakonazol (tekuté lékové formy) | p.o. | 0.2 | GM | 402,81 | P |
| 56067 | SPORANOX | sol 1x150ml/1.5gm | JAN |
| 275 | J02AC | triazolová antimykotika | parent. | U/P |
Therapeutic: severe, life-threatening systemic mycosis.
Prophylactic: in immunocompressed or transplant patients.
| 275.1 | J02AC01 | flukonazol | parent. | 0.2 | GM | 904,23 | U/P |
| 46979 | FLUCONAZOL-SLOVAKOFARMA PRO INF | inf 1x100ml/200mg | SLO | SK |
| 65989 | MYCOMAX INF. | inf 1x100ml/200mg | LEX | CZ |
| 275.2 | J02AX01 | flucytosin | parent. | 10 | GM | 2710,83 | U/P |
| 276 | J04AB | antibiotika k léčbě tuberkulózy | p.o. | |
Treatment with rifabutin is performed by a pneumologist or infectionist: treatment of tuberculosis caused by atypical mycobacteria.
| 276.1 | J04AB02 | rifampicin | p.o. | 0.6 | GM | 12,76 | |
| 96735 | ARFICIN | cps 100x150mg | BLU | CHO |
| 96780 | ARFICIN | cps 100x300mg | BLU | CHO |
| 276.2 | J04AB04 | rifabutin | p.o. | 0.15 | GM | 125,72 | P |
| 277 | J04AB | antibiotika k léčbě tuberkulózy | parent | |
| 277.1 | J04AB03 | rifamycin | parent. | 0.6 | GM | 244,40 | |
|
| 277.2 | J04AB30 | kapreomycin | parent. | 1 | GM | 553,11 | |
| 278 | J04AC | hydrazidy k léčbě tuberkulózy | p.o. | |
| 278.1 | J04AC01 | isoniazid | p.o. | 0.3 | GM | 2,00 | |
| 03303 | NIDRAZID | tbl 250x100mg | LEX | CZ |
| 279 | J04AK | další léčiva k léčbě tuberkulózy | p.o. | |
| 279.1 | J04AK01 | pyrazinamid | p.o. | 1.5 | GM | 14,85 | |
| 75508 | TISAMID | tbl 100x500mg | ORN | SF |
| 279.2 | J04AK02 | ethambutol | p.o. | 1.2 | GM | 12,42 | |
| 03023 | SURAL | tbl 100x400mg | CHN | H |
| 280 | J04BA | chemoterapeutika k léčbě lepry | p.o. | |
| 280.1 | J04BA02 | dapson | p.o. | 50 | MG | 1,37 | |
| 93821 | DISULONE 100 AU PROTOXAL.DE FER | tbl 100x100mg | SPC | F |
Treatment with brivudine, aciclovir, famcyclovir and valaciclovir is performed by an infectionist, oncologist, hematologist, gynecologist, dermatologist, clinical immunologist, neurologist and transplant specialist:
(a) treatment of the initial phase of herpes genitalis in pregnant women after 20 weeks of pregnancy,
(b) treatment of herpes zoster and herpes genitalis in immunocompromised patients (in cytostatic therapy, immunosuppressive therapy, corticosteroid treatment, or in subjects with evidence of immunodeficiency, and in atopic patients, respectively),
c) treatment of herpes zoster at facial location,
(d) prophylaxis after allogeneic bone marrow transplantation.
Treatment of aciclovir in patients with herpes zoster in facial localisation is indicated by the treating physician also by the adult physician and by the practitioner for children and adolescents.
Treatment with inosine pranobex is performed by an allergologist or an immunologist in patients with established immune impairment.
Treatment with antiretroviral agents (zidovudine, didanosine, zalcitabine, saquinavir, ritonavir, indavir, stavudine, efavirenz, nevirapine, nelfinavir, lamivudine, and abacavir) is indicated by an AIDS centre infectious agent.
Treatment with lamivudine is further indicated by the treating physician in chronic viral hepatitis B.
Treatment with ganciclovir is performed by an infectious, oncologist, hematologist and transplant centre specialist:
(a) treatment and secondary prophylaxis of severe CMV infections in HIV / AIDS patients;
(b) prophylaxis and treatment of CMV infections in patients with allogeneic and autologous bone marrow transplantation;
(c) prophylaxis and treatment of CMV infections in patients with organ transplantation.
| 281.1 | J05AB | brivudin | p.o. | 0.5 | GM | 458,88 | P |
|
| 281.2 | J05AB01 | acyklovir do 200 mg včetně | p.o. | 4 | GM | 330,00 | P |
| 54031 | PROVIRSAN | tbl 30x200mg | PMP | CZ |
| 88303 | ZOVIRAX | tbl 25x200mg | BWE | GB |
| 281.3 | J05AB01 | acyklovir nad 200 mg | p.o. | 4 | GM | 265,00 | P |
| 54216 | RANVIR 400 | tbl 25x400mg | RXG | IND |
| 67323 | ZOVIRAX | tbl 35x800mg | BWE | GB |
| 96448 | ZOVIRAX | tbl 70x400mg | BWE | GB |
| 281.4 | J05AB04 | ribavirin | p.o. | 1200 | MG | 877,00 | H |
|
| 281.5 | J05AB06 | gancyklovir | p.o. | 3 | GM | 2002,96 | P |
| 53102 | CYMEVENE 250MG | cps 84x250mg | SYN | POR |
| 281.6 | J05AB09 | famcyklovir | p.o. | 0.75 | GM | 458,88 | P |
|
| 281.7 | J05AB11 | valacyklovir | p.o. | 3 | GM | 440,00 | P |
| 53075 | VALTREX | tbl obd 10x500mg | BWE | GB |
| 87205 | VALTREX | tbl obd 42x500mg | BWE | GB |
| 281.8 | J05AE01 | saquinavir | p.o. | 1,8 | GM | 504,14 | P |
| 55688 | INVIRASE | cps 270x200mg | HLR | CH |
| 281.9 | J05AE02 | indinavir | p.o. | 2,4 | GM | 504,14 | P |
|
| 281.10 | J05AE03 | ritonavir | p.o. | 1,2 | GM | 504,14 | P |
|
| 281.11 | J05AE04 | nelfinavir | p.o. | 2,25 | GM | 504,14 | P |
|
| 281.12 | J05AF01 | zidovudin | p.o. | 1.5 | GM | 685,28 | P |
|
| 281.13 | J05AF02 | didanosin | p.o. | 0.4 | GM | 236,43 | P |
|
| 281.14 | J05AF03 | zalcitabin | p.o. | 2.25 | MG | 241,76 | P |
| 66734 | HIVID 0.75MG | tbl obd 100x0.75mg | HLR | CH |
| 281.15 | J05AF04 | stavudin | p.o. | 80 | MG | 302,07 | P |
| 53210 | ZERIT 40MG | cps 60x40mg | BMS | F |
| 53209 | ZERIT 40MG | cps 56x40mg | BMS | F |
| 281.16 | J05AF05 | lamivudin do 100 mg v jedné tabletě včetně respektive do 5 mg v jednom mililitru včetně | p.o. | 0,3 | GM | 327,60 | P |
| 02086 | ZEFFIX 100 MG | tbl obd 84x100mg | GOW | GB |
| 02085 | ZEFFIX 100 MG | tbl obd 28x100mg | GOW | GB |
| 281.17 | J05AF05 | lamivudin nad 100 mg v jedné tabletě respektive nad 5 mg v jednom mililitru | p.o. | 0,3 | GM | 248,01 | P |
|
| 281.18 | J05AF06 | abacavir | p.o. | 600 | MG | 360,00 | P |
|
| 281.19 | J05AF30 | kombinace antiretrovirových virostatik | p.o. | 2 | DF | 522,13 | P |
| 281.20 | J05AG01 | nevirapin | p.o. | 0,4 | GM | 353,49 | P |
| 57777 | VIRAMUNE | tbl 60x200mg | UUI | P |
| 281.21 | J05AG03 | efavirenz | p.o. | 0,6 | GM | 431,00 | P |
|
| 281.22 | J05AH01 | zanamivir | inhal. | 20 | MG | 130,00 | P |
| 59862 | RELENZA | inh plv 5x20mg/4dav | GWE | F |
Zanamivir is indicated for the treatment of influenza A and B in patients who have not been vaccinated against influenza or where vaccination has failed for reasons of contraindication, in the following patient groups:
1. children over 12 years of age with cystic fibrosis, children with cancer for immunosuppressive treatment
2. Adults with severe chronic lung or cardiac disease on permanent medication
3. Patients with severe immunodeficiency where an antibody response is unlikely after vaccination.
One package for five-day treatment is covered by public health insurance for one therapeutic cortex. Zanamivir is administered by the treating physician only at the time of the influenza epidemic declared by the chief hygienist.
| 281.23 | J05AX05 | inosin pranobex | p.o. | 1 | GM | 30,55 | P |
| 88174 | ISOPRINOSINE | tbl 5x10(=50)x500mg | EWO | CH |
| 282 | J05AB | antivirotika ze skupiny nukloeosidů | parent. | U/P |
Comments 0